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Remodelling of keratin cytoskeletal network is essential for cells to respond to 
environmental cues upon wounding. To understand the stress/wound response, 
immortalized keratinocytes were used which expressed a keratin mutation mimicking 
severe EBS Dowling-Meara (a skin fragility disorder), fluorescently tagged for live-
cell imaging. 
All keratinocytes are “activated” to a stress state through up-regulation of kinases and 
wound response proteins, but revert to quiescence after confluence. In mutant cells, 
“activation” is reflected by the presence of keratin aggregates, a hallmark of severe 
EBS-DM. These keratin aggregates accumulate at the leading edge of the cell; they 
are highly dynamic and constantly undergo remodelling. It has been proposed that 
avoiding aggregate formation may improve the disease phenotype. When mutant 
keratinocytes were grown to confluence in a monolayer, a reduction of peripheral 
aggregates was observed, accompanied by a decrease in wound response proteins 
such as β1 integrin and fibronectin. However, upon scratch wounding, these mutant 
keratinocytes migrated faster and have higher induction of wound response proteins 
such as K17 than wild-type keratinocytes, highlighting their “pre-stressed” state of 
activation. 
Epidermal growth factor (EGF) is a major signalling molecule in wound healing and 
thus the EGF signalling pathway was examined for a role in regulating keratin 
remodelling. EGF-treated wild-type keratinocytes have an increased keratin 14 
synthesis and solubility but not mutant keratinocytes. When mutant keratinocytes 
were cultured in media without EGF, a reduction of peripheral keratin aggregates was 
observed, accompanied by a change in desmoplakin localization, both of which were 
xi 
 
reversed upon re-stimulation with EGF. This EGF-mediated effect appears to be 
associated with the cytoskeletal linker protein, plectin. Inactivation of ERK1/2 kinases 
downstream in the pathway, by both inhibitor treatment and siRNA knockdown, 
resulted in fewer mutant keratinocytes with peripheral aggregates, accompanied by a 
decrease in plectin levels. Fluorescence live-cell imaging was used to confirm the 
relationship between ERK1/2 activation, keratin aggregate status and cell migration in 
mutant keratinocytes. Conversely, plectin knockdown reduced the number of mutant 
keratinocytes with peripheral aggregates and slowed down cell migration in scratch 
wound assays. Understanding the link between keratin remodelling and the EGF 
pathway may identify intervention points for new therapies.  
Keratin remodelling is believed to be driven by phosphorylation/dephosphorylation 
cycles. Examination of the mutation sequence most commonly causing EBS Dowling-
Meara suggested a possible interference of the mutation with a nearby 
phosphorylation site. Phospho-mimetic and phospho-null constructs were therefore 
made for involved serine and tyrosine residues to investigate this possibility. 
Phospho-mimetic constructs mimicking phosphorylation at K14 Y129 increased 
keratin aggregate formation and stress response in osmotic stress assays. A phospho-
null construct at K14 Y129 prevents aggregates and slows down cell migration in 
scratch wound assays. In keratinocytes with both the K14 R125P mutation and a 
phospho-null K14 Y129 mutation, fewer cells with keratin aggregates were observed 
than with K14 R125P mutation alone. This implication that the pathogenic effect of 
the EBS-DM mutations may be working through interference with phosphorylation is 
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1.1  The importance of skin 
The skin (integumentary system) is the largest organ system of the body, and forms 
the exterior surface of the human body. The skin comprises of 15-18% of the total 
body weight and covers a surface area of approximately 1.5-2.0 m2 for an adult human 
being (reviewed in Goldsmith, 1990). Being a sensory organ, the skin harbors many 
receptors that are capable of sensing pain (nociceptors), pressure (mechanoreceptors) 
and temperature (thermoreceptors) (reviewed in Schmelz, 2011), thus giving the 
organisms an awareness of the surroundings. The skin is also a highly regenerative 
multilayered tissue that is continuously replaced through a process of regeneration 
(proliferation of basal cells) and desquamation (flaking cells from stratum corneum) 
that occurs at the same rate. The typical time for epidermal turnover is about 14-30 
days, which varies with age, health and body site (Reddy et al., 2000). 
1.1.1  Barrier functions of the epidermis 
One of the most important functions of the skin is to form an efficient barrier to 
protect the body from external insults such as microbial (bacteria/fungi/virus), 
chemical/biochemical (irritants/allergens) and physical (mechanical/ultra-violet 
radiations) assaults (reviewed in Proksch et al., 2008). For instance, the sebaceous and 
sweat glands in the skin secrete oil and sweat onto its surfaces to create an acidic 
environment that is unfavorable for growth of micro-organisms. In addition, 
hydrolytic enzymes, antimicrobial peptides and macrophages that are residing in the 
skin can form an immunological barrier against the percutaneous penetration of any 
irritants or allergens (reviewed in Proksch et al., 2008). Moreover, skin pigmentation 
(melanin) is photoprotective against the harmful effects of solar radiation, thus 
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reducing the risk of DNA damage and occurrences of skin cancer (Westerhof et al., 
1981;  reviewed in Kollias et al., 1991). 
1.1.2  Homeostasis of the epidermis  
The skin also plays an important role in internal homeostatic maintenance of body 
temperature and hydration through its ability to regulate heat and water loss 
respectively. For example, rising body temperatures result in dilation of blood vessels 
near the skin surface, allowing heat to dissipate, followed by the evaporation of sweat 
released by the sweat glands which cools the body down (Taylor, 1986).  Likewise, 
the skin barrier prevents the body from excessive water loss and desiccation in a dry 
environment, thus allowing for adaptation to different terrestrial lives. Most 
remarkably, the ability of the skin to repair itself after wounding, through a controlled 
repertoire of phases of cell migration, proliferation and wound contraction, further 
highlights the vital role of the skin in restoring epidermal barrier function of the body, 
hence maintaining homeostasis (reviewed in Martin, 1997). 
1.1.3  Mechanical resilience of the skin 
The skin also exhibits mechanical resilience to physical insults. The ability of the skin 
to withstand large physical forces and thus protect the underlying organs comes 
mostly from the elastic, compressible properties of both dermal collagen and elastic 
fibers (elastin) (Silver et al., 2001). This may then explain why skin can be flexible 
enough to be stretched to large amounts, for example during pregnancy, and to also 
allow a large range of body flexture and limb movements. 
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Some insights into the skin‟s ability to provide mechanical resilience and barrier 
function come from understanding the structure of the skin. In the following 
paragraphs, the compositions of the skin will be discussed in detail. 
 
1.2  Skin composition and functions 
1.2.1  The hypodermis  
The skin comprises of three distinctive layers: namely, the innermost tissue 
hypodermis, the dermis and the outermost epidermis. The mesodermally derived 
hypodermis (subcutis or subcutaneous fat) consists of mainly the loose connective 
tissues and adipose (fatty) tissues that connect the lower reticular dermis to the 
underlying skeletal components (McGrath et al., 2004). 
1.2.2  The dermis 
Overlying the hypodermis is the dermis which consists of connective tissues and is 
separated into two major compartments: the upper papillary layer which lies just 
below the dermal-epidermal junction (basement membrane), and the lower reticular 
layer which is connected to the hypodermis. Epidermal appendages such as hair 
follicles, sebaceous and sweat glands are embedded in the dermis. The major cell 
types that are residing in this dermal layer are the fibroblasts,  macrophages, mast cells 
and circulating immune cells. These cells are embedded in a fibrous matrix consisting 
of collagen and elastin, which provide structural flexibility and tensile strength. The 
fibroblasts are the ones responsible for the production and metabolism of the collagen 
fibers (Rudnicka et al., 1994), a major component of the dermis, and elastin (Davis et 
al., 1999). This ensures control of the dermal composition and configuration.  
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The blood vessels are found in the dermis, such as the cutaneous plexus (lower part of 
the reticular layer), and the subpapillary plexus (near the papillary layer), from which 
fine capillaries loop just below the epidermis. This vascularized dermis provides 
nutrients to the overlying epidermis, which in itself is devoid of any vascularization. 
The dermis contains most of the sensory system of the skin, with Meissner‟s 
corpuscles (touch receptors) located just below the epidermis and Pacinian corpuscles 
(mechanoreceptors that detect pressure) located deeper in the dermis. 
There are several important functions that take place within the dermis, such as the 
regulation of body temperature, activation of immune responses against penetrating 
antigens, and mechanical resilience through the plasticity and remodelling of the 
buffering collagen fibers (Demarchez et al., 1992). Thus, the dermis plays an 
important role in providing mechanical strength and elasticity of the skin.  
1.2.3  The basement membrane 
The basement membrane is a thin sheet of highly specialized extracellular matrix 
(ECM) found at the dermal-epidermal junction and is involved in mediating the 
attachment and orientation of epithelial cells (Edwards and Streuli, 1995). The major 
components of the basement membrane are type IV collagen, heparin sulfate 
proteoglycan, fibronectin and laminin (reviewed in Burgeson and Christiano, 1997). 
The basal cell layer of the epidermis is anchored to the basement membrane by 
hemidesmosomes or focal contacts (discussed later), whilst the basement membrane is 
anchored to the underlying dermis by collagen type VII anchoring fibrils (reviewed in 




 Figure 1.1 Architecture of the epidermis
Figure redrawn after Brooke et al., 2012. Picture courtesy of Kenneth Tan  
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1.2.4  The epidermis 
In early embryogenesis, a single-layered ectoderm gives rise to the mesoderm by cells 
migrating down to lie between the ectoderm and the endoderm. Later, the ectoderm 
becomes multilayered and gives rise to the epidermis. At the single layer stage, 
ectodermal proliferation occurs with the mitotic plane perpendicular to the embryo 
surface. This process gives rise to two layers, which results in a superficial layer 
known as the periderm (Weiss and Zelickson, 1975). During development of the 
postnatal epidermis, basal progenitor cells undergo both symmetric and asymmetric 
cell divisions to increase surface area and skin thickness respectively (Smart, 1970; 
Lechler and Fuchs, 2005). In symmetric cell division, mitotic spindles are oriented 
parallel to the underlying basement membrane, allowing basal keratinocytes to 
proliferate and expand in the basal layer of the epidermis. The beginning of 
differentiation is associated with the progenitor cells undergoing asymmetric cell 
division wherein mitotic spindles are oriented perpendicular to the basement 
membrane, giving rise to a proliferative basal cell in the basal layer and another 
daughter cell committed to differentiation in the suprabasal cell layer of the epidermis 
(reviewed in Ray and Lechler, 2011). During the transition, the keratinocytes undergo 
both biochemical and morphological changes till they become anucleated, form an 
impervious cornified envelope and their keratins and cytoplasmic matrix proteins 
become highly cross- linked and are eventually desquamated from the outermost 
epidermis. The desquamated keratainocytes are constantly replaced by inner cells 
differentiating upwards (reviewed in Koster and Roop, 2007). Hence, these 
continuous processes mediate the self-regenerative properties of the epidermis and are 




1.2.4.1 Cell types within the epidermis  
The epidermis is a non-vascularized, stratified keratinizing squamous epithelium that 
is composed mostly of keratinocytes. Other cell types that reside in this epithelium are 
the melanocytes (pigment-producing cells), Langerhans cells (antigen-presenting 
immune cells) and the neuroendocrine Merkel cells (sensory cells). Melanocytes and 
Merkel cells typically reside in the basal layer whereas Langerhans cells reside in the 
suprabasal layer. During development, both melanocytes (Holbrook et al., 1989) and 
Merkel cells (Szeder et al., 2003) originate from the neural crest whereas Langerhans 
cells are immune cells derived from the bone marrow (Shelley and Juhlin, 1976; 
Klareskog et al., 1977; Frelinger et al., 1979; Katz et al., 1979). One conundrum in 
understanding the origin of Langerhans cells is that although they are of 
hematopoietic origin, they are derived from precursors that are present in the skin 
prior to birth and bone marrow development. One possibility is that the Langerhans 
cells are derived from the yolk sac primitive macrophages that migrate to the skin via 
blood circulation during mid-embryogenesis (reviewed in Ginhoux and Merad, 2010), 
because they expressed Gr1-CD11b+MCSF-R+F4/80+CX3CR1
+ (Bertrand et al., 2005), 
a phenotype similar to the putative Langerhans precursors found in embryonic day 
18.5 (E18.5) epidermis (reviewed in Ginhoux and Merad, 2010). 
The epidermis can be subdivided into four or five different layers depending on body 
site, namely: stratum basale (basal layer), stratum spinosum (spinous layer), stratum 
granulosum (granular layer), stratum lucidum (clear layer - only in palms and soles) 
and the stratum corneum (cornified layer) (see Figure 1.1). 
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1.2.4.2 The stratum basale 
The stratum basale consists of columnar-shaped proliferative keratinocytes that 
adhere tightly to the basement membrane. These basal keratinocytes express both 
keratin 5 (K5) and keratin 14 (K14). Some of these basal cells are epidermal stem or 
progenitor cells, others are transit amplifying cells (reviewed in Blanpain et al., 2007). 
These epidermal stem cells divide and continuously supply a population of daughter 
cells that migrate upwards in the epidermis, while at the same time commit to 
terminal differentiation and cell cycle withdrawal. The stem or progenitor cells of the 
epidermis maintain epidermal renewal throughout life; there are now believed to be 
discrete populations of stem cells responsible for different parts of the hair follicle and 
sweat gland as well as for the interfollicular epidermis (reviewed in Arwert et al., 
2012). 
1.2.4.3 The stratum spinosum 
The stratum spinosum forms part of the suprabasal layer that is generally three to four 
cell layers thick. Cells residing in this layer are named spinous keratinocytes because 
in histological preparations, these cells appear to be joined by „spines‟; this 
appearance is actually caused by a strong uptake of histological stain into the bundles 
of keratin filaments that attach to desmosome cell-cell junctions. The uppermost 
spinous cells contain lamellar granules (or lamellar bodies, Odland bodies), which are 
membrane-bound cytoplasmic organelles that contain a mixture of lipids, proteases, 
antimicrobial peptides and corneodesmosomal proteins (reviewed in Ishida-
Yamamoto and Kishibe, 2011). Ultrastructurally, lamellar granules appear as round 
granules of 0.2 - 0.5 μm in diameter, with parallel stacks of lipid-enriched disks 
enclosed by a trilaminar membrane (Menon, 2002). Their appearance marks the 
various aspects of epidermal differentiation through protein and lipid synthesis. At the 
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upper spinous layer, the cells begin to flatten and elongate, and migrate to the stratum 
granulosum. Both keratin 1 (K1) and keratin 10 (K10) are biochemical markers for 
this spinous layer. 
1.2.4.4 The stratum granulosum 
The stratum granulosum consists of two to three layers of non-dividing, flattened 
keratinocytes that produce distinctive electron dense keratohyalin granules. These 
keratohyalin granules contain both the intermediate filament-associated protein 
profilaggrin and the protein loricrin (Steven et al., 1990). Lamellar granules are also 
found in these granular keratinocytes but are clustered at the cell margins  and fused 
with the plasma membrane. In the uppermost granular layer, keratinocytes discharge 
the ceramide-rich lipid contents of the lamellar granules into the intercellular space, 
where they form extracellular lipid-enriched layers. This granular zone encompasses 
the final viable epidermal layers with the uppermost granular layer connecting to the 
terminally differentiated, non-viable stratum corneum. 
1.2.4.5 The stratum corneum 
The stratum corneum forms the outermost layer of the epidermis where  anucleated 
cornified keratinocyes (corneocytes) are located. However, in palmoplantar tissues, 
there is an additional zone known as stratum lucidum seen between the granulosum 
and stratum corneum. These cells are still nucleated, and are thus referred to 
transitional cells. Corneocytes in the stratum corneum are interconnected to adjacent 
cells via the corneodesmosomes. The borders of these corneocytes overlap, interlock 
and insert into adjacent cells to enhance the stability and strength for the epidermis. It 
is not surprising that any alterations in cell-cell adhesions may result in disrupted 
barrier functions. For instance, mutations in SPINK5 for the gene encoding the serine 
11 
 
protease inhibitor LEKTI, alter the stability of desmosomal proteins, hence leading to 
Netherton syndrome (Chavanas et al., 2000), which result in defective cell-cell 
adhesion. 
During the final stages of normal differentiation, the keratin filaments of the 
corneocytes aggregate with filaggrin to form disulphide cross- linked macrofibres 
(Lynley and Dale, 1983), which caused the cells to collapse into a flattened 
morphology. The cornified envelope, a tough protein/lipid polymer structure, forms 
the cell membrane of the terminally differentiated corneocytes by the progressive 
addition of several cornified envelope proteins (reviewed in Proksch et al., 2008), 
such as involucrin (Rice and Green, 1977), which is cross- linked by the action of a 
transglutaminase (Buxman and Wuepper, 1978).  
Because a large proportion of the cornified envelope is made up of lipids and 
cholesterols, mutations affecting the functions of cholesterol efflux transporter (ATP-
binding cassette subgroup 1 membrane 12 transporter, ABCA12) can lead to 
harelequin ichthyosis (Kelsell et al., 2005), resulting in barrier function defects.  This 
suggests that the maintenance of epidermal barrier function is crucial for the integrity 
of the skin. A list of proteins associated with human skin disorders disrupting barrier 




Human diseases of the epidermis 
Stratum corneum 
 
Molecular target Disease Clinical phenotype (s) Original finding (s) 
ABCA12 (lipid 
transport) 
Harlequin ichthyosis (OMIM 
# 242500) 
Distorted facial features such as eclabion, 
ectropion 
(Kelsell et al., 2005) 
Filaggrin Ichthyosis vulgaris (OMIM # 
146700) 
Diffuse, fine superficial scaling; Kerotosis 
pilaris; Marked palmar hyperlinearity  
(Smith et al., 2006) 
Atopic dermatitis (OMIM # 
605803) 
Eczema associated with asthma; Food 
allergy; Allergic rhinitis 
(Palmer et al., 2006) 
Corneodesmosin Hypotrichosis simplex of 
scalp (OMIM # 146520) 
Late childhood onset of alopecia (Levy-Nissenbaum et 
al., 2003) 
Generalized peeling of skin 
syndrome (OMIM # 270300) 
Superficial exfoliation with unusal 
ichthyosiform erythema; Scaling of 
erythematous patches  
(Oji et al., 2010) 
SPINK5 (LEKTI) Netherton syndrome (OMIM 
# 256500) 
Congenital ichthyosis with defective 
cornificaton; Trichorrexis invaginata; atopic 
dermatitis and hay fever 
(Chavanas et al., 2000) 
Transglutaminase 1 Lamellar ichthyosis (OMIM 
# 242300) 
Newborns covered with colloid membrane 
accompanied with erythroderma; After 
membrane shedding, the skin developed 
severe ichthyosis with large hyperkeratotic 
scales 
(Huber et al., 1995) 
Loricrin Vohwinkel‟s syndrome 
(Keratoderma hereditaria 
mutilans) (OMIM # 604117) 
Hyperkeratosis of palms and soles with a 
honeycomb appearance; Pseudoinhum 
leading to autoamputation; Distinctive 
starfish- like acral keratoses; Sensorineural 
hearing loss  
(Maestrini et al., 1996) 
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Figures redrawn after Fuchs and Raghavan, 2002 and Simpson et al., 2011. 
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1.3  Anchoring junctions mediating cell-cell adhesion 
Throughout the epidermis, keratinocytes are held together by different cell-cell 
junctions such as the desmosomes, adherens junctions, gap junctions and the tight 
junctions (see Figure 1.2). Desmosomes (macula adherens) attach the keratin 
cytoskeleton of neighboring cells together and confer mechanical resilience (reviewed 
in Green and Simpson, 2007), whereas adherens junctions (zonula adherens) and tight 
junctions (zonula occludens) associate with actin microfilaments and seal cells 
together in an epithelial sheet (reviewed in Madara, 1998; Niessen, 2007). Gap 
junctions comprise of connexins that allow free exchange of chemical or electrical 
signals from one cell to another (reviewed in Mese et al., 2007). Taking all these 
observations together, understanding the properties of each type of junctional proteins 
can provide some insights in the skin‟s ability to provide mechanical resilience. In the 
following paragraphs, the compositions of the anchoring junctions mediating cell-cell 
adhesion will be discussed in detail.  
1.3.1  Desmosomes 
Desmosomes (a composition of the Greek words: „desmos‟ meaning bond and „soma‟ 
meaning body) are the major adhesion complex found in the epidermis in many 
stress-bearing tissues such as the skin and the heart. They are responsible for 
anchoring keratin intermediate filaments to the cell membrane and bridging adjacent 
keratinocytes, to confer mechanical resilience. The desmosomes have a characteristic 
ultrastructural appearance, consisting of two principle domains, namely: (1) the 
extracellular core domain where plasma membrane of two adjacent cells forms a 
symmetrical junction with a central intercellular space of 30 nm, containing the 
electron-dense midline region and (2) the plaques of electron dense material running 
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along the cytoplasm parallel to the junctional region. This cytoplasmic plaque consists 
of two distinctive regions known as the outer dense plaque (ODP) and the inner dense 
plaque (IDP) into which intermediate filaments are observed to insert (North et al., 
1999). The main desmosomal components comprise of the products of three gene 
families: the desmosomal cadherins, the armadillo family of nuclear and junctional 
proteins and the plakins (reviewed in Green and Gaudry, 2000). The extracellular core 
domain is largely composed of the heterophillic associations of the extracellular 
domains of desmosomal cadherins such as desmocollins and desmogleins (reviewed 
in Buxton and Magee, 1992; Koch and Franke, 1994). The cytoplasmic plaque 
comprises of the cytoplasmic tails of desmocollins and desmogleins, together with 
armadillo proteins (plakoglobin and plakophilin) and plakin proteins (desmoplakin). 
The localization of these desmosomal proteins within the desmosomal plaque has 
been mapped using immunogold labeling (North et al., 1999).  
1.3.1.1  Desmosomal cadherins 
Desmocollins (Dsc) and desmogleins (Dsg) are transmembrane glycoproteins of the 
desmosomes. In humans, there are seven desmosomal cadherins, three desmocollins 
(Dsc1-3) (Collins et al., 1991; Mechanic et al., 1991) and four desmogleins (Dsg1-4) 
(Koch et al., 1990; Amagai et al., 1991; Parker et al., 1991; Schafer et al., 1994; 
Kljuic et al., 2003). Each of the desmocollin genes encodes a pair of proteins that are 
generated by alternative splicing, yielding a longer „a‟ form and a shorter „b‟ form 
that differ in the length of their cytoplasmic tail (Collins et al., 1991; Parker et al., 
1991). Desmosomal cadherins are expressed in a variety of epithelial and cardiac 
tissue, of which Dsc2 and Dsg2 are expressed in all desmosomal tissues (Schafer et al., 
1994; Nuber et al., 1995). Within the epidermis, there is a differential pattern of 
desmosomal cadherin expressions across the different layers. For instance, Dsc1 and 
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Dsg1 are preferentially expressed in the suprabasal layers whereas Dsc2 and Dsg2 are 
preferentially expressed in the basal layers. Dsc3 and Dsg3, on the other hand, are 
expressed in both the basal and suprabasal layers (see Figure 1.3). Hence, these 
expression patterns make desmosomal cadherins a useful differentiation marker for 
stratified epithelia. In support of this, Dsc1 knockout mice exhibited epidermal 
hyperproliferation with overexpression of keratins 6 and 16 (K6 and K16), indicating 
abnormal differentiation (Chidgey et al., 2001). However, the process of epidermal 
stratification does not depend entirely on the presence of desmosomal cadherins 
because corneal epithelia only express Dsc2 and Dsg2 (Messent et al., 2000). Other 
regulated gene expression programs such as differentiation-specific keratin expression 
can also play a role in it (reviewed in Fuchs, 1995).  
The importance of desmosomal cadherins in maintaining the integrity of the skin was 
revealed when it was discovered that autoantibodies against desmosomal cadherins 
led to skin blistering disorders. For example, the production of autoantibodies against 
Dsg1 resulted in pemphigus foliaceus (Allen et al., 1993), while autoantibodies 
against Dsg3 resulted in pemphigus vulgaris (Amagai, 1994). Likewise, Dsg3 
knockout mice resulted in a similar phenotype as that of pemphigus vulgaris patients 
(Koch et al., 1997).  Hence, these observations suggest that desmosomal cadherins are 
important in maintaining tissue integrity.   
1.3.1.2  Desmosomal armadillo proteins 
The cytoplasmic plaque of the desmosomes comprises mainly of the plakophilins 1-3 
(PKP1-3), plakoglobin (PG) and desmoplakin (DP). Other proteins identified as 
associated with desmosomes are desmocalmin (Tsukita, 1985), IFAP 300 (Skalli et al., 
1994), pinin (Ouyang and Sugrue, 1996) and periplakin (Ruhrberg et al., 1997). Both 
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PG and PKP belong to the armadillo family of signalling proteins (Peifer et al., 1992). 
They are characterized by the presence of a central domain containing a variable 
number of imperfect 42 amino acid repeats (arm repeats) (reviewed in Garrod and 
Chidgey, 2008). All PKPs contain 9 arm repeats with a flexible insert between repeats 
5 and 6 that introduces a major bend in the overall structure (Choi and Weis, 2005), 
whereas PG contains 12 arm repeats (reviewed in Garrod and Chidgey, 2008). This 
kind of structure can also be found in β-catenin (McCrea et al., 1991; Butz et al., 1992)  
and armadillo (Riggleman et al., 1989; Peifer and Wieschaus, 1990), also members of 
the armadillo family of proteins.   
Plakophillin (PKP) exists as three distinct isoforms (PKP1-3) that are expressed in a 
differentiation-specific manner in the epidermis (reviewed in Hatzfeld, 2007). PKP1 
shows increased expression in suprabasal cells whereas PKP2 shows highest 
expression in basal cells. In contrast, PKP3 is expressed equally throughout the 
epidermal layers (reviewed in Getsios et al., 2004). PKP1 has been shown to localize 
at the cytoplasmic face of the desmosomal plaque (Kapprell et al., 1988; Heid et al., 
1994) where molecular mapping showed that PKP1 lie closer to the plasma membrane 
as compared to PG or DP (North et al., 1999). A role for PKP1 in mediating tissue 
integrity of the skin was demonstrated by the discovery of mutations in PKP1 gene 
that led to ectodermal dysplasia / skin fragility syndrome. Hence, this reveals the 
importance of PKP1 in both cutaneous cell-cell adhesion and epidermal 
morphogenesis (McGrath et al., 1997).  
Plakoglobin (PG), unlike other members of the armadillo family, can interact with the 
desmosomal cadherins (Cowin et al., 1986). PG interacts with the cytoplasmic 
domains of the desmosomal cadherins (Dsc and Dsg) that have sequence similarity 
with other catenin-binding domain of classical cadherins (Mathur et al., 1994; 
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Troyanovsky et al., 1994). Moreover, PG can also bind to the N-terminal domain of 
DP, an intermediate filament linker protein (Kowalczyk et al., 1997). These 
observations demonstrate that PG can link the desmosomal cadherins to the 
cytoskeleton. Molecular mapping of the desmosome provided the evidence for the 
localization of the PG interacting with Dsg, Dsc and DP (North et al., 1999). It has 
been suggested that PG was globular (Kapprell et al., 1987), which could position its 
internal arm repeats nearer to the plasma membrane than its N- or C- terminals. In 
consistent with this, it has been shown that the central domain of PG could bind to the 
N-terminus of the DP (Kowalczyk et al., 1997). 
The notion that PG can interact with both desmosomal cadherins and DP suggests that 
it is important for maintaining tissue integrity. Indeed, deletion in PG led to Naxos 
disease, which was characterized by arrhythmic right ventricular cardiomyopathy 
(ARVC), striate palmoplantar keratoderma and woolly hair (McKoy et al., 2000). 
Likewise, the absence of PG could also lead to lethal congenital epidermolysis bullosa 
(Pigors et al., 2011), hence emphasizing the crucial role played by PG in maintaining 
epithelial and cardiomyocyte integrity. 
1.3.1.3  Desmosomal plakin proteins 
One of the essential components of the desmosome in all tissues is desmoplakin (DP), 
a member of plakin family. Other members include BP230, plectin and periplakin 
(Green et al., 1992; Ruhrberg et al., 1997). The common structural features of this 
family is first described for DP (Green et al., 1990), and all members in this family 
can bind to intermediate filaments. In addition, members such as plectin have an 
actin-binding domain that is thought to connect various cytoskeletal systems together 
(reviewed in Ruhrberg and Watt, 1997). 
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DP consists of an N-terminal plakin domain, a central coiled-coil rod domain and a C-
terminus consisting of three highly homologous plakin repeat domains, namely: A, B 
and C (Choi et al., 2002). As mentioned earlier, the N-terminus of desmoplakin can 
bind to the desmosomal outer plaque proteins such as PG and PKP (Kowalczyk et al., 
1997) whereas the C-terminus can bind to intermediate filament. The central α-helical 
rod domain is thought to be involved in dimer formation (Green et al., 1990). Two 
isoforms of DP exist: DP1 and DP2, where DP2 lacks most of the rod domain due to 
alternative splicing of exon 23 (Green et al., 1988; O'Keefe et al., 1989). DP1 is 
expressed in both skin and heart whereas DP2 is mainly expressed in the skin (Angst 
et al., 1990). Molecular mapping of desmosomes showed that DP could extend across 
most of the outer plaque and the whole of the inner plaque, suggesting that DP was 
localized at where it could interact with most of the desmosomal components (North 
et al., 1999).  
The observation that DP can interact with most of the desmosomal components and 
aid in tethering the intermediate filaments to the neighboring cells suggests that it is 
crucial for maintaining tissue integrity. Indeed, DP knockout mice are usually 
embryonic lethal (Gallicano et al., 1998; Gallicano et al., 2001). Using a conditional 
DP knockout, it was found that the mice exhibited peeling skin and desmosomes 
lacking inner plaques which were devoid of keratin attachment (Vasioukhin et al., 
2001). Moreover, a recessive mutation in DP led to a human disorder characterized by 
generalized striate keratoderma, woolly hair and dilated left ventricular 
cardiomyopathy, resulting in the collapse of keratin network and large intercellular 
spaces (Norgett et al., 2000). On the other hand, DP haploinsufficiency arising from 
the deletion of the amino-terminus do not result in heart defects but present 
palmoplantar keratoderma (Armstrong et al., 1999; Whittock et al., 1999).   
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1.3.1.4  Calcium pumps regulating desmosomal adhesions 
Since desmosomal adhesions are dependent on extracellular calcium concentration 
(Kimura et al., 2007), mutations in the ATP2A2 and ATP2C1 genes coding for 
intracellular calcium pumps are thought to disrupt desmosomal adhesion. Indeed, 
human conditions such as Darier‟s disease and Hailey-Hailey disease implicated an 
important role for calcium in regulating desmosomal adhesions (Sakuntabhai et al., 
1999b; Hu et al., 2000) (see Table 1.3). 
Taken all these observations together, the presence of desmosomes in tissues 
experiencing large amounts of mechanical stress, such as the epidermis or the heart, 
highlights the importance of strong cell-cell adhesion in tissues. This is obvious from 
the severe phenotypes resulting from mutations or loss of desmosomal components. A 
list of desmosomal proteins associated with human skin disorders disrupting tissue 






Figure 1.3  Differential expressions of the junctional proteins
Figure redrawn after Simpson et al., 2011. 
22 
 
Table 1.2  
Human diseases of the epidermal junctions  
Desmosomes 
Molecular target Disease Clinical phenotype (s) Original finding (s) 
DSG1 Bullous impetigo Epidermal blisters at the granular layer caused 
by bacterial proteolytic attack (neonatal mice 
and human keratinocyte cell line) 
(Amagai et al., 2000) 
Staphylococcal scalded skin 
syndrome 
Pemphigus foliaceus Epidermal blisters at the granular layer caused 
by autoantibodies; Acantholysis 
(Koulu et al., 1984) 
DSG3 Pemphigus vulgaris (OMIM # 
169610) 
Epidermal blisters at the basal-suprabasal layer 
caused by autoantibodies; Mucosal erosions 
(Amagai et al., 1991) 
DSG4 Hypotrichosis (OMIM # 
607903) 
Sparse, fragile hair with bullous “bleb” and 
curled ingrown hair shafts within hair follicle 
(Kljuic et al., 2003) 
DSC2 Arrhythmogenic right 
ventricular cardiomyopathy 
(ARVC); ARVC with mild 
palmoplantar keratoderma and 
woolly hair (OMIM # 
610476) 
Ventricular arrhythmias with mild interstitial 
fibrosis and fatty infiltration of myocardium; 
Mild thickening of palms and soles; Tightly 
coiled hair 
(Heuser et al., 2006; 
Simpson et al., 2009) 
DSC3 Hypotrichosis with skin 
vesicles (OMIM # 613102) 
Sparse, fragile hair with normal hair follicles; 
Recurrent skin vesicles 
(Ayub et al., 2009) 
DP/ DSG1 Striate palmoplantar 
keratoderma (DSG1: OMIM # 
148700; DP: OMIM # 
612908) 
Hyperkeratotic bands on the palms and soles (Armstrong et al., 1999; 
Rickman et al., 1999; 
Whittock et al., 1999; 








Table 1.3  
Human diseases of the epidermal junctions  
Calcium pumps 
DP Carvajal syndrome (OMIM # 
605676) 
Longitudinal hyperkeratosis of a striate 
palmoplantar keratoderma with woolly hair 
and dilated cardiomyopathy 
(Norgett et al., 2000) 
Lethal acantholytic 
epidermolysis bullosa (OMIM 
# 609638) 
Universal alopecia; neonatal teeth and nail 
loss; Acantholysis; Early death 
(Jonkman et al., 2005) 
PKP1 Ectodermal dysplasia/skin 
fragility syndrome (OMIM # 
604536) 
Cutaneous fragility and congenital ectodermal 
dysplasia affecting skin, hair and nails 
(McGrath et al., 1997) 
PG Naxos disease (OMIM # 
601214) 
Woolly hair; Non-epidermolytic palmoplantar 
keratoderma; Arrhythmogenic right ventricular 
cardiomyopathy 
(McKoy et al., 2000) 
Lethal congenital 
epidermolysis bullosa 
Generalized erythema and epidermolysis with 
no known cardiomyopathy; Total alopecia; 
Early death 
(Pigors et al., 2011) 




(OMIM # 169600) 
Erythema blistering in the suprabasal layers; 
Acantholysis 
(Hu et al., 2000) 
ATP2A2 
(calcium pump) 
Darier‟s disease (OMIM # 
124200) 
Acantholysis; Keratotic papules coalescing 
into a hyperkeratotic plaque 
(Sakuntabhai et al., 




1.3.2  Adherens junctions 
Adherens junctions are electron dense transmembrane structures that associate with 
the actin cytoskeleton, which are responsible for cell adhesion, motility and changes 
in cell shape (Gumbiner, 1996). The transmembrane core of the adherens junctions 
consists of classical cadherins, namely: epithelial cadherin (E-cadherin) and placental 
cadherin (P-cadherin).  
1.3.2.1  Cadherins 
The extracellular domains of E-cadherin form calcium-dependent homophillic 
adhesive interactions with E-cadherin from adjacent cells. Its cytoplasmic domain, on 
the other hand, is responsible for clustering of surface cadherins to form a junctional 
structure (reviewed in Vasioukhin and Fuchs, 2001). The main linkage to the actin 
cytoskeleton is through α-catenin (Rimm et al., 1995), which apart from its role of 
mediating E-cadherin-catenin adhesions, is also responsible for regulating actin 
dynamics and polymerization (reviewed in Vasioukhin and Fuchs, 2001). The 
regulation of actin dynamics allows for the extension and anchorage of filopodia into 
neighboring keratinocytes, strengthening cell-cell adhesions. Conditional deletion of 
E-cadherin in mice resulted in hyperproliferation, abnormal differentiation and 
impaired barrier formation of the epidermis (Young et al., 2003; Tinkle et al., 2004; 
Tunggal et al., 2005), while ablation of both E-cadherin and P-cadherin resulted in 
lethal blistering (Tinkle et al., 2008). Patients harboring CDH3 mutations targeting P-
cadherin suffered from hair loss and macular degeneration (Sprecher et al., 2001; 
Kjaer et al., 2005) (see Table 1.4). Hence, adherens junction components are not only 
















Hypotrichosis with juvenile 
macular dystrophy (OMIM # 
601553) 
Hair loss heralding progressive macular 
degeneration and early blindness 
(Sprecher et al., 2001) 
Ectodermal dysplasia; 
Ectrodactyly; Macular 
degeneration (EEM) syndrome 
(OMIM # 225280) 
Hypotrichosis and sparse hair; Syndactyly in 
hands and feets 
(Kjaer et al., 2005) 
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1.3.3  Gap junctions  
Gap junctions are intercellular channels that mediate the direct passage of low 
molecular weight metabolites (< 1 kDa) and ions between the cytoplasm of adjacent 
cells (Kelsell et al., 2001). Gap junctions are formed by connexins, which are 
composed of oligomers of six connexons (Cxs), of which Cx26, Cx43, Cx30, Cx30.3 
and Cx31 are expressed in the epidermal keratinocytes. These connexons can form a 
homotypic or heterotypic channel. Missense mutations in the genes encoding Cx26, 
Cx30, Cx30.3 or Cx31 can lead to several forms of inherited human disorders such as 
Vohwinkel‟s syndrome, Clouston syndrome and Erythrokeratodermia variabilis, 
causing keratoderma and/or hearing loss (see Table 1.5). Hence, gap junction 
components are not only essential for regulating cell-cell communication but also 




Table 1.5  




Molecular target Disease Clinical phenotype (s) Original finding (s) 
Cx26 Keratitis ichthyosis deafness 
syndrome (OMIM # 148210) 
Vascularizing keratitis; Progressive 
erythrokeratoderma; Profound sensorineural 
hearing loss 
(Richard et al., 2002) 
Vohwinkel‟s syndrome 
(Keratoderma hereditaria 
mutilans) (OMIM # 124500) 
Papular and honeycomb keratoderma associated 
with constrictions of digits leading to 
amputations; Distinctive starfish- like acral 
keratoses; Moderate sensorineural hearing loss 
(Maestrini et al., 1999) 
Bart-Pumphrey syndrome 
(OMIM # 149200) 
Hyperkeratosis of knuckle pads; Diffuse 
palmoplantar keratoderma with keratotic bands; 
Sensorineural hearing loss 
(Richard et al., 2004) 
Hereditary non-syndromic 
sensorineural deafness 
(OMIM # 148350) 
Palmoplantar keratoderma; Profound deafness 
and high-frequency hearing loss 
(Kelsell et al., 1997) 
Cx30 Clouston syndrome (hidrotic 
ectodermal dysplasia) (OMIM 
# 129500) 
Palmoplantar hyperkeratosis; Generalized 
alopecia; Nail dystrophy 
(Essenfelder et al., 2004) 
Cx30.3, Cx31 Erythrokeratodermia 
variabilis (OMIM # 133200) 
Diffuse scaling and erythema gyratum repens- like 
migratory lesions 
(Richard et al., 1998; 
Macari et al., 2000) 
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1.3.4  Tight junctions  
Tight junctions are formed by transmembrane and intracellular molecules such as 
occludin, junction adhesion molecule and claudins (reviewed in Bazzoni and Dejana, 
2001). In the granular layer of the epidermis, tight junctions seal epithelial sheets 
together by forming a belt- like adhesion between the cells, creating an environmental 
barrier that controls water loss and protects against pathogen invasion (reviewed in 
Niessen, 2007). Intracellular tight junction components also include scaffolding 
proteins such as zonula occludens (ZO) proteins, namely: ZO1, ZO2 and ZO3, which 
cluster the transmembrane molecules and couple to the actin cytoskeleton (reviewed 
in Niessen, 2007). The role of a transmembrane molecule, claudin, in regulating 
epidermal permeability was found when mice ablated of claudin-1 died of profound 
trans-epidermal water loss (Furuse et al., 2002). Moreover, missense mutations in 
claudin-1 gene led to sclerosing cholangitis associated with ichthyosis (Hadj-Rabia et 
al., 2004), a gastrointestinal syndrome affecting bile secretion, confirming a role for 
claudin-1 in regulating paracellular permeability between epithelial cells . Hence, 
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Figures redrawn after Jonkman, 1999 and de Pereda et al., 2009. 
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1.4  Anchoring junctions mediating cell-matrix adhesion 
At the dermal-epidermal junction (basement membrane), keratin intermediate 
filaments of the basal keratinocytes are anchored to the dermal matrix through the 
hemidesmosomal proteins, whereas actin microfilaments and microtubule filament 
systems are anchored through focal adhesions (see Figure 1.4). Hemidesmosomes are 
multi-protein complexes that mediate epithelial-stroma cohesion in stratified and 
complex epithelial (reviewed in Borradori and Sonnenberg, 1999). These complexes, 
which appear as three- layered structures along the plasma membrane of basal cells, 
are composed of at least five different proteins, namely: the laminin-332 receptor 
α6β4 integrins, the bullous pemphigoid antigens 180 and 230 (BP180 and BP230), 
tetraspanin (CD151) and plectin (reviewed in Jones et al., 1998).  
Focal adhesions are dynamic structures that not only mediate cell-matrix adhesions, 
but also play an important role in cell migration, proliferation and survival. Focal 
adhesions typically undergo assembly and disassembly through the continuous 
association of proteins such as α3β1 integrins, vinculin, talin, kindlin-1 and α-actinin 
(reviewed in Watt, 2002). The presence of these complexes provides a means to 
enhance the stability and also attribute dynamics for the epidermis. The understanding 
of the properties of these different complexes can provide some insights in the skin‟s 
ability to provide mechanical resilience and also adaptability to environmental cues. 
In the next paragraphs, the compositions of the anchoring junctions mediating cell-
matrix adhesion will be discussed in detail.  
1.4.1  Hemidesmosomes 
There are two distinct types of hemidesmosomes, of which type II hemidesmosomes, 
found in intestinal epithelial cells or mammary gland epithelial cells, do not have a 
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clear three- layered structure and are composed solely of α6β4 integrins and plectin 
(Uematsu et al., 1994). Ultrastructurally, type I hemidesmosomes appear as electron-
dense structures comprising of an inner and an outer plaque, accompanied by a sub-
basal dense plate. The inner plaque is composed of hemidesmosomal proteins such as 
plectin and BP230, which serves as an anchorage site for kertain intermediate 
filaments. The outer plaque, on the other hand, consists of the α6β4 integrins and 
BP180 (reviewed in Nievers et al., 1999). The basement membrane underlying the 
hemidesmosomes constitutes a network of interconnecting proteins (reviewed in 
Timpl, 1996). It consists of laminin-332, collagen type IV, and glycoproteins such as 
nidogen, perlecan and fibulins that act as stabilizing bridges (reviewed in Yurchenco 
and O'Rear, 1994). Anchoring filaments, which are composed of BP180 (Masunaga et 
al., 1997) and laminin-332 (Rousselle et al., 1991), traverse across the sub-basal dense 
plate and the lamina lucida of the basement membrane, and connect the 
hemidesmosome to the anchoring fibrils (collagen type IV and VII) in the lamina 
densa and sub-basal lamina densa respectively. These collagens extend further into 
the dermis to connect with collagen I from where they loop back into the lamina 
densa, or insert into anchoring plaques (Keene et al., 1987). This reinforces the 
attachment of the epidermal basement membrane to the underlying dermal connective 
tissue. 
1.4.1.1  α6β4 integrins 
In the outer plaque of the hemidesmosomes, α6β4 integrins serve as a transmembrane 
receptor for laminin-332 and they together make up the core structure of the 
hemidesmosome. α6β4 integrins belong to the large family of heterodimeric receptors 
that mediate the attachments of cells to the extracellular matrix (reviewed in Buck and 
Horwitz, 1987). Both α and β subunits of the integrins have a large extracellular 
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portion, a transmembrane segment, and a shorter cytoplasmic domain. α6β4 integrins 
differ from other integrins in that the cytoplasmic domain of β4 subunit contains over 
1000 amino acids in length and contains two pairs of type III fibronectin (FNIII) 
repeats separated by a connecting segment (Tamura et al., 1990). Transfection of the 
second FNIII repeat and the adjacent 27 amino acids of the connecting segment are 
demonstrated to be critical for the correct localization of α6β4 integrins to the 
hemidesmosomes (Niessen et al., 1997). The cytoplasmic domain of β4 is also crucial 
for the organization of hemidesmosomes because overexpression of tail- less β4 could 
block hemidesmosomal formation (Spinardi et al., 1993). Moreover, the extracellular 
domain of α6β4 integrins is important for cell adhesion. Antibodies against α6β4 
prevent hemidesmosomal assembly and induce dermal-epidermal separation in vitro 
(Kurpakus et al., 1990). This is further supported by studies using α6β4 knockout 
mice where it is observed that there was extensive epithelial detachment devoid of 
hemidesmosomes (Georges-Labouesse et al., 1996; van der Neut et al., 1996). Indeed, 
mutations in the genes encoding α6 and β4 integrin subunits led to patients suffering 
from junctional epidermolysis bullosa associated with pyloric atresia (PA-JEB), 
resulting in cutaneous aplasia and mucosal erosions (Vidal et al., 1995; Shimizu et al., 
1996). Hence, these studies demonstrate that α6β4 integrins are important in 
maintaining the mechanical integrity of both the basal keratinocytes and the basement 
membrane. 
1.4.1.2  Laminin-332 
The α6β4 integrins are receptors for various laminins, but preferentially bind to 
laminin-332 (Niessen et al., 1994), which is predominately found in the epidermal 
basement membrane (Rousselle et al., 1991). Laminin-332 belongs to the 
heterotrimeric proteins of the laminin family, consisting of the α3, β3 and γ2 subunits 
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(Marinkovich et al., 1992), which can act as a ligand for α6β1 and α3β1 integrins as 
well as α6β4 integrins. The first repeat of the G domain of α3 subunit of laminin-332 
is responsible for the binding sites of these integrins (Rousselle et al., 1995). Laminin-
332 also interacts with the NC1 domain of collagen VII, the major component of the 
anchoring fibrils, linking the α6β4 integrins to the dermal matrix (Rousselle et al., 
1997). Cross-linking of laminin-332 with laminin-311 and laminin-321 can result in 
their self-associations and promote stable epithelial-stromal attachment (Champliaud 
et al., 1996). The importance of laminin-332 in maintaining anchorage and motility of 
epithelial cells was demonstrated by the targeted deletion of the α3 subunit of 
laminin-332 in mice that resulted in junctional blisters and disrupted 
hemidesmosomes. Moreover, keratinocytes isolated from these mice had a deficit in 
cell motility (Ryan et al., 1999). Indeed, mutations/deletions in the genes encoding 
laminin-332 subunits led to patients suffering from lethal (Herlitz) junctional 
epidermolysis bullosa (JEB), resulting in severe epidermal fragility associated with 
early death (Kivirikko et al., 1995; Kivirikko et al., 1996). 
1.4.1.3  BP180 
The other transmembrane component of hemidesmosome is BP180 (also known as 
BPAG2 or collagen type XVII). BP180 is a type II transmembrane protein with its C-
terminus located at the extracellular site of the plasma membrane (Giudice et al., 
1992). It contains a series of collagenous repeats in its extracellular domain, which are 
predicted to form collagen- like triple helix (Hirako et al., 1996). Sequences within the 
N-terminus of the cytoplasmic tail of BP180 interact with β4 integrin tail (Borradori 
et al., 1997; Aho and Uitto, 1998) while the NC16A domain of BP180 interacts with 
the α6 integrin subunit (Hopkinson et al., 1995; Hopkinson et al., 1998). The 
importance of BP180 in maintaining the stability/assembly of hemidesmosomes was 
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demonstrated when it was discovered that autoantibodies against BP180 led to bullous 
pemphigoid, a skin blistering disorder (Stanley et al., 1981). Moreover, inherited 
mutation or deletion of BP180 led to patients suffering from generalized atrophic 
benign epidermolysis bullosa (GABEB), resulting in universal alopecia with skin 
atrophy (Jonkman et al., 1995; McGrath et al., 1995). Deficiencies in BP180 do not 
seem to affect the normal localization of α6β4 integrins, laminin-332 and BP230 to 
the basal membrane although the hemidesmosomes are disrupted with a lack of well-
defined cytoplasmic plaques. These studies demonstrate that BP180 is important in 
mediating hemidesmosome assembly and stability.  
1.4.1.4  BP230 
In the inner plaque of the hemidesmosomes, the major cytoplasmic plaque proteins 
are the BP230 (Stanley et al., 1988; Sawamura et al., 1991) and plectin (Wiche et al., 
1991). BP230 and plectin belong to the plakin family of cytoskeletal linker proteins 
that anchor intermediate filaments to the plasma membrane (Tanaka et al., 1991). 
Transfection studies and yeast two-hybrid studies have shown that the N-terminus of 
BP230 could interact with the N-terminus of the cytoplasmic domain of BP180 
(Borradori et al., 1998; Hopkinson and Jones, 2000), which was mediated by the Y-
domain of BP230 (Koster et al., 2003). A role for BP230 in attaching keratins to the 
hemidesmosomal plaque is determined by the C-terminus which contains two copies 
of plakin repeat domains. This was first demonstrated in BP230 knockout mice that 
exhibited poorly formed hemidesmosomes devoid of keratin intermediate filament 
attachment. Moreover, these mice suffered from epidermal blistering, which could be 
a result of the impaired anchorage of intermediate filament to desmosomes that 
caused a deficit in mechanical resilience (Guo et al., 1995). In addition, these mice 
also exhibited spinal nerve degeneration when the gene encoding the neuronal 
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isoform of BP230 (dystonin) was inactivated (Brown et al., 1995). Indeed, the 
importance of BP230 in maintaining the stability/assembly of hemidesmosomes was 
demonstrated when a homozygous nonsense mutation within BP230 gene was found 
in patients suffering from autosomal recessive epidermolysis bullosa simplex, 
resulting in skin blistering (Groves et al., 2010). Hence, these studies demonstrate that 
BP230 is crucial for hemidesmosome assembly and stability.  
1.4.1.5  Plectin 
Another major plaque protein in the hemidesmosome is p lectin. Plectin is a large 
phosphoprotein expressed in both stratified and simple epithelial, where it acts as the 
most versatile cytoskeletal linker protein (Steinbock and Wiche, 1999). Plectin, being 
part of the plakin family, consists of a central α-helical rod domain that is flanked by 
large globular structures of the N- and C- terminal domains (Wiche et al., 1991). The 
N-terminus of plectin can associate with the cytoplasmic tail of β4 (Niessen et al., 
1997; Rezniczek et al., 1998). This region also has a highly conserved actin-binding 
domain that is homologous to that of actin-binding proteins such as spectrin and 
dystrophin (Elliott et al., 1997). The binding site of plectin to intermediate filament is 
determined by the C-terminus, which contains six copies of plakin repeat domains, 
and the interaction has been mapped to a stretch of approximately 50 amino acids 
linking the plakin repeat domains 5 and 6 (Nikolic et al., 1996).  The importance of 
plectin in maintaining hemidesmosomal organization was demonstrated by the 
observation that plectin knockout mice exhibited epidermal blistering coupled with 
abnormalities in cardiac and skeletal muscles (Andra et al., 1997), similar to patients 
suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) 
(Gache et al., 1996; McLean et al., 1996; Smith et al., 1996). Hence, these studies 
36 
 
demonstrate that plectin is a critical cytoskeletal linker in mediating hemidesmosome 
assembly and stability. 
1.4.2  Hemidesmosomal assembly 
Taken together, a model can be used to describe the sequence of hemidesmosomal 
assembly based on the interactions between different hemidesmosomal proteins 
(reviewed in Nievers et al., 1999). Firstly, clustering of the α6β4 integrins with plectin 
may occur at the inner plaque because both the N- and C- terminus of plectin can 
directly associate with the first pair of FNIII repeats and the connecting segment of β4 
integrin (Rezniczek et al., 1998) and also its cytoplasmic tail (Niessen et al., 1997). 
Consequently, co-clustering of plectin with the α6β4 integrins results in the 
association of plectin to keratin intermediate filaments (Nikolic et al., 1996), thus 
forming type II hemidesmosomes. Subequently, BP180 is recruited to the site of 
α6β4-plectin clustering because BP180 can directly interact with the cytoplasmic tail 
of β4 (Borradori et al., 1997; Aho and Uitto, 1998) and also interact with plectin 
(Gache et al., 1996). Finally, hemidesmosomal assembly is completed by the 
recruitment of BP230 to the inner plaque, possibly by BP180 (Borradori et al., 1998),  
and its connection to the keratin intermediate filament (Guo et al., 1995), hence 
forming type I hemidesmosomes.  
In conclusion, hemidesmosomal proteins play an important role in maintaining 
epidermal morphology and integrity. A summary list of hemidesmosomal proteins 





Table 1.6  
Human diseases of the epidermal junctions  
Hemidesmosomes 




Bullous pemphigoid or 
Herpes gestationis  
Fluid-filled subepidermal blisters caused by 
autoantibodies 
(Morrison et al., 1988; 
Diaz et al., 1990) 
Generalized atrophic bullous 
epidermolysis bullosa 
(GABEB) (OMIM # 226650) 
Scalp alopecia with follicular atrophy; Nail 
atrophy 
(Jonkman et al., 1995; 





simplex (autosomal recessive) 
Generalized trauma-induced spontaneous blisters 
and erosions; Episodic limb numbness 
(Groves et al., 2010) 
 
α6β4 integrins Junctional epidermolysis 
bullosa with pyloric atresia 
(PA-JEB) (OMIM # 226730) 
Pyloric atresia and cutaneous aplasia; Mucosa 
erosions 
(Vidal et al., 1995; 
Shimizu et al., 1996) 
Plectin Epidermolysis bullosa 
simplex with muscular 
dystrophy (EBS-MD) (OMIM 
# 226670) 
Epidermal blisters heal with atrophic scarring; 
Nail dystrophy; Muscle weakness that 
progressively leads to widespread muscular 
atrophy and ptosis 
(McLean et al., 1996; 
Smith et al., 1996) 
Laminin-332: 
α3, β3 and γ2 
Herlitz  junctional 
epidermolysis bullosa (OMIM 
# 226700) 
Extensive blistering of the skin and mucosal 
surfaces  
(Pulkkinen et al., 1994a; 
Pulkkinen et al., 1994b; 
Kivirikko et al., 1995) 
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1.4.3  Focal contacts 
Another structure connecting the basal keratinocytes to the dermal matrix is the focal 
adhesions (FAs). FAs are large complexes of proteins that function as cell-matrix 
adhesions through connecting the actin microfilaments and microtubule filaments to 
the underlying extracellular matrix (ECM) such as the dermis (reviewed in Zamir and 
Geiger, 2001). FAs are dynamic structures that are responsible for signal transduction 
and cell migration. In migrating cells, FAs frequently undergo assembly and 
disassembly through the associations and disassociations of many proteins (reviewed 
in Jockusch et al., 1995).  
1.4.3.1  α3β1 integrins 
α3β1 integrins are the major transmembrane ECM receptors found in focal contacts 
(reviewed in Watt, 2002). Integrin clustering occurs at the formation of focal contacts, 
where focal adhesion kinase (FAK) and tensin are recruited (Miyamoto et al., 1995). 
Integrin occupancy by ligands such as fibronectin or laminin can further recruit other 
proteins such as paxillin, vinculin, α-actinin, talin and kindlin to associate with the 
clustered integrins and initiate signal transduction (Dogic et al., 1998; Sondermann et 
al., 1999).  
1.4.3.2  α-actinin 
The first protein to be identified in the adhesion plaque was α-actinin (Lazarides and 
Burridge, 1975). α-actinin is a rod-shaped antiparallel homodimer that cross- links and 
bundles actin filament (Meyer and Aebi, 1990). α-actinin can also bind to the 




1.4.3.3  Vinculin 
The second protein to be identified in the adhesion plaque was vinculin (Geiger, 1979; 
Burridge and Feramisco, 1980). Vinculin is an anchor protein found within focal 
adhesions where it is responsible for linking actin microfilaments to the plasma 
membrane (reviewed in Burridge et al., 1982).  
1.4.3.4  Paxillin 
Among the adhesion proteins, paxillin is a major component of the focal adhesions. 
Paxillin contains several distinct structural domains (Turner and Miller, 1994), 
suggesting that paxillin can act as a scaffold in recruiting structural and regulatory 
proteins into the focal complex. The N-terminus of paxillin also contains binding sites 
for vinculin and FAK (Turner and Miller, 1994). 
There are two FERM (protein 4.1, ezrin, radixin, and moesin) domain-containing 
proteins such as talin and kindlin that are responsible for inside-out and outside- in 
signalling of the integrins (reviewed in Kinashi, 2012).  
1.4.3.5  Talin 
Talin is an ubiquitous 270 kDa protein that links integrin to actin microfilaments. It 
consists of a N-terminal globular head that contains the integrin-binding FERM 
domain, and a rod domain that can associate with the F-actin binding protein vinculin 
(reviewed in Kinashi, 2012). Talin is important in regulating cell adhesion to the 
ECM that is essential for cell migration (ie. during embryogenesis, angiogenesis and 
immune responses), tumour invasion and metastasis (reviewed in Frame and Norman, 




1.4.3.6  Kindlin 
Kindlin is part of the kindlin family that contains a FERM and a pleckstrin homology 
(PH) domain. Like talin, kindlin is also a linker of the integrins to the actin 
cytoskeleton. The importance of kindlin in regulating integrin signaling was derived 
from mutations in gene encoding FFH-1 (KIND1) leading to patients suffering from 
Kindler syndrome which was characterized by poikiloderma and trauma- induced 
blistering (Jobard et al., 2003; Siegel et al., 2003).  Kindler syndrome was thus the 
first FA disorder discovered and the first hereditary skin fragility disorder caused by a 
defect in actin-ECM attachments, rather than keratin-ECM linkages (Siegel et al., 
2003).  
Hence, these studies show how focal adhesion complex is important in regulating 
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Epithelial cells isolated 
directly from the skin can be 
passaged for many 
generations when cultured 
together with the fibroblast 
feeder layer. (Rheinwald and 
Green, 1975)   
  
 
EGF increases the culture 
lifetime of epidermal 
keratinocytes by delaying 
senescence and keeping 
them in a proliferative state. 
(Rheinwald and Green, 
1977)  
A quantitative description of 
the in vitro assembly/re-
assembly of intermediate 
filaments from BHK-21 cells 
and established conditions 
for regulation of intermediate 
filament assembly. (Zackroff 
and Goldman, 1979) 
First catalog of 
human cytokeratins 
established and the 
nomenclature is still 
used presently. (Moll 
et al., 1982)  
  
Complete sequencing 
of epidermal type I 
keratin subunit and 
implications of its 
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and Weber, 1990; 
Steinert, 1990) 
Changes in keratin gene 
expression during terminal 
differentiation of the 
keratinocyte results largely 
from changes in synthesis. 
(Fuchs and Green, 1980) 
Nuclear lamins undergo 
reversible mitotic 
disassembly through 
phosphorylation of its 
subunits. (Gerace and 
Blobel, 1980) 




consistent to the 10- 
nm filament model. 
(Aebi et al., 1983)  
  
Keratin type I and II 
subunits form 
heterodimers in a 1:1 ratio 
and exist as parallel 
chains in axial register. 
(Hatzfeld and Franke, 
1985; Parry et al., 1985; 
Weber and Geisler, 1985) 
 
Effects of EGF and TGF-α 
in colony expansion by 
increasing cell migration 
rate. (Barrandon and 
Green, 1987)  
Complete sequencing of 
epidermal type II keratin. 
(Steinert et al., 1985) 
 
Mapping of K18 gene 
to chromosome 12 
(Waseem et al., 1990) 
 
Figure 1.5 Key events in the field of epithelial biology with emphasis on intermediate filaments                   
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with mutations in 
keratin intermediate 
filaments.  
(Bonifas et al., 1991; 




Discovery of a point 
mutation at the helix 
termination domain of 
K5, which leads to 
pathogenesis of EBS. 
(Lane et al., 1992)   
 
EBS severity correlates 
with the position of 
keratin point mutations 
(phenotype-genotype 
correlations). (Letai et 
al., 1993) 
EGF and TGF-α induce 
the activation and 
hyperproliferation-
associated K6 and K16. 
(Jiang et al., 1993) 
Functional human K14 
“knockout” leading to 
severe EBS. (Chan et 





of K15 with K5, in K14 
knockout mice, at the 
basal layer of stratified 
squamous epithelial. 
(Lloyd et al., 1995) 
 
The catalog of human 
hair keratins, I. 
(Langbein et al., 1999)  
 
First report of the 
intermediate 
filament peptide 
structure of helix 2B 
motif with atomic 
resolution. 
(Herrmann et al., 
2000) 
 
Keratins turn over 
by ubiquitination in 
a phosphorylation-
modulated manner. 
(Ku and Omary, 
2000) 
The catalog of human 
hair keratins, II. 




to unravel the atomic 
structure of intermediate 
filaments. (Strelkov et 
al., 2001)  
 
Complete cytolysis 
and neonatal lethality 
of K5 knockout mice. 
(Peters et al., 2001) 
Keratin dynamics 
(FRAP analysis) in 
living epithelial cells. 
(Yoon et al., 2001) 
 
Role of 14-3-3 binding to 
keratins during mitosis. 
(Ku et al., 2002)  
 
Unraveling the roles of 
conserved segments 1A 
and 2B of the intermediate 
filament dimer in filament 
assembly with atomic 
resolution. (Strelkov et al., 
2002)  
 
Unit length filaments 
(ULFs) resulting from 
lateral association of 
vimentin intermediate 
filament dimers. 
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Role of protein 
phosphatases in 
regulating the structural 
organization of 
intermediate filaments. 
(Eriksson et al., 1992)  
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Roles of K6 and K17 
during wound closure 
in embryonic skin. 
(Mazzalupo et al., 
2003)   
K8 and K18 mutations 
are risk factors for 
developing liver 
diseases. (Ku et al., 
2003) 
Assymetric cell 















growth and size by 
regulating protein 
synthesis. (Kim et 
al., 2006)  





skin integrity in EBS. 
(Kerns et al., 2007)
               
 
Consensus meeting on 
the diagnosis and 
classification of 
inherited EB. (Fine et 
al., 2008)   
Commencement of the 
human intermediate 
filament database. 
(Szeverenyi et al., 
2008)   
Gene targeting strategy 
that eliminates the entire 
keratin multiprotein family 
reveals the roles of 
keratins in growth and 
protein biosynthesis. 




epithelial injury by 
promoting 
phosphorylation and 
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1.5  Keratin intermediate filaments  
1.5.1  Keratin expression in the epidermis  
Keratinocyte differentiation plays an important role in the maintanence of epidermal 
barrier function. Since keratins are the most abundant epidermal proteins that are 
found in keratinocytes, changes in keratin expressions as the keratinocytes undergo 
the terminal differentiation program are likely to play a role in epidermal 
morphogenesis. 
Indeed, within the epidermis, there exists a differential pattern of keratin expressions 
that are tighly regulated across the different layers.  For instance, basal keratinocytes 
at the basal layer express K5 and K14 as their major keratins (Nelson and Sun, 1983), 
whereas keratinocytes at the spinous and granular layers are found to express K1 and 
K10 predominantly (Fuchs and Green, 1980). Keratin 2e (now called K2) has been 
found to localize further up in the granular layer, and its expression is delayed relative 
to K1 and K10 (Collin et al., 1992). Other site-specific suprabasal keratins include K9, 
which is confined to palmo-plantar skin (Fuchs and Green, 1980). Why there is a need 
for different keratin expression in the epidermis is not so well understood, but one 
reason could be that keratin filaments are differentially orientated in their spatially 
confined compartments to perform specific functions. Keratin filaments (K5 and K14) 
are orientated in a parallel manner in basal keratinocytes, wherein these cells can 
compact together in epidermal folds seen in histological section (see Figure 1.1), 
allowing them to proliferate in the basal layer. Keratin networks (K1 and K10) are 
arranged in either parallel arrays or cubic-like structures in the uppermost cornified 
layers of the epidermis to establish a stiff corneocyte keratin network (Norlen and Al-
Amoudi, 2004), and the spacing out of corneocytes seen in histological section (see 
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Figure 1.1) could therefore confer mechanical resilience to the epidermis. In support 
of this, in vitro formation of the suprabasal cytoskeleton (K1 and K10) is dependent 
on the pre-existing basal cell intermediate filament (K5 and K14) network (Kartasova 
et al., 1993; Paramio and Jorcano, 1994), hence stressing the need for different keratin 
expressions in the epidermis.  
1.5.1.1  Stratification process 
How these switches in keratin expression occur so precisely as keratinocytes 
progressively undergo terminal differentiation has not been well understood until 
recently. A few recent discoveries highlight key events leading to stratification 
processes. It is shown that in response to canonical Notch/RBP-J (recombining 
binding protein suppressor of hairless) signalling, basal keratinocytes became 
committed to undergo terminal differentiation. This occurs through suppression of 
basal cell gene expression, such as K5 and K14, via Hes-1 (a downstream target of 
Notch/RBP-J) -independent pathways, and induction of spinous cell differentiation 
through switching on differentiation-specific genes such as K1 and K10 expression 
via Hes-1 dependent pathways (Blanpain et al., 2006). In addition, AP2 transcription 
family factors can promote spinous cell commitment by exerting effects antagonistic 
to EGFR signalling, which is known to promote proliferation and serve as a 
suppressor of Notch signalling (Kolev et al., 2008).  Moreover, stratification is 
initiated by asymmetric cell divisions (mitotic spindles perpendicular to basement 
membrane) to enable vertical expansion of the suprabasal keratinocytes (Lechler and 
Fuchs, 2005). The control points for mitotic orientation in epidermal development 
were recently identified in mouse, which involved both the tightly regulated 
expression of mInsc (mouse Inscuteable) and NuMA (nuclear mitotic apparatus 
protein), to direct apical-basal spindle orientation during asymmetric cell division 
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(Poulson and Lechler, 2010).  This process was recently reported to be also under the 
influence of Notch signaling (Williams et al., 2011).  
1.5.1.2  Wound healing (re-epithelialization) 
In situations of epidermal injury, wounded keratinocytes induce K6 proteins (K6a, b 
and c), K16 and K17 in suprabasal cells at the expense of K1 and K10 (Weiss et al., 
1984; Jiang et al., 1993). At this stage known as the re-epithelialization phase of 
wound healing, keratinocytes at the wound edge change their morphology from 
cuboidal to become flattened and extend numerous ruffles known as lamellipodia in a 
polarized manner. Before they migrate into the wound site, they must disassemble 
their desmosomes and hemidesmosomes (at least partially), and relocate their 
integrins onto actin microfilaments to serve as focal adhesions during migration. This 
ensures that the keratinocytes detach from the basement membrane and enter the 
wound bed (reviewed in Santoro and Gaudino, 2005). Keratinocytes advance in 
epithelial sheets (also known as the epithelial tongue) across the wound site, secreting 
collagenases and proteases such as matrix metalloproteinases (MMPs) to dissolve 
parts of the damaged ECM at the front of the migrating sheet (Salo et al., 1994). 
These changes in keratinocyte motility and cell-cell adhesion during re-
epithelialization recapitulate several aspects of type II epithelial to mesenchymal 
transition (EMT) in wound repair (reviewed in Kalluri and Weinberg, 2009), wherein 
epithelial cells undergoing EMT convert from a sedentary to a migratory phenotype, 
remodel the ECM surrounding them and secrete MMPs to assist in their migration 
(reviewed in Leopold et al., 2012). Growth factors and cytokines (Myers et al., 2007), 
stimulated by integrins and MMPs, cause keratinocytes to proliferate close to wound 
edges to generate new keratinocytes for replacement of lost cells, which occurs at a 
much faster rate than in normal tissues (reviewed in Deodhar and Rana, 1997). 
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Keratinocytes continue migrating across the wound bed till cells from either end meet 
in the middle, at which contact inhibition prevents them from migrating further. At 
this point, keratinocytes begin to secrete new basement membrane proteins (Laplante 
et al., 2001) and reverse their morphology back to cuboidal shapes, re-establishing 
desmosomes to facilate cell-cell adhesion and hemidesmosomes to anchor to the new 
basement membrane again. The functional epidermis is then regenerated from 
epithelial stem cells originating from the basal layer of the interfollicular epidermis  
(reviewed in Liang and Bickenbach, 2002) and skin appendages such as hair follicle  
(Cotsarelis et al., 1990; Taylor et al., 2000; Ito et al., 2005) and sweat gland (Lu et al., 
2012). These epithelial stem cells are self-renewing, and are able to generate the 
rapidly proliferating keratinocytes (transit amplifying cells) needed to reconstruct the 
epidermal barrier (reviewed in Gurtner et al., 2008; Lau et al., 2009). These transit 
amplifying cells can undergo several cell divisions before differentiating via 
Notch/p63 cross-talk (Nguyen et al., 2006) to re- form the strata found in the re-
epithelialized skin, and restore the epithelial barrier function (reviewed in Raja et al., 
2007).  
The dramatic changes in keratin expression that are associated with this profound 
change in keratinocyte behaviour suggest that the functional properties of different 
keratins may directly regulate growth and regeneration of these epithelia. In the 
following paragraphs, the structure and functions of keratin proteins in the 
cytoskeleton will be discussed in detail.  
1.5.2  Keratin structure and assembly 
Keratins belong to the intermediate filament family of proteins, which all share 
similar structure, sequence and function, and are expressed in a tissue- and 
48 
 
differentiation-dependent manner. Intermediate filaments, together with actin 
microfilaments and microtubule filaments, form the major constituents of the cellular 
cytoskeleton. The name „intermediate filaments‟ is derived from their diameter, which 
is 10-12 nm, being intermediate between that of actin microfilaments (5-8 nm) and the 
microtubules (25 nm) (reviewed in Omary et al., 2006). Keratins are a major 
constituent of the epidermal keratinocytes. They typically connect to desmosomes and 
hemidesmosomes, thereby contributing not only to stability between epithelial cells 
but also to the stability of the epithelial attachment to the basement membrane, hence 
conferring mechanical resilience to the skin (reviewed in Fuchs and Karakesisoglou, 
2001).  
1.5.2.1  Keratin intermediate filament family 
Keratin genes form the largest group of the intermediate filament family in the human 
genome, comprising of 54 distinct functional genes. According to their biochemical 
properties (isoelectric points and molecular weights), keratins can be classified into 
two groups, the acidic type I and the basic to neutral type II keratins  (Moll et al., 
1982). A new consensus nomenclature for mammalian keratin genes and proteins has 
recently been reported, and is divided into three categories: (1) epithelial keratins, (2) 
hair keratins and (3) keratin pseudogenes (Schweizer et al., 2006). This nomenclature 
includes 28 type I (K9, K10, K12-K20, K23-K28, K31-K40) and 26 type II (K1-K8, 
K71-K86) keratins, which form two clusters of 27 genes each on chromosomes 
17q21.2 and 12q13.13 [the gene for type I K18 being located in the type II keratin 
gene domain as discovered in (Waseem et al., 1990)], thereby extending the catalog of 




1.5.2.2  Primary structure of keratin 
Like all other intermediate filament proteins, keratins contain a central α-helical rod 
domain of ~ 310 amino acids that is interrupted by non-α-helical linkers and flanked 
by non-α-helical amino-terminal “head” and carboxy-terminal “tail” domains, giving 
rise to a highly conserved tripartite structure (reviewed in Herrmann et al., 2009). The 
central rod domain is composed of sub-domains 1A, 1B, 2A and 2B (Weber et al., 
1988) which are separated by linkers L1, L12 and L2, and an additional interruption 
in segment 2B, the so-called stutter region (North et al., 1994). These regions of 
sequence discontinuity are highly conserved in all intermediate filament proteins 
(Weber and Geisler, 1985) and may not form α-helices (reviewed in Steinert et al., 
1994) (see Figure 1.6). A role for the stutter region in K14 rod 2B domain is recently 
suggested wherein the highly conserved cysteine residue at 367 (K14 C367) may be 
involved in mediating trans-dimer disulfide formation between K5 and K14 
heterodimers, hence promoting perinuclear organization of keratin filaments (Lee et 
al., 2012). Moreover, it is proposed that trans- filament disulfide linkages between 
pairs of keratin intermediate filament (K5 and K14) may affect its alignment in the 
reorganisation of nuclear shape in different calcium concentrations mimicking 
stratification process. It is observed that in low calcium medium, keratinocytes have 
parallel keratin bundles with elongated nucleus whereas at high calcium concentration, 
keratin filament bundles tend to wrap around the round shape nuclei, where they cross 
each other at various angles to form a cube- like architecture (Lee et al., 2012). This 
suggests that the orientation of keratin intermediate filaments may confer epithelial 
cells the network stiffness required for the mechanical resilience of the epidermis.  
The rod domain is composed of heptad repeats, ie. repeats of seven amino acid 
residues (a-b-c-d-e-f-g)n, in which positions “a” and “d” are generally occupied by 
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hydrophobic residues that drive coiled-coil heterodimer formation. Positions “e” and 
“g” are normally occupied by hydrophilic and charged residues that may provide 
additional interactions to strengthen the binding (see Figure 1.7). The starting residues 
of rod 1A domain and the ending residues of rod 2B domain, known as the helix 
initiation and the helix termination motifs respectively, comprise of ~ 20 amino acid 
sequence motifs that are highly conserved among the different keratins (see Figure 
1.6). These motifs are crucial for initiating keratin intermediate filament assembly and 
any mutations residing in these motifs will interfere with the early stages of filament 
elongation (Steinert et al., 1993). Indeed, the helix boundary motifs are known to be 
mutational “hot spots” in almost all inherited keratin disorders (Muller et al., 2006). 
On the other hand, variations in the amino acid sequences residing at the “head” and 
“tail” domains seem to account for the diversity among individual keratin proteins 
(reviewed in Lane and McLean, 2004). In addition, these end domains can undergo 
posttranslational modifications that can further modulate the solubility, organization 
and function of the keratin intermediate filaments (reviewed in Omary et al., 2006). 
1.5.2.3  Secondary structure of keratin 
Keratins are obligate heterodimers of epidermal type I (Steinert et al., 1983) and type 
II (Steinert et al., 1985) keratins in a 1:1 molar ratio, which exhibit a parallel, in-
register alignment (Parry et al., 1985; Hatzfeld and Weber, 1990; Steinert, 1990). 
Almost any type I and type II pair will co-polymerize in vitro (Hatzfeld and Franke, 
1985). However, the resulting filaments are not stable and co-polymerization is not 
efficient between pairs of keratins that are not normally co-expressed in tissues. Since 
full- length intermediate filament dimers spontaneously assemble into filaments, this 
makes intermediate filaments poor candidates for study by crystallization. Hence, up 
till now, there are still no crystal structure of the full- length intermediate filament 
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dimer, unlike that of the other cytoskeletal structures such as globular actin (Bubb et 
al., 2002) or the tubulin dimer (Nogales et al., 1998). In an attempt to overcome the 
difficulties in studying intermediate filament structure, a divide- and- conquer 
approach has been used (Strelkov et al., 2001). This method produced and 
characterized 17 overlapping soluble fragments of intermediate filament protein, and 
some of these fragments produced useful diffraction data at the resolution between 1.4 
and 3 Å. Using these results and molecular modeling, a model of the vimentin 
homodimer has been constructed (Strelkov et al., 2002). A more recent study revealed 
the crystal structure of K5-K14 coiled-coil heterodimer in the rod 2B domain, and 
some distinctive features of K5-K14 rod 2B heterodimer, as compared to vimentin rod 
2B homodimer, were observed. Firstly, the hydrogen bonds and most of the salt 
bridges in the K5-K14 model were unidirectional or asymmetric, which was different 
from those in vimentin homodimer. Secondly, the K5-K14 model formed more 
asymmetrical salt bridges with minimal symmetrical hydrophobic interaction clusters 
and these features could promote a strong inclination for the formation of K5-K14 
heterodimers (Lee et al., 2012). Moreover, the crystal structure of the K5-K14 rod 2B 
heterodimer indicated a strong negative charge potential at the C terminus and a 
strong positive charge at the N terminus where both K5 and K14 could contribute to 
the polarized surface potential of the 2B coiled-coil in a complementary manner. This 
bias in surface-charge distribution was distinct from that of other filament crystal 
structures previously observed, such as that of the rod 2B domains of lamin A/C 
(Strelkov et al., 2004) and vimentin (Strelkov et al., 2002), and were thought likely to 
play a role in the axial alignment of K5-K14 heterodimers in forming larger oligomers 




1.5.2.4  Keratin intermediate filament formation 
Physiologically, the smallest soluble oligomer that can be detected in vivo is a 
tetramer consisting of two anti-parallel heterodimers (Soellner et al., 1985). It was 
proposed that two adjacent lengths of the coiled-coil dimers aligned in an anti-parallel 
and a half-staggered arrangement such that their coil 1B subdomains could overlap, 
forming a protofilament (one tetramer) (Steinert et al., 1993; Bernot et al., 2005). This 
resultant anti-parallel formation of the tetramer makes keratin filaments apolar in 
nature. Two of these protofilaments then intertwine to form a protofibril (two 
tetramers) (Aebi et al., 1983). Four of these protofibrils then rapidly associate laterally 
into unit- length filaments (eight tetramers) (Herrmann et al., 1996) from where they 
longitudinally anneal to form short filaments. These filaments then further assemble 
by end-to-end annealing of filaments which then undergo radial compaction to form 
~10 nm diameter intermediate filaments (reviewed in Herrmann et al., 2009) (see 
Figure 1.8). In vivo demonstration of these processes was shown recently whereby 
exchanges of intermediate filament subunits could occur along the lengths of 
intermediate filament and this was known as intercalary subunit exchange (Colakoglu 














Helix initiation motif 
Helix termination motif 
Figure redrawn after Herrmann et al., 2009   
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Figure 1.7 Pairing of type I (K14) and type II (K5) keratins at the helix motifs  
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Figure 1.8 Phases of intermediate filament assembly  
Parallel dimer in exact register 
Anti-parallel tetramer in staggers 
Lateral association of 8 tetramers 
into unit-length filaments (ULFs) 
X 7 
Longitudinal annealing of 
ULFs and filaments 
Radial compaction of extended filaments 
Figure redrawn after Herrmann et al., 2009   
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1.6  Post-translational modifications of keratin intermediate filament  
1.6.1  Phosphorylation 
Keratins are subjected to multiple post-translational modifications that have important 
consequences for their structures and properties (reviewed in Coulombe and Omary, 
2002). Post-translational modifications can occur via several modalities including 
phosphorylation (Gilmartin et al., 1980; Ikai and McGuire, 1983), glycosylation (Tao 
et al., 2006a), sumoylation (Snider et al., 2011), caspase cleavage (Caulin et al., 1997) 
and ubiquitylation (Ku and Omary, 2000), of which phosphorylation is the most 
widely studied (reviewed in Coulombe et al., 2000). For instance, increased levels of 
phosphorylated keratins were detected in mitotic cells (Celis et al., 1983) or in various 
stress paradigms (Liao et al., 1997; Toivola et al., 2002), where keratin filaments 
either disassembled completely into soluble subunits and granular aggregates or 
collapsed into cage-like thick filament bundles (Lane et al., 1982). Phosphorylation 
may also affect keratin organization by shifting the equilibrium between the soluble 
and filamentous state towards the soluble form (Chou and Omary, 1993).  
1.6.1.1  Kinases regulating keratin organization 
One of the emerging families of kinases that play a role in phosphorylating keratin 
intermediate filaments is the mitogen activated protein kinases (MAPKs). Several 
growth factors, including epidermal growth factor (EGF), vascular endothelial growth 
factor (VEGF), insulin and inflammatory cytokines, activate MAPKs. The best 
characterized of the MAPK pathways is the MEK/ERK signalling cascade.  This 
signalling casade is activated by protein tyrosine kinase receptors, such as EGF 
receptor (EGFR) or VEGF receptor (VEGFR). When the growth factors bind to their 
cognate receptors, the tyrosine receptor dimerizes and concomitantly activates its 
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intracellular protein tyrosine kinase via auto-phosphorylation. The phosphotyrosine 
then serve as docking sites for SH2 or PTB domain containing proteins (reviewed in 
Schlessinger and Lemmon, 2003; Pawson, 2004). These docking proteins include 
FRS2 (FGF receptor substrate-2), IRS1 (insulin receptor substrate-1), and Gab1 (the 
Grb2-associated binding protein), which when phosphorylated, recruit multiple Grb2 
and Shp2 molecules (reviewed in Lemmon and Schlessinger, 2010). The Grb2 and 
Shp2 molecules, together with SOS, are brought in close proximity to Ras and 
activate it. Activated Ras, in turn, triggers a cascade of activation of three protein 
kinases, Raf1, MEK1/2 and ERK1/2 (Ullrich and Schlessinger, 1990). Activated 
ERK1/2 can then translocate into the nucleus where it phosphorylates and activates 
transcription factors such as ATF2, c-Jun, Elk1 and SAP1 (Hill and Treisman, 1995).  
Recent studies have revealed the presence of scaffold proteins that can confer spatial 
and temporal regulation of the MAPK pathway. Originally identified in yeast (Elion, 
2001), these scaffold proteins bring multiple components of the MAPK cascade in 
close proximity to facilitate efficient propagation of the signal (reviewed in Brown 
and Sacks, 2009). Scaffold proteins that can modulate the assembly and activation of 
ERK1/2 module have been identified, including KSR (kinase suppressor of Ras 
signalling) (Kornfeld et al., 1995), MP1 (MEK partner 1) (Schaeffer et al., 1998) and 
β-arrestin (Luttrell et al., 1999). 
Other MAPKs include c-Jun N-terminal kinase (JNK) and p38. JNK was originally 
identified as the protein kinase stimulated by UV radiation that could phosphorylate 
and activate the proto-oncogenic transcription factor c-Jun (Hibi et al., 1993). The 
JNK pathway is mainly activated by cellular stress (UV radiation) and 
proinflammatory cytokines such as TNFα and IL-1 (reviewed in Davis, 2000), 
resulting in the activaton of c-Jun and ATF2 (Derijard et al., 1994; Gupta et al., 1995). 
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These stimuli activate JNKs through several upstream kinases such as 
MEKK1/MKK4 complex and HPK-1/MLK1/MKK7 signalling module bound by JIP-
1 scaffold protein (reviewed in Chang and Karin, 2001; Weston and Davis, 2007).  
p38 MAPK was originally identified as a 38 kDa protein that was tyrosine 
phosphorylated in response to lipopolysaccharide-stimulated macrophages (Han et al., 
1994). The p38 MAPK pathway is predominantly activated by environmental stress 
such as osmotic shock, hypoxia, heat shock and UV radiation (reviewed in Ashwell, 
2006), resulting in the activation of ATF2, Fos, Jun and Elk1 (reviewed in Obata et al., 
2000). These stimuli activate p38 through several upstream kinases such as MKK3 
and MKK6, which are themselves phosphorylated by several upstream kinases, 
including TAK1 (through TRAF6/TAB1/2), MLK3 and ASK1 (MEKK5) (reviewed 
in Johnson and Lapadat, 2002; Brancho et al., 2003).  
It is suggested that in normal physiological condition, MAPK cascades would  occur 
independently but during pathological situations, there will be significant cross-talks 
between them (reviewed in Noselli and Perrimon, 2000). Because p38 MAPK and 
JNK are often activated in stress stimuli, they are collectively known as stress 
activated protein kinases (SAPK). 
A role for MAPKs in keratin phosphorylation was demonstrated when activated p38 
MAPK and MK2/3 cooperatively phosphorylated several epithelial keratins such as 
K8, K18 and K20 in intestinal epithelial cells (Menon et al., 2010). Moreover, p38 
MAPK was found to colocalize with keratin granules that were induced during 
mitosis, in various stress situations and in cells producing mutant keratins, which 
correlated with phosphorylation of K8 serine 74, a well known p38 target site. In 
addition, inhibiting kinase activity using p38 MAPK inhibitors reduced the formation 
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of these granules, suggesting a role for phosphorylation in regulating keratin 
organization (Woll et al., 2007). Also, when keratinocytes were subjected to hypo-
osmotic stress, a sustained stress-activated response (SAPK/JNK pathway) was 
observed in cells that produced mutant keratins as compared to control cells, 
concomitant with an increase in phosphorylated K5 (D'Alessandro et al., 2002). These 
studies show that signalling cascades involving phosphorylation are important in 
regulating keratin organization. 
1.6.1.2  Phosphatases regulating keratin organization 
Phosphatases regulate kinase activity by removing phosphate groups and are therefore 
key players in all phosphorylation driven signalling cascades. Phosphatases also play 
a role in regulating keratin and other intermediate filament organization. For instance, 
it was found that structural organization of intermediate filament in interphase cells 
required protein phosphatase activity (Eriksson et al., 1992). In another study, it was 
shown that phosphorylated K8 at serine 432 was a physiological substrate for 
phosphatase PP2A after hypo-osmotic stress and also occured preferentially in 
mitotically active cells (Tao et al., 2006b). Moreover, phosphatase of regenerating 
liver-3 (PRL-3), a member of the PRL protein tyrosine phosphatase family, was also 
shown to mediate the dephosphorylation of K8 at serine residues 74 and 432, and this 
led to the promotion of cells with increased migration and metastatic potential 
(Mizuuchi et al., 2009; Khapare et al., 2012). These studies show that signalling 





1.6.2  Glycosylation 
Keratins are also subjected to glycosylation, which refers to the addition of O-linked 
single N-acetylglucosamines (O-GlcNAc) to serine and threonine residues. K13 was 
the first keratin to be modified by glycosylation (King and Hounsell, 1989). It was 
later shown that keratins such as K8 and K18 (Chou et al., 1992; Chou and Omary, 
1993) were being glycosylated, and mutational analysis of these sites suggested a role 
for glycosylation in filament assembly (Ku and Omary, 1995). A role for keratin 
glycosylation in protecting epithelial tissue from injury was recently suggested 
through the promotion of phosphorylation and activation of cell survival kinases (Ku 
et al., 2010). 
1.6.3  Ubiquitylation 
The ubiquitin-proteasome pathway starts with the activation of ubiquitin by the 
ubiquitin-activating enzyme (E1), followed by the transfer of ubiquitin to an 
ubiquitin-conjugating enzyme (E2). E2 then shuttle the ubiquitin molecule to the 
substrate-specific ubiquitin ligase (E3), which then delivers the ubiquitin to the 
substrate destined to be degraded. Polyubiquitin chain formation continues with the 
conjugation of subsequent ubiquitin moieties to the attached ubiquitin on the substrate 
and the substrate-ubiquitin conjugate is then degraded by 26S proteasome in an ATP-
dependent manner (Hershko and Ciechanover, 1998; Ciechanover et al., 2000). 
Specifically, the E2s involved in keratin degradation are from the UbcH5/Ub3 
families (Jaitovich et al., 2008) whereas the E3s involved in keratin degradation are 
the RING finger proteins (He et al., 2008; Duan et al., 2009). One of the pathological 
features of intermediate filament-associated diseases is the accumulation of 
intracytoplasmic inclusion bodies (aggresomes) that are made up mainly of 
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intermediate filament proteins and ubiquitin (Lowe et al., 1988). Studies have also 
shown that there is cross-talk between phosphorylation and ubiquitylation of keratins 
(Ku and Omary, 2000). For instance, phosphorylation of K8 at Ser 73 was required 
for ubiquitylation of the keratin protein following shear stress in alveolar epithelial 
cells (Jaitovich et al., 2008). Signalling kinases such as p38, ERK and src may also 
play a role in the formation of aggresomes (Wu et al., 2005; Nan et al., 2006), thus 
strengthening the link between phosphorylation of keratins and ubiquitylation fate for 
degradation. 
1.6.4  Sumoylation 
Other than ubiquitylation, sumoylation is also an important regulatory modification 
for keratin intermediate filament. Sumoylation is a reversible process of adding and 
removing small ubiquitin- like modifier (SUMO) polypeptides (SUMO-1, -2 or -3) 
(Bergink and Jentsch, 2009) that targets the internal lysine residues of protein and 
affects protein localization, interactions with binding partners and degradation (Geiss-
Friedlander and Melchior, 2007). A recent study had revealed the role of sumoylation 
on keratin intermediate filament in response to stress, affecting keratin organization 
and solubility (Snider et al., 2011). Moreover, the degree of sumoylation could 
determine keratin dynamics, where modest sumoylation of wild-type K8 could 
promote solubility whereas hypersumoylation of K8, prominent in chronic liver 
disease, could result in reduced solubility (Snider et al., 2011).  
In summary, these studies have revealed the requirements for rapid assembly and 
proper organization of intermediate filament subunits into stable filaments in 
maintaining the cytoskeletal structure of epidermal keratinocytes. Hence, the first 
discovery of pathogenic mutations in keratin intermediate filaments leading to 
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patients suffering from the epidermal fragility disorder, epidermolysis bullosa simplex 
(EBS), further reinforced the idea that keratins play an important role in providing 
cells with mechanical resilience. 
1.7  Keratinopathies (mutations in keratins) 
The association between keratin intermediate filament and inherited skin fragility 
disorders such as EBS was first described in the early 1990s (Bonifas et al., 1991; 
Coulombe et al., 1991a; Lane et al., 1992). Since then, the number of keratin 
mutations associated with pathological conditions has increased, with mutations in 
more than 100 different genes including approximately 20 different keratin genes (for 
details, see the Human Intermediate Filament Database, www.interfil.org; Szeverenyi 
et al., 2008). These mutations are mostly autosomal dominant because mutations in 
one keratin can affect its heterodimer partner in a dominant negative manner during 
filament assembly and elongation (reviewed in Arin, 2009).  
1.7.1  Spectrum of disease phenotypes of keratin mutations  
In addition, there exists a wide spectrum of disease phenotypes that are associated 
with the site (s) at which these mutant keratins are located in the epidermis. For 
instance, K14 and K5 (expressed in epidermal basal keratinocytes) mutations result in 
EBS (Bonifas et al., 1991; Coulombe et al., 1991a; Lane et al., 1992) whilst keratin 
mutations in K10 and K1 (expressed in suprabasal keratinocytes) lead to bullous 
congenital epidermolytic hyperkeratosis, also known as epidermolytic hyperkeratosis 
(Cheng et al., 1992; Chipev et al., 1992). K2 (K2e expressed in upper spinous layers) 
mutations give rise to ichthyosis bullosa of Siemens (Rothnagel et al., 1994), K9 
(palmoplantar skin) mutations result in epidermolytic palmoplantar keratoderma (Reis 
et al., 1994), K4 and K13 (oral mucosa) mutations lead to white-sponge nevus 
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(Richard et al., 1995; Rugg et al., 1995) and K6 (K6a, b), K16, K17 (plamoplantar 
skin, oral mucosa and epithelial oesophagus, nail) mutations give rise to 
pachyonychia congenita (Bowden et al., 1995; McLean et al., 1995) (See Table 1.7 
for clinical descriptions).  
1.7.1.1  Phenotypic variation between different mutations in the same gene 
Of note, there is a phenotypic variation between different mutations in the same gene 
(reviewed in Lane, 1994; McLean and Lane, 1995). For instance, mutations found at 
the helix motifs of the keratin intermediate filament usually result in a more severe 
phenotype than a mutation that is located at the other non-helical domains. These 
severe phenotypes are usually presumably attributed to a deficit in filament assembly 
kinetics and organization. Hence, a genotype-phenotype correlation in keratin 
disorders exists (Letai et al., 1993). In addition, in patients suffering from severe EBS 
with mutations in K14, the most frequently mutated residue is the arginine at the 
codon 125 within the helix initiation motif (Szeverenyi et al., 2008). This residue, 
found within the helix initiation motif, is highly conserved throughout the type  I 
keratins and contain a CpG dinucleotide sequence. CpG nucleotides have a very high 
rate of mutation due to the de-amination of 5-methylcytosine to thymine. This 
thymine is not removed by uracil DNA glycosylase during DNA synthesis and thus is 
subjected to pair with adenine during replication, hence giving rise to a point mutation 
(reviewed in Corden and McLean, 1996). Point mutations found in the helix initiation 
motif or the helix termination motif in K5 and K14 have been reported to cause most 
of the severe EBS Dowling-Meara phenotypes. On the other hand, mutations affecting 
residues found at the nonhelical head and linker domains in K5/K14 often contribute 




1.7.1.2  Phenotypic variation between different mutations of the same amino 
acid residue in the same gene 
Different mutations of the same amino acid residue in the same gene can also 
contribute to phenotypic variation. For example, K14 M119T mutation results in 
EBS-DM (severe phenotype) whereas K14 M119V mutation results in EBS-
generalized (mild phenotype) (Cummins et al., 2001). Likewise, K14 A413P mutation 
results in EBS-localized whereas K14 A413T mutation results in normal phenotype 
(Murrell et al., 2011; Natsuga et al., 2011). The Natsuga study was supported by in 
silico modelling where proline substitution resulted in deleterious structural defects of 
K14 protein but not threonine substitution in which slight instability of the structure 
was observed (Natsuga et al., 2011). It was believed that structurally, threonine and 
adenine could be considered interchangeable because they could substitute for one 
another on a frequency that equals their occurence in structured proteins (Henikoff 
and Henikoff, 1992).  
1.7.1.3  Phenotypic variation due to genetic modifiers  
In cases where there is an aggravation of disease condition, it was shown that genetic 
modifiers can play a role in the pathogenesis. Coinheritance of both filaggrin (FLG) 
(p. R2447X) and K16 (KRT16) (p. L132P) mutations resulted in a more severe 
pachyonychia congenita condition than that of K16 mutation (p. L132P) alone 
(Gruber et al., 2009). Hence, this indicates that FLG can serve as a genetic modifier 




1.7.1.4  Phenotypic variation due to functional redundancy for keratins  
In addition, there is a functional redundancy for keratins. For instance, functional 
redundancy was observed in relatively mild phenotype of patients with recessive EBS 
due to the lost of both K14 alleles. This was probably a result of the compensatory 
presence of K15 in basal keratinocytes (Jonkman et al., 1996; Batta et al., 2000). 
Another example was that patients with K1 mutations suffered from palmoplantar 
keratoderma but not in patients with K10 mutations. This was possibly due to the 
compensatory presence of another type I keratin, K9, in the palmoplantar skin 
(DiGiovanna and Bale, 1994). Of note, patients with K9 mutations suffered from 
palmoplantar keratoderma as well because K10 cannot replace the loss of K9 in 
palmoplantar skin.  
Since basal keratinocytes express K14 and K5 predominately and that K14 and K5 
mutations are associated with skin fragility disorder such as EBS (which is within the 
scope of this thesis), the classification of epidermolysis bullosa (EB) and its subtype 
EBS will be discussed in detail in the following paragraphs. 
1.8  Classification of epidermolysis bullosa (EB) 
Epidermolysis bullosa (EB) encompasses a group of heterogenous hereditary diseases 
that have skin fragility (blister formation) upon mild trauma. The term was first used 
in 1886 (Koebner, 1886). Over the years, as improvements in the diagnostic and 
research techniques coupled with insights in the molecular background of EB 
increased, a novel classification system was developed (Pearson, 1962) and the latest 
consensus was recently established (Fine et al., 2008). 
66 
 
Presently, EB can be classified into four major subtypes known as EBS, junctional EB 
(JEB), dystrophic EB (DEB) and Kindler syndrome (KS), distinguished by 
differences in the ultrastructural level within which blisters occur in the skin, either 
spontaneously or following minor friction or trauma (Fine et al., 2008). This is often 
diagnosed using immunofluorescence antigen mapping and/or electron microscopy 
analysis. For instance, in EBS, the plane of cleavage is intraepidermal (basal or 
suprabasal). In JEB, the blisters cleave the lamina lucida. In DEB, the blisters form 
beneath the lamina densa (sub-lamina densa). Skin fragility in KS can give rise to 
multiple (mixed type) planes of cleavage (see Figure 1.9). A list of EB subtypes is 
also tabulated in Table 1.8.  
67 
 
Table 1.7  
Human keratinopathies of the epidermis  
        
    
Molecular target Disease Clinical phenotype (s) Original finding (s) 
K5, K14 Epidermolysis bullosa 
simplex (OMIM # 131760) 
Skin fragility from cytolysis of basal 
keratinocytes 
(Bonifas et al., 1991; 
Coulombe et al., 1991a; 
Lane et al., 1992). 
K1, K10 Epidermolytic hyperkeratosis 
(OMIM # 113800) 
Erythematous blistering due to fragility of 
suprabasal keratinocytes; Later development of 
hyperkeratosis 
(Cheng et al., 1992; 
Chipev et al., 1992) 
K2 Ichthyosis bullosa of Siemens 
(OMIM # 146800) 
Bullous ichthyosis without erythroderma; 
Epidermolysis limited to upper spinous layers; 
Later development of dark brown hyperkeratosis 
(Rothnagel et al., 1994) 
K9 Epidermolytic palmoplantar 
keratoderma (OMIM # 
144200) 
Epidermolysis and hyperkerotosis of palm and 
soles 
(Reis et al., 1994) 
K4, K13 White-sponge nevus (OMIM 
# 193900) 
Spongy white plaques, often on buccal mucosa; 
Oral leukokeratosis 
(Richard et al., 1995; 
Rugg et al., 1995) 
K6, K16, K17 Pachyonychia congenita 
(PC-1: OMIM # 167200; PC-
2: OMIM # 167210)  
Dystrophic nails; Palmoplantar hyperkeratosis; 
Follicular hyperkeratosis; Oral leukokeratosis  
(Bowden et al., 1995; 
McLean et al., 1995) 
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Table 1.8  
Classification of epidermolysis bullosa (EB) 
  
Molecular target  Disease Clinical phenotype (s) Original finding (s) 






simplex (basal) (OMIM # 
131760) 
Skin fragility from cytolysis of basal 
keratinocytes 
(Bonifas et al., 1991; 
Coulombe et al., 1991a; 
Lane et al., 1992). 
Epidermolysis bullosa 
simplex (suprabasal) (PKP1: 
OMIM # 604536; DP: OMIM 
# 609638) 
Cutaneous fragility and congenital ectodermal 
dysplasia affecting skin, hair and nails 
(McGrath et al., 1997; 
Jonkman et al., 2005) 
Laminin-332: 





epidermolysis bullosa (OMIM 
# 226700) 
Extensive blistering of the skin and mucosal 
surfaces 
(Pulkkinen et al., 1994a; 
Pulkkinen et al., 1994b; 
Kivirikko et al., 1995) 
Junctional epidermolysis 
bullosa with pyloric atresia 
(OMIM # 226730) 
Pyloric atresia and cutaneous aplasia; Mucosa 
erosions 
(Vidal et al., 1995; 
Shimizu et al., 1996) 
Collagen VII Dystrophic epidermolysis 
bullosa (OMIM # 226600) 
Severe blistering with atrophic scarring; Nail 
atrophy;  Mucosa erosions 
(Christiano et al., 1993) 
FFH-1  
(KIND1) 
Kindler syndrome (OMIM # 
173650) 
Congenital blistering; Photosensitivity; 
Progressive poikiloderma with dyschromatic 
macules; Telangiectases and cutaneous atrophy 
(Jobard et al., 2003; 
Siegel et al., 2003) 
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Figure 1.9 Classification of epidermolysis bullosa (EB) 
  








Type I and III collagen 
Normal skin 
+ 
Figure redrawn after Shinkuma et al., 2011. 
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1.9  Classification of epidermolysis bullosa simplex (EBS) 
1.9.1  Characterization of EBS phenotypes 
EBS is one of the major subtypes of EB and is characterized by an intraepidermal 
level of blister formation (see Figures 1.9 and 1.10). EBS is the most prevalent type of 
EB with approximately 1 in 25,000 live births (Horn and Tidman, 2000). According 
to the latest EB classification, EBS has been subdivided into basal and suprabasal 
EBS, depending on the ultrastructural level of blistering within the epidermis (Fine et 
al., 2008). At the structural level, electron microscopy consistently revealed 
aggregates of electron-dense material in a subset of patients suffering from severe 
EBS Dowling-Meara (Anton-Lamprecht and Schnyder, 1982). Consequently, 
immunoelectron microscopy confirmed the presence of keratin intermediate filaments 
in these electron-dense aggregates (Ishida-Yamamoto et al., 1991) (Figure 1.10). A 
role for keratins in EBS phenotype was suggested from the expression of mutant 
keratin cDNAs (both truncations and mutations) in cultured epithelial cells that 
resulted in a dominant-negative disruption and aggregation of endogenous keratin 
network (Albers and Fuchs, 1989; Coulombe et al., 1991b). Mutations in the KRT5 
and KRT14 genes encoding the basal proteins K5 and K14 were subsequently reported 
in individuals suffering from basal EBS (Bonifas et al., 1991; Coulombe et al., 1991a; 
Lane et al., 1992). These studies provide the first evidence that epidermal keratins are 




Figure 1.10 Clinical photograph, histological section and ultrastructural 
details of the skin of EBS-DM patient 
  
Histological section  
Intraepidermal 
cleavage of the 
epidermal basal layer, 
immunostained with 
K14 (RCK 107). 
(Picture courtesy of 
Declan Lunny and 
John Common)  
Ultrastructural section  
Electron dense 
clumping of keratin 
tonofilaments, 
forming aggregates. 
(Picture courtesy of 
Robin Eady)  
Clinical photograph of a EBS-DM patient 
Singaporean patient 
having K14 R125C 
mutation. Note the severe 
blistering at the feet. 
(Photograph courtesy of 
Jean Ho, National Skin 
Center, Singapore)  
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1.9.1.1  Genotype-phenotype correlation of EBS  
Missense mutations and small in- frame deletions or insertions are commonly found in 
the rod domain of K5 and K14 that result in a dominant-negative effect on disrupting 
keratin cytoskeleton in basal keratinocytes. The phenotype of basal EBS patients 
varies with the onset and severity of blistering and they can be classified into three 
main subtypes, namely: EBS-localized (formerly known as Weber Cockayne), which 
is the mildest form, characterized by mild blistering confined to hands and feets, 
occurring at 1-2 yrs when the child starts walking; EBS-generalized (previously 
known as Koebner) with generalized blistering throughout life, occurring upon birth, 
and EBS-DM (also known as EBS Dowling-Meara), the most severe form, with 
congenital blistering in a herpetiform (clusters) pattern on erythematous skin, usually 
involving the oral mucosa and onycholysis. The main distinctive diagnosis for EBS-
DM was the presence of keratin clumps (aggregates) in basal keratinocytes (Anton-
Lamprecht and Schnyder, 1982). Hence, there exists a genotype-phenotype 
correlation in EBS based on the positions of keratin mutation and the severity of the 




Table 1.9  
Classification of basal epidermolysis bullosa simplex (EBS)   
 
EBS subtypes  Molecular target (s) Clinical phenotype (s) Original finding (s) 
EBS-localized (OMIM # 
131800) 
K5, K14  Blistering localized at hands and feet (Weber, 1926; 
Cockayne, 1947) 
EBS-generalized (OMIM # 
131900) 
K5, K14 Blistering mainly at hands and feet with 
generalized skin fragility 
(Koebner, 1886) 
EBS, Dowling-Meara (EBS-
DM) (OMIM # 131760) 
K5, K14 Severe, generalized, clusters, hemorrhagic 
blistering, mucosal and nails affected  
(Dowling and 
Meara, 1954) 
EBS, autosomal recessive 
(EBS-AR) (OMIM # 601001) 
K14 Very rare variant. Similar to EBS-generalized 
though frequency of blistering may be lower 
(Batta et al., 2000) 
EBS, migratory circinate 
(EBS-migr) (OMIM # 609352) 
K5 Very rare variant. Annulatory migratory multiple 
erythema circinatum, multiple vesicles on hands 
and feet, lesions heal with pigmentation  
(Gu et al., 2003) 
EBS with mottled 
pigmentation (EBS-MP) 
(OMIM # 131960) 
K5 Mild skin blistering, mottled pigmentation of trunk 




EBS, Ogna (EBS-Og) (OMIM 
# 131950) 
Plectin Widespread skin blistering, Onychogryphosis (Olaisen and Gedde-
Dahl, 1973; Koss-
Harnes et al., 2002) 
EBS with pyloric atresia 
(EBS-PA) (OMIM # 612138) 
Plectin Pyloric atresia and cutaneous aplasia; Skin 
blistering on trunk and limbs 
(Nakamura et al., 
2005) 
EBS with muscular dystrophy 
(EBS-MD) (OMIM # 226670) 
Plectin Epidermal blisters heal with atrophic scarring; Nail 
dystrophy; Muscle weakness that progressively 
leads to widespread muscular atrophy and ptosis 
(McLean et al., 




1.10  Other functions of keratin intermediate filament 
1.10.1  A role for keratins in regulating cell size and protein synthesis 
Cell growth requires the strict orchestration during development and in response to 
various injuries. Two recent studies demonstrate a keratin-mediated modulation of 
epidermal cell size  (Kim et al., 2006; Galarneau et al., 2007). K17, an intermediate 
filament protein rapidly induced in wounded stratified epithelia, is reported to regulate 
keratinocyte size by upregulating protein synthesis through association with 14-3-3σ. 
This could allow the nuclear translocation of 14-3-3σ to initiate protein translation, 
which takes place through activation of the Akt and mTOR signalling pathways (Kim 
et al., 2006). In addition, K8 and K18 could also regulate hepatic cell size and protein 
synthesis through regulating Akt kinase activity (Galarneau et al., 2007). Additional 
support of a role for keratins in regulating cellular metabolism came from the 
generation of transgenic mice devoid of the entire keratin intermediate filament 
family, which (although lethal) revealed a role for keratin in cells localizing glucose 
transporters (GLUT1 and 3) via activation of mTOR signalling pathways (Vijayaraj et 
al., 2009).  
1.10.2  A role for keratins in regulating stress kinase activity 
Keratins may also protect tissues from injury by serving as a phosphate “sponge” to 
absorb stress- induced kinase activity such as p38 and JNK (Ku and Omary, 2006).     
To summarize, these studies emphasize that there is now an emerging shift in 
paradigm, that intermediate filaments are not only structural proteins but also play an 




1.11 Aims and outline of thesis   
The observations that keratin aggregates (which co-exist with proper filament 
formation) arised solely from EBS-DM mutations (K14 R125C/K14 R125H) but not 
EBS-generalized type of mutation (K14 L384P) (Letai et al., 1993) were particularly 
intriguing because this would mean that the severity of disease might be attributed to 
the impairment of proper elongation of keratin filaments (since EBS-DM mutations 
are known to predominantly reside in the helix initiation or helix termination motifs 
of the keratin) and this could affect the physiological condition of the keratinocytes. 
To address this issue, keratinocytes were derived from the skin of patients suffering 
from EBS-localized and EBS-DM conditions, immortalized and maintained in cell 
cultures (Morley et al., 2003). These led to reports showing that EBS-DM 
keratinocytes had an intrinsic upregulation of stress kinases and they showed 
sustained stress responses to osmotic stress (D'Alessandro et al., 2002) and faster 
migration during scratch wound assays (Morley et al., 2003). These reports were in 
line with their intrinsic down-regulation of dual-specificity phosphatases (DUSPs) 
(Liovic et al., 2008) and junction proteins (Liovic et al., 2009) respectively. Moreover, 
ERK1/2 activation in EBS-DM keratinocytes provided resistance for these mutant 
cells against apoptosis during mechanical stress (Russell et al., 2010). Hence, these 
studies demonstrate that there exists a change in the physiological condition of EBS-
DM keratinocytes. Though much work has been done to characterize these cells, the 
detailed molecular mechanism underlying keratin remodelling in stress (in terms of 
keratinocyte activation status, keratin dynamics and modifications) in these EBS-DM 
keratinocytes is still not well understood. 
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Therefore, experiments are designed to address the following questions: 
1. Why do EBS-DM cells show faster re-epithelialization in culture than wild-
type cells? – Chapter 3 
Hypothesis: EBS-DM cells are in a constitutively stressed or activated state 
reminiscent to a wound condition.  
Hypothesis testing: Analyze for markers of wound activated state such as wound-
associated keratin, integrin, extracellular matrix protein and matrix metalloproteinase 
in various cell culture conditions such as subconfluence, confluence (monolayer) and 
scratch wound assays that will mimic an in vitro assay system of the experimental 
keratinocyte activation cycle. 
2. What influences keratin remodelling and how does it play a role in cell 
migration? – Chapter 4 
Hypothesis: EGF influences keratin remodelling to affect cell migration 
Hypothesis testing: Analyze for indicators of keratin remodelling such as keratin 
solubility, keratin aggregate formation and changes in keratin dynamics using kinase 
inhibitors or siRNAs to intervene with the EGF/ERK1/2 signaling pathway. 
3. Why do EBS-DM cells form peripheral keratin aggregates? – Chapter 5 
Hypothesis: Phosphorylated K14 residues at the rod 1A domain influences keratin 
aggregate formation. 
Hypothesis testing: Generate phospho-null and phospho-mimetic constructs of the 
serine and tyrosine residues involved at the K14 rod 1A domain and analyze their 









CHAPTER 2        










Table 2.1.1  Chemicals and reagents used in this thesis 
Company Chemicals and reagents 
Calbiochem (Darmstadt, Germany) EGFR inhibitor, AG1478 
Promega (Madison, USA) MEK1/2 inhibitor, U0126 
Invitrogen (Carlsbad, USA) Agarose 
A.G. Scientific, Inc. (San Diego, 
USA) 
NP-40 
GE Healthcare (Piscataway, USA) Urea 
Amersham Hyperflim 
Amersham ECLTM Prime reagents 
Sigma-Aldrich (St. Louis, USA) Sodium orthovanadate 






Ethylenediaminetetraacetic acid (EDTA) 
Sodium deoxycholate 
Paraformaldehyde 
Epidermal growth factor (EGF) 
Ponceau S solution 
Roche Applied Science (Indianapolis, 
USA) 
Complete mini EDTA-free Protease 
inhibitor 
Calbiochem (Darmstadt, Germany) Phenylmethanesulfonyl Fluoride (PMSF) 
Applied Biosystems Power SYBR® green PCR master mix 
1st base Tris buffer (pH 8.0)  
Tris-buffered saline (TBS) 
VWR International Ltd (Radnor, 
USA) 
Triton X-100 
Thermo Fisher Scientific Inc. 
(Waltham, USA) 
Lonza GelStar* nucleic acid gel stain 
Lab-Tek II #1.5 chambered coverslips  
(2-well/4-well). 
WillCo-wells (Amsterdam, The 
Netherlands) 






Table 2.1.2  Antibodies used in this thesis 
Company Antibody 
Cell signaling Technology Inc. 
(Danvers, MA, USA) 
Mouse monoclonal anti-phospho-ERK1/2 
(Thr202/Tyr204) 
Mouse monoclonal anti-phospho-p38 
(Thr180/Tyr182) 
Mouse monoclonal anti-phospho-JNK 
(Thr183/Tyr185) 
Rabbit polyclonal anti-ERK1/2 
Rabbit polyclonal anti-p38 
Rabbit polyclonal anti-JNK 
Rabbit polyclonal anti-GAPDH 
BD Biosciences (San Jose, CA, 
USA) 
Mouse monoclonal anti-plectin (clone 31) 
Mouse monoclonal anti- fibronectin (clone 10)  
Sigma-Aldrich (St. Louis, USA) Mouse monoclonal anti-FLAG (clone M2) 
Mouse monoclonal anti-actin (clone AC-15)  
Jackson ImmunoResearch 
Laboratories 
(West Grove, USA) 
Rhodamine red-X-conjugated donkey anti-
mouse secondary antibodies 
Rhodamine red-X-conjugated donkey anti-rabbit 
secondary antibodies 
FITC-conjugated donkey anti-mouse secondary 
antibodies 
Dako Cytomation (Glostrup, 
Denmark) 
Horseradish peroxidase (HRP)–conjugated 
swine anti-rabbit secondary antibody 
Horseradish peroxidase (HRP)–conjugated 
rabbit anti-mouse secondary antibody 
Novacastra (Wetzlar, Germany) Mouse monoclonal anti-β1 (CD29) 
Mouse monoclonal anti-K5 (XM-26) 
Mouse monoclonal anti-K17 (E3)  
(Troyanovsky et al., 1989) 
Molecular probes (Life 
Technologies; Carlsbad, USA) 
Alexa Fluor® 647 Phalloidin 
Antibodies generated by our 
laboratory or gifts from other 
laboratories 
Mouse monoclonal anti-K14 (LL001)  
(Purkis et al., 1990) 
Rabbit polyclonal anti-K5 (BL-18)  
(Purkis et al., 1990) 
Rabbit polyclonal anti-phospho-K5 (LJ4) 
(Liao et al., 1997) 
Mouse monoclonal anti-desmoplakin (11-5F) 





2.1.3  Plasmids 
pXJ40 FLAG-ERK2 mammalian expression vector encoding rat ERK2 protein was 
fused to an N-terminal FLAG epitode tag that was driven by the cytomegalovirus 
(CMV) enhancer/promoter.  This plasmid, together with the pXJ40 FLAG expression 
vector (Manser et al., 1997), was kindly provided by Dr. Edward Manser, Institute of 
Medical Biology, Singapore. The pEGFP K14 WT and pEGFP K14 R125P 
mammalian expression vectors, encoding for either human K14 wild-type protein or 
K14 mutant protein respectively, were fused to an N-terminal EGFP epitode tag that 
was driven by the CMV promoter. These two plasmids were previously made and 
described in (Liovic et al., 2009). pLVX-EF1α-AcGFP1-C1 lentiviral expression 
vector was kindly provided by Dr. Lim Sai Kiang, Institute of Medical biology, 
Singapore. pHR-CMV 8.2 delta packaging vector and pCMV VSV-G envelope vector 
were kind gifts from Nick Leslie, University of Dundee. 
2.1.4  Cell lines and cell culture  
Both NEB-1 and KEB-7 keratinocytes were patient-derived cell lines that were 
immortalized through HPV16. NEB-1 keratinocytes express wild-type keratins while 
KEB-7 keratinocytes express the severe EBS-DM mutation R125P in the K14 rod 1A 
domain (Morley et al., 2003). Isogenic pathomimetic cell lines, NEB-1 EGFP-K14 
WT and NEB-1 EGFP-K14 R125P, were generated as previously described in (Liovic 
et al., 2009). Cell lines were cultured in 75% DMEM (Dulbecco‟s modified Eagle‟s 
medium) plus 25% Ham‟s F12 medium, containing 1% L-glutamine, 1% 
penicillin/streptomycin and 10% fetal bovine serum (FBS), with additional growth 
factors such as hydrocortisone (0.4 g/ml), transferrin (5 g/ml), lyothyronine (2 x 
10-11 M), adenine (1.9 x 10-4 M), insulin (5 g/ml) and epidermal growth factor (EGF) 
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(10 ng/ml). EGF was omitted from culture media for cells to be cultured in the 
absence of EGF. N/TERT-1 was an hTERT-immortalized human keratinocyte cell 
line that maintained the ability to differentiate (Dickson et al., 2000). N/TERT-1 cells 
were cultured at low density in serum-free media (KSFM, Invitrogen), supplemented 
with 0.3 mM Ca2+, 0.2 ng/ml EGF, 25 μg/ml BPE, 1% L-glutamine and 1% 
penicillin/streptomycin. To sustain confluent cultures, medium was changed to a 1:1 
mixture of KSFM and DF-K medium (DF-K medium consisted of equal volumes of 
DMEM high glucuose and Ham‟s F-12 supplemented with 0.3 mM Ca2+, 0.2 ng/ml 
EGF, 25 μg/ml bovine pituitary extract (BPE), 1% L-glutamine and 1% 
penicillin/streptomycin). HEK293T cells were cultured in DMEM supplemented with 
10% FBS and 1% penicillin/streptomycin. These cell lines were fibroblast feeder cell 
independent and were cultured at 37 C in 5% CO2. Cells were regularly passaged at 
80-90% confluence, except for N/TERT-1 cells (30-40% confluence). This procedure 
began by aspirating the existing culture media from the tissue culture flask, washed 
with phosphate buffer saline (PBS) once, and then incubated in the presence of 
trypsin/versene with 0.125% EDTA. After incubation at 37 C for 7 min, the detached 
cells were neutralized with 5 ml of media and transferred into an empty 15 ml falcon 
tube. Cells were pelleted by centrifuging at 1000 rpm for 5 min, and the pellets were 
resuspended in 1 ml culture media, and seeded at 1:10 in new tissue culture flasks.   
2.1.5  Cryopreservation of cell lines 
Subconfluent cell cultures were trypsinised, pelleted and resuspended in freezing 
media containing 70% DMEM, 20% FBS and 10% dimethylsulphoxide (DMSO). The 
cell suspensions were then aliquoted at 1 x 106 cells/ml in cryovials, placed into Mr. 
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Frosty freezing container (Nalgene, NUNC), and kept at -80 C overnight before 
transferring to liquid nitrogen tank for longer storage.  
2.1.6  Thawing of cell lines 
Frozen cryotubes were taken out from liquid nitrogen tank, rapidly thawed in a 37 C 
water bath and transferred into 5 ml of pre-warmed culture media. The cell suspension 
was pelleted by centrifugation, resuspended in culture media and seeded into tissue 
culture flask to allow for overnight adhesion of cells to the vessel surface.  
2.2  Drug/EGF treatment methodology 
Cells were seeded onto either 6-well plates with 22 mm² glass coverslips or 100 mm 
petri dish for 3 days to reach 80% confluence before the drug treatment regime. The 
inhibitors, U0126 (10-100 µM) (Promega) and AG1478 (10 µM) (Calbiochem) were 
dissolved in dimethylsulphoxide (DMSO). Final concentrations of DMSO added to 
cells were ≤ 1% and this amount was observed to have no effect on cell viability in 
these experiments. U0126 (10-100 µM) were added into the media and cells were 
then incubated for 1 hr before fixation or lysis. For EGF treatment study, cells were 
cultured in media without EGF for 48 hrs and subjected to EGF (10-100 ng/ml) 
treatment for 48 hrs before being harvested for RNA and immunoblot analysis. 
Alternatively, cells were cultured in media without EGF (-EGF) for two passages 
before seeding them onto either 6-well plates with 22 mm² glass coverslips or 100 
mm petri dish. Cells were then first serum starved (in the absence of FBS) for 6  hrs 
before incubation in media supplemented with EGF (100 ng/ml) for 2 hrs. After 2 hrs, 
drug inhibitors such as U0126 (10 µM) or AG1478 (10 µM) were then added into the 
media in the presence of EGF (100 ng/ml) and cells were incubated for another hour 
before lysis or fixation. 
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2.3  Molecular biology methodology 
2.3.1  Site-directed mutagenesis 
Site-directed mutagenesis was performed using the QuikChange Site-directed 
Mutagenesis kit (Agilent Technologies, CA, USA) according to manufacturer‟s 
instructions. pEGFP-K14 WT plasmid DNA was used as a template at 100 ng/μl for 
introducing specific mutations (underlined red) through PCR-based method by using 
the following mutagenic primers to generate the respective constructs: K14 S128A 
(Forward: 5‟-CAA TGA CCG CCT GGC CGC CTA CCT GGA CAA GG-3‟; 
Reverse: 5‟-CCT TGT CCA GGT AGG CGG CCA GGC GGT CAT TG-3‟); K14 
S128D (Forward: 5‟-CAA TGA CCG CCT GGC CGA CTA CCT GGA CAA GG-3‟; 
Reverse: 5‟-CCT TGT CCA GGT AGT CGG CCA GGC GGT CAT TG-3‟); K14 
Y129F (Forward: 5‟-GCC TGG CCT CCT TCC TGG ACA AGG TG-3‟; Reverse: 
5‟-CAC CTT GTC CAG GAA GGA GGC CAG GC-3‟) and K14 Y129E (Forward: 
5‟-GAC CGC CTG GCC TCC GAA CTG GAC AAG GTG CGT G-3‟; Reverse: 5‟-
CAC GCA CCT TGT CCA GTT CGG AGG CCA GGC GGT C-3‟) respectively. 
Likewise, pEGFP-K14 R125P plasmid DNA was also used as a template at 100 ng/μl 
for introducing specific mutations (underlined red) by using the following mutagenic 
primers to generate K14 R125P_Y129F as follows: (Forward: 5‟-GCC TGG CCT 
CCT TCC TGG ACA AGG TG-3‟; Reverse: 5‟-CAC CTT GTC CAG GAA GGA 
GGC CAG GC-3‟). For introducing deletions (strikethrough red), pEGFP-K14 WT 
plasmid DNA was used as a template at 100 ng/μl by using the following mutagenic 
primers to generate K14 S128del as follows: (Forward: 5‟-CAA TGA CCG CCT 
GGC CTCCTA CCT GGA CAA GG-3‟; Reverse: 5‟- CCT TGT CCA GGT AGG 
AGG CCA GGC GGT CAT TG-3‟); and pEGFP-K5 WT plasmid DNA was used as a 
template at 100 ng/μl by using the following mutagenic primers to generate K5 
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S181del as follows: (Forward: 5‟-CTC AAC AAT AAG TTT GCC TCC TTC ATC 
GAC AAG GTG CGG-3‟; Reverse: 5‟- CCG CAC CTT GTC GAT GAA GGA GGC 
AAA CTT ATT GTT GAG-3‟). The mixture of 1 x QuikChange reaction buffer, 
template DNA, forward and reverse mutagenic primers, dNTPs, H2O and PfuTurbo 
DNA polymerase were then incubated in the thermal cycler with the following 
cycling parameters: Step 1: 95ºC for 1 min (initial denaturation), Step 2: 95ºC for 50 s 
(denaturation), Step 3: 65ºC for 50 s (annealing), step 4: 68ºC for either 8 min (EGFP-
K14) or 10 min (EGFP-K5) (extension). Steps 2-4 were then repeated for either 18 
cycles (single amino acid changes) or 19 cycles (deletions), and at the end of it Step 5 
was operated at 68ºC for 7 min (final extension). The resulting PCR product was 
mixed with Dpn I restriction enzyme and incubated at 37ºC for 3 hrs to digest the 
parental methylated and hemimethylated DNA. The intact site-mutated plasmid DNA 
was then transformed using XL-1 blue supercompetent cells. The mixture of plasmid 
DNA and supercompetent cells were heat-shocked at 42°C for 30 s, and incubated 
with SOC media at 37°C shaker for 1 hr. The mixture was then spread onto LB agar 
plate containing 240 µg/ml kanamycin and incubated at 37°C overnight for growing 
single colonies. Positive clones were verified and all the mutant constructs were 




2.3.2  Cloning 
2.3.2.1  Restriction digestion of DNA 
The pEGFP-C1 plasmid DNA was first linearised using the restriction enzyme XbaI, 
and the K14 (WT, R125P, S128del, Y129F, Y129E and R125P_Y129F) DNA 
sequences were next sub-cloned from the pEGFP-C1 plasmid into the pLV-EF1α-
AcGFP1-C1 lentiviral plasmid through PCR-based method. A unique BstBI 
restriction enzyme recognition site was introduced in the design of the forward primer 
(in bold) (5‟-TCC ATC CAT TCG AAT ACT ACC TGC AGC CGC CAG-3‟) and 
was used together with the reverse primer (5‟-GGT TCA GGG GGA GGT GTG GG-
3‟). The mixture of 1 x PCR reaction buffer, template DNA, forward and reverse 
primers, Q buffer, dNTPs, H2O and Taq DNA polymerase were then incubated in the 
thermal cycler with the following cycling parameters: Step 1: 94ºC for 2 min (initial 
denaturation), Step 2: 94ºC for 30 s (denaturation), Step 3: 60ºC for 30 s (annealing), 
Step 4: 72ºC for 1 min 30 s (extension). Steps 2-4 were then repeated for 35 cycles, 
and at the end of it Step 5 was operated at 72ºC for 10 min (final extension). Both 
pLV-EF1α-AcGFP1-C1 lentiviral vector and the respective PCR products were 
digested by BstBI and BamHI restriction enzymes in the presence of restriction 







Figure 2.1 Map of mammalian expression vector pEGFP-C1 
Genes of interest (K14 WT/R125P) were ligated into the multicloning sites 





Figure 2.2 Map of mammalian expression vector pLVX-EF1α-AcGFP1-C1 
Genes of interest (K14 WT/R125P/S128del/Y129F/Y129E/R125P_Y129F) 
were cloned from pEGFP-C1 plasmid and ligated into the multicloning sites 
(MCS) of pLVX-EF1α-AcGFP1-C1 plasmid (from www.clontech.com) and 
fused with AcGFP1.  
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2.3.2.2  DNA agarose gel electrophoresis 
A 1% (w/v) agarose gel was cast by weighing 1 g of agarose into 100 ml of 1 x TBE 
buffer and microwaved till the agarose melted. Lonza GelStar* nucleic acid gel stain 
was added to the melted agarose, poured into the gel casting apparatus and allowed to 
solidify. 6x DNA loading dye was added to DNA samples to a final 1x concentration 
and loaded onto the wells of the gel which was submerged in 1x TBE buffer and 
electrophoresed at 70 V for 2 hrs. The separated DNA bands were visualized using 
the Fujiflim LAS4000 illuminator and photographed for record purpose.  
2.3.2.3  DNA gel extraction 
DNA gel extraction was performed using the QIAquick Gel Extraction Kit. Briefly, 
DNA band was excised from the gel using a clean scalpel under blue light and 
weighed in eppendorf tubes. 3 volumes of QG buffer were added to the gel slice and 
the mixture was incubated at 50ºC for 10 min until the agarose gel was completely 
melted. 1 gel volume of isopropanol was added to the tubes and mixed before 
transferring into the QIAquick spin column. The column was centrifuged at 13,000 
rpm for 1 min to allow binding of the DNA to the column. 750 μl of PE buffer was 
added to wash the filter column once and the DNA was eluted into 30 μl of RNAse-
free water.  
2.3.2.4 Dephosphorylation of plasmid DNA 
To facilitate efficient ligation of vector DNA (lentiviral plasmid) to insert DNA (PCR 
product), vector DNA was dephosphorylated by incubating with the shrimp alkaline 




2.3.2.5  Ligation of DNA 
Ligation of both vector and insert DNA was performed at a ratio o f 1:5 respectively in 
the presence of T4 DNA ligase buffer and T4 DNA ligase. The mixture was incubated 
at room temperature for 1 hr for ligation to take place.  
2.3.3  Transformation of chemically competent cells 
5 μl of ligated DNA product was mixed into one vial of One Shot® TOP10 chemically 
competent E.coli cells and incubated on ice for 30 min. The mixture of ligated DNA 
product and competent cells was heat-shocked at 42°C for 30 s, and incubated with 
SOC media at 37°C shaker for 1 hr. The mixture was then spread onto LB agar plate 
containing 100 µg/ml ampicillin and incubated at 37°C overnight for growing single 
colonies. 
2.3.4  PCR analysis of transformants  
Bacterial colonies were screened for positive ligation events as follows: A single 
bacterial colony was inoculated to 6 μl of sterile H2O to serve as a PCR template. 
PCR reactions were carried out in 10 μl volumes comprising of 1 x Green GoTaq® 
Flexi buffer, template DNA, forward and reverse primers, dNTPs, MgCl2, H2O and 
GoTaq® DNA polymerase. The PCR cycling parameters were as follows: Step 1: 
95ºC for 6 min (initial denaturation), Step 2: 95ºC for 30 s (denaturation), Step 3: 
52ºC for 30 s (annealing), Step 4: 72ºC for 4 min (extension). Steps 2-4 were then 
repeated for 30 cycles, and at the end of it Step 5 was operated at 72ºC for 5 min 
(final extension). PCR products were resolved on 1% agarose gels at 70 V for 2 hrs to 
check for correct insert size. 
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2.3.5  Amplification and isolation of plasmid DNA from bacteria (Mini-prep) 
Bacterial colonies containing positive ligation events were inoculated into 3 ml LB 
broth with 100 µg/ml ampicillin and leave it to incubate at 37ºC with shaking for 8 hrs. 
Plasmid DNA isolation from bacteria was performed using the QIAprep® Spin 
Miniprep Kit. Briefly, 2 ml of overnight bacterial culture was retrieved and 
centrifuged at 13,000 rpm. The supernatant was removed and the bacterial pellet was 
resuspended in 250 μl of P1 buffer containing RNase A and LyseBlue reagent. 250 μl 
of P2 lysis buffer was added and the tube was inverted gently and left for 5 min. 350 
μl of chilled N3 buffer was then added immediately for neutralization and the cell 
debris was pelleted by centrifugation at 13,000 rpm. The supernatant was collected 
and decanted into the QIAprep spin column. The column was centrifuged at 13,000 
rpm for 1 min to allow DNA to settle onto the column and bounded to it by PB buffer. 
750 μl of PE buffer was added to wash the filter column once and the plasmid DNA 
was eluted by 30 μl of RNAse-free water.  
2.3.6.  DNA sequencing 
DNA sequencing was carried out using BigDye® Terminator v3.1 Cycle sequencing 
kit by mixing the DNA template, forward or reverse primer, H2O and Terminator 
Ready Reaction Mix in a total of 10 μl reaction volumes. The PCR cycling parameters 
were as follows: Step 1: 96ºC for 1 min, Step 2: 96ºC for 10 s, Step 3: 50ºC for 5 s, 
Step 4: 60ºC for 4 min. Steps 2-4 were then repeated for 25 cycles, and at the end of it 
hold at 4ºC. Samples were submitted to the DNA sequencing facility at Institute of 
Molecular and Cell Biology for purification and subjected to capillary electrophoresis 




2.3.7.  Bacterial DNA maxi-prep using Endofree® Plasmid Maxi Kit  
Large-scale amplification of plasmid DNA and its isolation from bacteria was 
performed using the Endofree® Plasmid Maxi Kit. Briefly, 1 ml of bacterial culture 
broth was added into 100 ml of lysogeny broth (LB) containing 100 µg/ml ampicillin 
and incubated at 37ºC with shaking for 16 hours. 90 ml of overnight bacterial culture 
was retrieved and centrifuged at 6,000 g for 15 min at 4 ºC. The supernatant was 
removed and the bacterial pellet was resuspended in 10 ml of P1 buffer containing 
RNase A and LyseBlue reagent. 10 ml of P2 lysis buffer was added and the tube was 
inverted gently and left for 5 min. 10 ml of chilled P3 buffer was then added 
immediately for neutralization and the cell debris was decanted into the QIAfilter 
Maxi Cartridge. The cell lysate was filtered through the cartridge and collected onto a 
50 ml falcon tube. 2.5 ml of ER buffer was added to the filtered lysate, mixed by 
inverting and incubate on ice for 30 min. The filtered lysate was then decanted into 
the QIAGEN-tip and then washed twice with 30 ml QC buffer. Plasmid DNA was 
eluted with 15 ml QN buffer and precipitated with 10.5 ml isopropanol. The plasmid 
DNA pellet was collected by centrifugation at 4,000 rpm for 1 hr, washed with 70% 
ethanol for 1 hr at 4,000 rpm, air-dried and finally dissolved in endotoxin free TE 
buffer.  
2.3.8  Preparation of bacteria stocks 
Bacterial stocks of successful transformation events were prepared in 50% glycerol. 
The LB-glycerol suspension was thoroughly mixed and then placed in -80ºC freezer 




2.3.9  Transient transfection 
For transient transfection studies, NEB-1 cell line was plated at 80% confluency on 22 
mm² coverslips in a 6-well plate and transfected with the pEGFP-K14 WT and mutant 
constructs using the EffecteneTM reagents (Qiagen, Germany) according to 
manufacturer‟s protocol. Briefly, 0.4 μg of DNA were added into an eppendorf tube  
with 100 μl of DNA condensation (EC) buffer, and 3.2 μl of Enhancer. Mixture was 
vortexed and incubated at room temperature for 5 min. 10 μl EffecteneTM transfection 
reagent was then added into the mixture followed by vortexing and incubated at room 
temperature for 10 min to allow transfection complex to form. Meanwhile, culture 
media was aspirated from the flask and replenished with new media. After 10 min, the 
transfection mixture was then added dropwise onto the cells and cells were harvested 
for respective assays at least 24 hrs post transfection. The expression of pEGFP-K14 
WT and mutant constructs were then analyzed after 36 hrs post-transfection using 
immunofluoresence.  
2.3.10  Viral packaging and collection 
To establish stable cell lines expressing EGFP-K14 constructs, high- titre lentiviruses 
were ultilized. Non-replicative lentiviruses were produced by triple transfection of 
HEK293T cells in 15 cm dishes with 1.5 µg pLVX-EF1α-AcGFP1-C1 lentiviral 
expression vector, 1 µg pHR-CMV 8.2 delta packaging vector and 1 µg pCMV VSV-
G envelope vector using Effectene transfection reagent (Qiagen, Germany). The viral 
supernatant was collected after 48 hrs and 72 hrs post transfection before filtering 
through 22 µm filter system to remove cell debris. The supernatant was then 
ultracentrifuged at 16,000 g for 2 hrs at 4ºC. The resultant pellet was resuspended in 
DMEM and frozen at -80ºC in aliquots.  
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2.3.11  Viral titration of N/TERT-1 cells and quantification  
40, 000 N/TERT-1 cells were seeded onto each well of the 24-well plate for 16 hrs 
before they were infected by the various viral-packaged constructs in the presence of 
24 µg/ml of polybrene in titrations of 10-2, 10-3, 10-3/2 dilutions (of each construct) 
and incubated for 72 hrs. The cells in each well were then trypsinized, collected onto 
fluorescence-activated cell sorting (FACS) tubes and centrifuged for 5 min at 1000 
rpm. The pellet was then washed once in PBS, centrifuged and resuspended in PBS 
for FACS analysis. The viral titer for each construct was then derived from the 
percentage of GFP-positive cells in a population of 40, 000 infected cells at the 
specific dilution and determined as the number of viral particles per ml. The 
multiplicity of infection (M.O.I) was then calculated by determining the number of 
cells to be infected divided by the viral titer (number of viral particles per ml) and the 
volume of viral supernatant to be added in experiments could be derived.  
2.3.12  Viral infection of N/TERT-1 cells to generate stable cell lines 
To generate stable cell lines, various viral-packaged constructs (M.O.I =1.0) were 
added together with 24 µg/ml of polybrene to infect 1 million N/TERT-1 cells in 
suspension and pre-incubated at 37ºC for 1 hr before seeding them onto 100 mm 
dishes. GFP-positive cells were then selected by FACs sorting after one week of 
transduction and remained in culture for further experiments. The levels of expression 
of transfected AcGFP-K14 wild type and mutant constructs and their ratio with the 
endogenous wild-type K14 were then assessed by immunoblotting with LL001 
monoclonal antibody against K14 (Purkis et al., 1990). Cells having a 1:1 ratio of 
transfected AcGFP-keratin wild type or mutant protein to endogenous wild type 
keratin were then cultured and expanded.  
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2.3.13  Transient infection of N/TERT-1 cells 
For transient viral infection, viral-packaged constructs (AcGFP-K14 R125P, AcGFP-
K14 R125P_Y129F) of various multiplicity of infection values (M.O.I = 0.5, 1.0, 2.0) 
were added together with 24 µg/ml of polybrene to infect 100, 000 N/TERT-1 cells in 
suspension and pre- incubated at 37ºC for 1 hr before seeding them onto 22 mm² 
coverslips in a 6-well plate. The cells were then incubated at 37ºC for 72 hrs before 
fixation. 
 
2.4  Gene expression analysis 
2.4.1  RNA extraction 
Total RNA was extracted from the cells using the RNeasy Mini Kit (Qiagen, 
Germany). Briefly, cells were kept on ice, washed in ice-cold PBS, scrapped and 
collected in 1 ml of PBS onto respective tubes. Cells were pelleted by centrifugation 
at 5,000 rpm at 4ºC and the pellet was lysed in 350 μl of RLT buffer with β-
mercaptoethanol. Lysate was homogenized using the QIAshredder spin column and 
RNA was precipitated with 70% ethanol. The precipitated RNA was decanted into 
RNeasy spin column and centrifuged at 13,000 rpm for 1 min. The column was 
washed with 700 μl RW1 buffer and DNase digestion was carried out on the column 
using the RNase free DNase set to avoid genomic DNA contamination. Column was 
then washed with 500 μl RPE buffer twice before the RNA was eluted by 30 μl of 
RNAse-free water. The RNA quantity and concentration were determined using 




2.4.2  cDNA synthesis 
cDNA (complementary DNA) synthesis was performed with 1 μg of total RNA, using 
the Transcriptor First Strand cDNA Synthesis kit (Roche Applied Science). Briefly, 
total RNA was first denatured with oligo(dT)15 primer for 10 min before mixing with 
the 1x reaction buffer, protector RNase inhibitor, dNTPs, H2O and reverse 
transcriptase. Reverse transcription was then carried out at 50ºC for 60 min.  
2.4.3  Quantitative real-time PCR (qPCR) 
Real-time quantitative PCR was carried out using the ABI-PRISM 7500 Sequence 
Detection System (Applied Biosystems). 3 μl of 10 x diluted reversed transcribed 
cDNA samples were added to 5 μl of Power SYBR Green PCR Master Mix (Applied 
Biosystems) and 2 μl of primers mix (forward and reverse primers). Reactions were 
conducted in triplicate within 384-well reaction plates (Applied Biosystems) at a final 
volume of 10 μl on the ABI-PRISM 7500 machine. The list of forward and reverse 
primers was listed in Table 2.2. The cycling parameters were as follows: Step 1: 95ºC 
for 10 min, Step 2: 95ºC for 15 s and Step 3: 60ºC for 60 s. Steps 2-3 were repeated 
for 40 cycles. A dissociation curve was added as an additional parameter to check 
primer amplification integrity with the following steps: 95ºC for 15 s, 60ºC for 15 s 
and 95ºC for 15 s. Data was analyzed using the Sequence Detection System 7500 
software (Applied Biosystems). Relative quantification was ca lculated by the ΔΔCt  
method normalized to either hypoxanthine-guanine phosphoribosyltransferase (HPRT) 




2.4.4  Over-expression studies 
For over-expression studies, isogenic pathomimetic cell lines were plated at 80% 
confluence in 100 mm dishes and transfected with a rat FLAG-tagged ERK2 cDNA 
using 2 g DNA and 60 l EffecteneTM reagent. The expression of FLAG-ERK2 was 
then analyzed from a time scale of 24-48 hrs post-transfection using western blotting.  
2.4.5  RNA interference (siRNA) 
For knockdown studies, isogenic cell lines were plated at 80% confluence in 100 mm 
dishes and transfected with DharmaFECTTM 1 siRNA transfection reagent 
(Dharmacon) according to the manufacturer‟s instructions. Cells were transfected 
with either ON-TARGETplus siRNA (Dharmacon) targeting MAPK3 (ERK1), 
catalog no: J-003592-08-0020, ON-TARGETplus SMARTpool siRNA (Dharmacon) 
targeting MAPK1 (ERK2), catalog no: L-003555-00-0005 or ON-TARGETplus 
siRNA (Dharmacon) targeting plectin (PLEC), catalog no: J-003945-09-0020 (see 
Table 2.3). The mixture of ERK1-ERK2 siRNAs, PLEC siRNAs or control siRNA 
against GAPD (Dharmacon), catalog no: D-001830-01-20, was used in experiments at 
100 nM concentrations. After 24 hrs, fresh medium was replaced and cells were 




Table 2.2 Primer sequences for qPCR using SYBR Green Master Mix 
 
Table 2.3 siRNAs for knockdown studies 
 
   
Genes Forward primer Reverse primer 
β1 integrin 5‟-TTA TTG GCC TTG 
CAT TAC TGC T-3‟ 




5‟-ACA TTG TGC AGG 
ACC TGA TGG AGA-3‟ 
5‟-TAA GGT CGC AGG TGG 
TGT TGA TGA-3‟ 
ERK2 
(MAPK1) 
5‟-CCA CCC ATA TCT 
GGA GCA GT-3‟ 
5‟-CAG TCC TCT GAG CCC 
TTG TC-3‟ 
Fibronectin 5‟-CAC AGC TTC TCC 
AAG CAT CA-3‟ 
5‟-TGG CTG CAT ATG CTT 
TCC TA-3‟ 
HPRT 5‟-CCT GGC GTC GTG 
ATT AGT GAT-3‟ 
5‟-AGA CGT TCA GTC CTG 
TCC ATA A-3‟ 
KRT17 5‟-GGT GGG TGG TGA 
GAT CAA TGT-3‟ 
5‟-CGC GGT TCA GTT CCT 
CTG TC-3‟ 
MMP9 5‟-TAC CAC CTC GAA 
CTT TGA CAG CGA-3‟ 
5‟-GCC ATT CAC GTC GTC 
CTT ATG CAA-3‟ 
Plectin 5‟-ACC CTC TGA GCT 
TTG CAT GT-3‟ 
5‟-CCC ACG GTC AGG TTA 
GTG TT-3‟ 
KRT14 5‟-CTT GGG TGG TGG 
CTT TGG-3‟ 
5‟-GTC CAC TGT GGC TGT 
GAG AA-3‟ 
KRT5 5‟-CAC TGT CAA CCA 
GAG TCT CCT GAC T-3‟ 
5‟-CGG TCC TCA CCC TCT 
GGA T-3‟ 
RPLP0 5‟-CAG ATT GGC TAC 
CCA ACT GTT-3‟ 
5‟-GGG AAG GTG TAA TCC 
GTC TCC-3‟ 
ON-TARGETplus siRNA Target sequences 
Human ERK1 (MAPK3) 5‟-CCU GCG ACC UUA AGA UUU G-3‟ 
Human ERK2 (MAPK1) 5‟-UCG AGU AGC UAU CAA GAA A-3‟ 
 5‟-CAC CAA CCA UCG AGC AAA U-3‟ 
 5‟-GGU GUG CUC UGC UUA UGA U-3‟ 
 5‟-ACA CCA ACC UCU CGU ACA U-3‟ 
Human Plectin (PLEC) 5‟-GAA GAG ACA CAG AUC GAC A-3‟ 
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2.5  Protein expression analysis 
2.5.1  Cell lysis and protein quantification 
1 million cells were seeded onto 100 mm petri dish and grown to 80% confluence. 
Cells were kept on ice, washed in ice-cold PBS, scrapped and collected in 1 ml of 
PBS onto respective tubes. The cell suspensions were then centrifuged at 5,000 rpm 
for 5 min. The supernatant was removed and the cell pellet was re-suspended in 100 
µl of lysis buffer containing: 20 mM Tris-HCl (pH 7.6), 140 mM NaCl, 5 mM EDTA, 
1% (v/v) NP-40, 0.5% (w/v) sodium deoxycholate supplemented with Complete, Mini 
(EDTA-free) protease inhibitor cocktail tablet (Roche) per 10 ml lysis buffer, 1 mM 
sodium orthovanadate (Na3VO4) and 1 mM phenylmethylsulphonyl fluoride (PMSF), 
5 mM sodium fluoride, 50 mM β-glycerolphosphate, of which all were added fresh, 
immediately prior to use. The cells were then lysed on ice for 15 min. Cell lysates 
were then centrifuged at 16, 000 g for 15 min at 4 ºC. Supernatant was then 
homogenized by passing through a QIAshredder column tube (QIAGEN) with 
centrifugation at 16, 000 g for 2 min at 4 ºC. The homogenized supernatant was 
collected and stored at -80 ºC. For the pellet, it was re-suspended in pelleting buffer 
[Tris-HCL (pH 8.0). 10 mM MgCl2, 5 mM EDTA, 1 mM Na3VO4 and 1 mM PMSF] 
containing 250 U benzonase nuclease (Novagen) and was incubated for 30 min at 
room temperature. After repelleting, the final pellets were washed in PBS containing  
1 mM PMSF and 1 mM Na3VO4 and then re-suspended in 4X LDS buffer 
(Invitrogen), in a volume equivalent to the supernatant. Protein concentration of the 
supernatant was then determined by BCA assay (Thermo Scientific Pierce) and 





2.5.2  Sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
For sodium dodecylsulphate (SDS) polyacrylamide gel electrophoresis, 20 – 40 g of 
each sample‟s supernatant or pellet was mixed with 4X LDS sample buffer 
(Invitrogen), boiled for 10 min at 70 ºC, and separated on 4-12 % Bis-Tris SDS 
polyacrylamide precast gels (invitrogen) for 50 min at 200V constant. In cases where 
higher molecular weight proteins (plectin, fibronectin or desmoplakin) are to be 
blotted, 20 – 40 g of each sample was mixed with 4X LDS buffer (Invitrogen), 
heated for 10 min at 70 ºC and separated on 3-8 % Tris-Acetate SDS polyacrylamide 
precast gels (invitrogen) for 60 min at 150V constant.  
2.5.3  Protein detection and chemiluminesence 
For immunoblotting, protein transfer was carried out using the iBlot dry blotting 
machine system onto nitrocellulose membranes (Invitrogen) for 7 min. Non-specific 
binding to the membrane was blocked by incubation in TBS-T containing 5% milk, 
for 1 hr with gentle agitation. Blots were then incubated overnight at 4 ºC with the 
primary antibodies in 5 ml TBS-T containing 5% BSA with gentle agitation. The 
membranes were then washed twice with TBS-T, and bound primary antibodies were 
then incubated for 1 hr with secondary antibodies. The membranes were then washed 
four times before visualized by enhanced chemiluminescence (ECL) using the 
Fujiflim LAS4000 illuminator.  
2.5.4  Immunocytochemistry 
100, 000 cells were seeded onto 22 mm² glass coverslips in 6-well plate and grown to 
80% confluence (either non-treated or prior to drug treatment regime) before being 
fixed with 4% parafarmaldehyde in PBS, pH 7.4 at room temperature for 7 min. After 
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fixation, cells were treated in blocking buffer (3% normal goat serum in PBS) and 
permeabilized with 0.1% Triton X-100 in PBS at room temperature for 20 min. On 
the other hand, for methanol fixation, cells were fixed with methanol at -20ºC for 10 
min and blocked with 10% FBS for 20 min. Cells were washed twice with PBS and 
then incubated overnight with primary antibodies. Cells were then washed 3 x 5 min 
in PBS and the primary antibodies were detected using the respective secondary 
antibodies by incubating 45 min in the dark. Cells were then washed 3 x 5 min in PBS 
and incubated in 4-6-diamidino-2-phenyllindole (DAPI) (1:2500) (Sigma) dissolved 
in PBS. Cells were subsequently washed 3 x 5 min in PBS and mounted on coverslips 
using Hydromount with 2.5% DABCO to reduce photobleaching. Slides were air-
dried and viewed with an inverted Deltavision epifluorescence microscope (Applied 
Precision, USA). Images were visualized with either an Olympus UApo/340 20x (N.A. 
0.75) objective lens; Olympus UApo/340 40x (N.A. 1.35) or an Olympus PlanApo 
60x (N.A. 1.42) oil immersion objective lens with a Photometric CCD camera 
(CoolSNAP HQ2) using the SEDAT filter set. Images were then processed using the 
SoftWorRx application (Applied Precision, USA).  
2.6  Time-lapse microscopy imaging and image processing 
2.6.1  Differential interference contrast (DIC) live-cell migration 
For DIC live-cell imaging, 100 – 300 cells were grown on a 4-well Lab-Tek II #1.5 
chambered coverslips. Single cell was selected with the „mark and visit‟ tool of 
SoftWoRx from each cell line. To generate movies of randomly migrating live cells, 
repetitive images were collected every 5 min for a total of 5 hrs using an Olympus 
UApo/340 20x (N.A. 0.75) objective lens. A minimum of ten individual fields was 
recorded for each cell line. DIC image stacks of single cell migration were analyzed 
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and processed using several macros written with ImageJ. One macro was written to 
apply top-hat and variance filters on the DIC time- lapse sequence while the other was 
written to segment the single cell body and analyzed the filtered sequence. During this 
stage, auto-threshold was manually adjusted for the best possible segmentation. Total 
distance travelled by each cell for 5 hrs was then extracted using another macro and 
their corresponding migration paths were plotted.  
2.6.2  Fluorescence live-cell imaging 
For fluorescence live-cell imaging, 10, 000 cells were grown on a 35 mm WillCo-
dish® glass-bottomed dish (WillCo-wells, Amsterdam). Images (1024x1024 dpi, 1x1 
binning) of cells expressing the fluorescence constructs were collected every 15 sec 
for a period of 30 min using an Olympus UPlanApo/IX70 100x (N.A. 1.35) oil 
immersion objective lens. These sequences of images were then converted into 
movies and subsequently analyzed using SoftWoRx software (Applied Precision, 
USA). Image series, presented as inverse fluorescence micrographs, were taken from 
time- lapse recordings and shown as data in the results section. Both DIC and 
fluorescence live-cell imaging were carried out using an inverted Deltavision 
epifluorescence microscope (Applied Precision, USA), equipped with a fully 
motorized Z stage (Applied Precision, USA) and linked to Photometrics CCD camera 
(CoolSNAP HQ2) using the SEDAT filter set. Samples were maintained at 37ºC in a 




2.6.3  Phase contrast live-cell imaging of scratch wounds using IncuCyteTM 
20, 000 cells were seeded onto each well of an Essen ImageLock 96-well plate and 
grown to confluence before being subjected to wounding with a 96-well 
WoundMaker Tool, which gently removed cells from the confluent monolayer using a 
96 array of PTFE pin tips. Cells were then washed twice with media and the plate was 
placed inside the IncuCyte. For EGF treatment study, cells were treated with either 
DMSO, AG1478 (10 µM) or U0126 (10 µM) in fresh media before imaging. 
Alternatively, cells grown to sub-confluence were transfected with DharmaFECTTM 1 
siRNA transfection reagent (Dharmacon) according to the manufacturer‟s instructions. 
Cells were transfected with ON-TARGETplus siRNA (Dharmacon) targeting plectin 
(PLEC), catalog no: J-003945-09-0020. The mixture of PLEC siRNAs or control 
siRNA against GAPD (Dharmacon), catalog no: D-001830-01-20, was used in 
experiments at 100 nM concentrations. After 24 hrs, fresh medium was replaced and  
after 48 hrs post-transfection, cells were then subjected to wounding with a 96-well 
WoundMaker Tool. Wound images were acquired immediately and at 1 hr intervals 
for 14-28 hrs. Scratch wound data was analyzed and processed using several macros 
written with ImageJ. One macro applies the built- in ImageJ Sobel edge filter to locate 
the edges of the wound while the other applies auto-threshold methods to find the 
wound area and calculate the recovery of the wound. Red line marks the denuded area 
from which cells were removed at the start of the wound (0 hr); green line marks the 
remaining uncovered area after 14-28 hrs. Areas between red (or green) lines were 
derived from a macro written with ImageJ. Area covered was obtained by the 
subtraction of the initial wound area and the remaining uncovered area, and the data 




2.6.4  Confocal live-cell imaging using MEK1/2 inhibitor treatment 
10, 000 cells were grown on a 35 mm WillCo-dish® glass-bottomed dish (WillCo-
wells, Amsterdam). Time-lapse analyses were then performed with a Zeiss LSM510 
inverted confocal microscope. For each movie, images were taken every minute for 1 
hr using an EC Plan-Neofluar 40x/1.30 oil immersion objective lens. This was 
performed by using the filter, BP-505-530 and the beam splitters: MBS: HFT 
405/488/561, DBS1: NFT 565, DBS2: NFT 490 respectively. Argon LASER was 
used at 488 nm wavelength at 19.8% power and the pinhole was set to 124 μm. The 
scan mode was: Plane, line series, with an average limited to Line 2 so as to limit the 
LASER exposure to the cells to minimize cell death or photobleaching. Drug 
treatment was initiated after 1 hr of acquisition by removing the original medium and 
replacing it with fresh medium containing the MEK inhibitor U0126 at 100  μM. Such 
treatment was maintained for another hour before washing out by replacing it with 
fresh medium. For image processing and migration analysis, false color coding 
images were obtained by first converting the images extracted from the movies to 
TIFF files, then importing them into ImageJ software and converting them to 8-bit 
images. Next, for each movie (“control”, “treatment” and “washout” movies), an 
artificial color was given to the images corresponding to the time points: 0 min, 30 
min and 60 min (green, blue and red color, respectively). The three images were then 




2.7  Functional studies 
2.7.1  Osmotic stress assay 
1 million cells were seeded onto 100 mm petri dish and cultured to 80% confluence. 
The subconfluent culture was left intact or being subjected to hypo-osmotic shock 
upon immersion in 150 mM urea for 5 min at 37 ºC as described in (D'Alessandro et 
al., 2002). Cells were then allowed to recover in fresh media for varying periods of 
time before being harvested for immunoblot analysis.  
2.7.2  Confluence assay 
100, 000 cells were seeded onto 22 mm² glass coverslips in 6-well plate or 1 million 
cells were seeded onto 100 mm petri dish and they were grown to subconfluence 
(80%), confluence (monolayer) (100%), 1 day post confluence (100% + 1) or 2 days 
post confluence (100% + 2) before being fixed for immunostaining or harvested for 
immunoblot analysis respectively. 
2.7.3  Multiple scratch wound assays 
100, 000 cells were seeded onto 35 mm petri dish and grown to 2 days post 
confluence. Upon confluent, the monolayer was left intact or subjected to wounding 
using 3 yellow tips mounted onto a multi-channel pipette to generate multiple scratch 
wounds vertically and horizontally across the 35 mm petri dish. Cells were then 
washed twice in media and left to recover for either 18 hrs or 24 hrs post-wounding 




2.8  Statistical analysis 
2.8.1  Differential interference contrast (DIC) live-cell migration 
For single cell migration study, the distribution of cell migration for each cell line was 
represented in the form of histograms using the histogram data analysis tool add- in in 
Microsoft® Excel. The total distance travelled by each cell for 5 hrs was determined 
and the results were represented as mean distance travelled by each cell for n = 55 
(NEB-1) and n = 45 (KEB-7) respectively. 
2.8.2  Confluence assay 
For confluence assay, 500 – 800 cells at different confluence states were counted 
using ImageJ analysis software. The total number of cells and the number of cells 
with aggregates were counted and represented as % of cells with aggregates.  
2.8.3  Drug/EGF treatment 
For the EGF treatment study, 700 – 900 cells from each treatment group were counted 
for 4 independent experiments using ImageJ analysis software. The total number of 
cells and the number of cells with aggregates were counted and represented as % of 
cells with aggregates.  
2.8.4  Phase contrast live-cell imaging of scratch wounds using IncuCyteTM 
For scratch wound assays, both the initial wound area (denoted by red line) and the 
area of wound region covered (denoted by the green line) for each treatments were 




2.8.5  Co-localization study 
For quantification of co-localization studies, data were obtained from 20 cells 
immunostained with either P-ERK1/2 (Thr202/Tyr204) or ERK1/2 and they were 
represented as Pearson Coefficient of Correlation values using the SoftWoRx 
software (Applied Precision, USA).  
2.8.6  MEK1/2 inhibitor treatment 
For the U0126 inhibitor treatment studies, 400-1000 cells from each treatment group 
were counted for n = 8 independent experiments using imageJ analysis software. The 
number of cells with aggregates were counted and represented as number of cells with 
aggregates relative to control.  
2.8.7  Viral titration of N/TERT-1 cells with AcGFP-K14 R125P and AcGFP-
K14 R125P_Y129F constructs 
For the infection study, 500 – 3000 cells from each multiplicity of infection (M.O.I) 
treatment group of 0.5, 1.0 and 2.0 respectively were counted for 3 independent 
experiments using ImageJ analysis software. The total number of cells, the number of 
GFP-positive cells and the number of cells with aggregates were counted and 
represented as % infection efficiency and % of cells with aggregates.  
2.8.8  General statistical analysis 
All data were presented as mean  SD, except for single cell migration which was 
presented as mean  S.E.M. Data analysis was performed by one-way analysis of 
variance (ANOVA) followed by post hoc Tukey‟s test for multiple comparisons of at 
least three groups or unpaired Student‟s t-test between two groups using Prism 5.0 











CHAPTER 3        









3.1  Introduction 
Normal homeostasis of the epidermis is maintained by a tightly controlled 
keratinocyte differentiation program that provides the barrier function of the body. 
However, in response to injury, this self-renewal program is interrupted and the 
keratinocytes become “activated”, which occurs not only on wounding but also in in 
vitro culture conditions (reviewed in Grinnell, 1990; Grinnell, 1992). During this 
wound healing process, the junction and adhesion molecules of the keratinocytes 
undergo significant changes (reviewed in Martin, 1997). For instance, the 
keratinocytes partially disintegrated their hemidesmosomes and began to express 
vitronectin, fibronectin receptors and α5β1 integrins, which allowed them to migrate 
over the provisional wound matrix (Cavani et al., 1993; Haapasalmi et al., 1996; 
Singer and Clark, 1999). Fibronectin is a major component of this provisional wound 
matrix (reviewed in Clark, 1990), which accumulates in wound fluid such as in the 
suction blisters (Wysocki and Grinnell, 1990).  
One of the markers of activated keratinocytes is the suprabasal expression of K6, K16 
and K17 proteins at the expense of K1 and K10 (Weiss et al., 1984), hence deviating 
from the usual differentiation program. It is thought that these wound- induced 
keratins provide plasticity and flexibility of the cytoskeleton of the migrating 
keratinocytes (Coulombe, 1997), hence promoting the reorganization of keratin 
filaments during the onset of re-epithelialization (Paladini et al., 1996). 
As the keratinocytes migrate, they form new focal adhesion complexes and undergo 
intracellular actinomyosin filaments contraction as they push forward towards the 
wound bed (Mitchison and Cramer, 1996). Due to the switching of integrin receptors 
(β4 to β1) and assembly of associated actin filament networks, there is a lag of several 
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hours before epidermal migration begins (Grinnell, 1992). Initiation of keratinocyte 
migration occurred 16-24 hours after injury (Winter, 1962), and its early phase was 
not affected by mitosis (Matoltsy, 1955). However, keratinocytes located behind the 
migrating sheet could undergo a transient burst of proliferation a few hours after the 
onset of migration, providing more cells to sustain re-epithelialization (Garlick and 
Taichman, 1994).  
Wound-edge keratinocytes also up-regulate several matrix metalloproteinases (MMP) 
such as MMP-2 and MMP-9 (gelatinases), which can cleave basal lamina collagen 
(type IV) and anchoring fibril collagen (type VII) (Salo et al., 1994), thus aiding in 
tissue remodelling.  
Once the activation cycle is completed, keratinocytes become deactivated and revert 
to normal differentiation, giving rise to the quiescent stratified epidermis. This 
process is termed the keratinocyte activation cycle (Freedberg et al., 2001).  
EBS Dowling-Meara (EBS-DM) keratinocytes have an intrinsic upregulation of 
activated stress kinases and they show sustained stress responses to osmotic stress 
(D'Alessandro et al., 2002) and faster migration during scratch wound assays (Morley 
et al., 2003). Why these EBS-DM keratinocytes have a faster wound response is not 
completely understood, although this could have something to do with their 
keratinocyte activation state.  
In this chapter, it is hypothesized that EBS-DM cells are in a constitutively stressed or 
activated state reminiscent to a wound condition. Experiments are designed to address 
the following: (1) the differences between wild-type and EBS-DM cells at sub-
confluence in terms of (a) their stress activated protein kinase (SAPK) activation, (b) 
their difference in migration speeds (single and collective cell migration) and (c) 
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wound response protein expression (K17, β1 integrin, fibronectin and MMP-9); (2) 
changes in wound response protein levels in EBS-DM cells as they transit to 
quiescent state (100 % confluence or more) and (3) changes in wound response 
protein levels upon reverting from confluence to an activation state when subjected to 
multiple scratch wounding. It is found that EBS-DM cells are intrinsically “primed” 
to be in the constitutively activated state, which might be a consequence of the 
pathogenesis of recurrent blister formation in EBS-DM patients. 
 
3.2  Results 
3.2.1  Characterization of EBS-DM cell lines 
As the first step to identify the physiological differences between wild-type cells and 
EBS-DM cells, wild-type keratinocytes isolated from the skin of a normal individual, 
immortalized and named as NEB-1 (wild-type K14) (Morley et al., 2003), mutant 
keratinocytes isolated from the skin of a EBS-DM patient (harbouring EBS-DM 
mutation K14 R125P), immortalized and named as KEB-7 (Morley et al., 2003) and 
NEB-1 keratinocytes stably expressing EGFP-tagged K14 WT and K14 R125P 
(Liovic et al., 2009) were used in this study.  
It was confirmed that KEB-7 keratinocytes show spontaneous appearance of keratin 
aggregates at the periphery, and that this occurs in the presence of intact filament 
formation [Figure 3.1 (I) (i) (B)], compared to wild-type NEB-1 keratinocytes in 
[Figure 3.1 (I) (i) (A)]. Characterization of NEB-1 keratinocytes stably expressing 
EGFP-K14 R125P showed a phenotype reminiscent to that of KEB-7 cells from their 
densely packed keratin bundles at the perinuclear region and keratin aggregates 
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segregated at the cell periphery [Figure 3.1 (I) (ii) (B)]. This was distinct from cells 
stably expressing EGFP-K14 WT, which did not show any peripheral keratin 
aggregates [Figure 3.1 (I) (ii) (A)]. Moreover, the presence of normal filament 
formation was not completely impaired in the EGFP-K14 R125P keratinocytes 
[Figure 3.1 (I) (ii) (B)], which was similar to that of KEB-7 cells [Figure 3.1 (I) (i) 
(B)], and showed a co-existent of normal filaments with peripheral keratin aggregates.  
It is also observed that there are variations in the level of K14 expression in t issue 
culture, as is commonly seen in many cell lines, and this could be due to the time 
lapse since the last cell division or due to an unidentified microenvironmental factor 
that affect keratin synthesis in culture.  
To evaluate the protein levels of endogenous and exogenous K14 of the different cell 
lines, immunoblot analysis was performed on cell lysates from NEB-1, KEB-7, 
EGFP-K14 WT and EGFP-K14 R125P cell lines at subconfluence [Figure 3.1 (II)]. It 
was shown that KEB-7 cells have significantly higher (* p < 0.05) levels of K14 
proteins (2.02 ± 0.99 folds) than NEB-1 cells (1.00 ± 0.00), although the ratio of wild-
type K14 and mutant K14-R125P proteins of the KEB-7 cells within this band could 
not be determined [Figure 3.1 (III) (i)]. Equal amounts of endogenous K14 (1.00 ± 
0.00) and exogenous K14 (1.03 ± 0.21 folds) protein levels were observed in EGFP-
K14 WT cells [Figure 3.1 (III) (ii)], whereas the amount of exogenous K14 proteins 
(1.59 ± 0.50 folds) were significantly higher (* p < 0.05) than that of the endogenous 
K14 proteins (1.00 ± 0.00) in EGFP-K14 R125P cells [Figure 3.1 (III (ii)], an 
observation similar to that reported in (Beriault et al., 2012) using the same cell lines. 
These results showed that NEB-1 K14 R125P cells predominantly expressed the 
exogenous mutant K14 proteins, with the endogenous wild-type K14 proteins 
contributing to 40% of the total [Figure 3.1 (III (ii)]. This may be because the CMV-
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driven transfected K14 construct is not responding to local feedback signals when the 
K14 level in the cell becomes too high, whereas the normal K14 promoter driving the 
endogenous K14 is responsive to such signals. Thus, synthesis of the endogenous K14 
can be regulated and shut down whilst the transfected K14 cannot. These observations 
also suggest that EBS-DM cell lines have an abnormal K14 expression profile, 
because the levels of K5 proteins are the same in all four cell lines [Figure 3.1 (III) 
(iii)], and this could be a response to the accumulating mutant keratins (in the form of 
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Figure 3.1 Characterization of EBS-DM cell lines. (I) Spontaneous formation of keratin 
aggregates co-existing with filaments in EBS-DM cells. (i) Immunostaining of (A) NEB-1 
and (B) KEB-7 keratinocytes with anti-K14 (LL001). Scale bar, 30 µm. (ii) Stable 
expression of (A) EGFP-K14 WT and (B) EGFP-K14 R125P in NEB-1 keratinocytes. 
Scale bar, 30 µm. (II) EBS-DM (KEB-7) cells expressed higher levels of K14 than wild-
type (NEB-1) cells. Insoluble fractions of cell extracts were prepared from these cell lines 
at subconfluence. Immunoblot analysis of these cell lysates shown using antibodies to K14 
(LL001) and K5 (XM-26). Actin used as loading control. (III) Densitometry values of (i) 
endogenous K14 levels, (ii) exogenous K14 relative to endogenous K14 levels and (iii) K5 
protein levels of the respective cell lines at subconfluence, normalized to actin loading 
control and data presented as relative to NEB-1 group or endogenous K14 group and as 
mean ± S.D for n= 3. Statistical significance was assessed by one-way analysis of variance, 
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3.2.2  Keratin aggregates localized at the leading edge are highly dynamic 
To demarcate the region where the keratin aggregates were segregated, mutant 
keratinocytes expressing EGFP-K14 R125P was immunostained with phalloidin, 
which could bind F-actin subunits specifically. It was observed that keratin aggregates 
were organized in a polarized manner [Figure 3.2 (i) (A)], at sites of lamellipodial 
protrusions where directed cell migration normally occurred [Figure 3.2 (i) (B)]. 
Time-lapse imaging of EGFP-K14 R125P cell line showed that the small, highly 
dynamic peripheral keratin aggregates originated from the base of the lamellipodium, 
coalesced to form larger keratin granules, disassembled and incorporated into the pre-
existing keratin network in a retrograde transport fashion [Figure 3.2 (ii)]. This 
observation was consistent to another study that utilized EYFP-K14 R125C, where 
the authors demonstrated that the keratin aggregates localized at the periphery were 
transported in an actin-meditated manner and incorporated into perinuclear keratin 
filaments (Werner et al., 2004). Hence, these results showed that keratin aggregates at 
lamellipodial protrusions were highly dynamic. This would allow for the rapid 











Figure 3.2 Keratin aggregates localized at the leading edge are highly dynamic. 
Continuous remodelling of keratin aggregates at sites of lamellipodial protrusions. (i) 
(A) Localization of keratin aggregates at sites of (B) F-actin (phalloidin) formation in 
EGFP-K14 R125P cells. Scale bar, 30 µm. (ii) Time-lapse imaging of EGFP-K14 
R125P cell at intervals of 15 sec for 30 min. The montage showed movements of 
keratin aggregates at intervals of 1 min during acquisition from 18
th
  to 23
th
 min. Small 
peripheral keratin aggregates observe to coalesce (red arrows), disassemble and 






































3.2.3  Intrinsic and sustained stress activation in isogenic EBS-DM cells during 
osmotic stress 
It was previously shown that EBS-DM (KEB-7) keratinocytes have an intrinsic 
upregulation of stress activated kinases and they showed sustained stress responses to 
osmotic stress (D'Alessandro et al., 2002). These results were reproducible when the 
isogenic pathomimetic cell line (EGFP-K14 R125P) was exposed to the same osmotic 
stress regime and then examined for stress kinase activation [Figure 3.3 (i)]. It was 
observed that upon 30-60 min recovery from 5 min of 150 mM urea treatment, 
phosphorylated K5 was upregulated in both cell lines, suggesting that there was a 
remodelling of keratin intermediate filaments under stress [Figure 3.3 (i)]. A 
concomitant increase in both JNK1/2 and p38 phosphorylation [Phospho-JNK (P-
JNK1/2) /phospho-p38 (P-p38)] were also observed in this recovery time course, 
confirming that both JNK1/2 and p38 activation were involved in this stress regime 
[Figure 3.3 (i)].  
One consistent observation was the intrinsic and sustained levels of stress-activated 
protein kinases (SAPKs: P-p38 and P-JNK1/2) in the mutant cells during the osmotic 
stress treatment regime as compared to the wild-type cells [Figure 3.3 (ii)]. For 
instance, the mutant cells have higher basal levels of P-p38 and P-JNK1/2 than wild-
type cells, suggesting intrinsic stress activation [Figure 3.3 (ii)]. Moreover, the mutant 
cells have higher levels of p38 and JNK1/2 activation than wild-type cells throughout 
the time course after recovery from osmotic stress, indicating sustained stress 
activation [Figure 3.3 (ii)]. This could be associated with altered filament kinetics of 
mutant keratin protein leading to a misfolded protein response (Russell et al., 2010). 
Keratinocytes derived from patients suffering from EBS-localized mutation (mild 
phenotype with no keratin aggregates) also have an intrinsic activation of SAPKs 
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(D'Alessandro et al., 2002). This state also leads to mutant keratinocytes 
downregulating their dual-specificity phosphatases which will further shift the 
















EGFP-K14 R125P EGFP-K14 WT 
CTRL 5’OS CTRL 5’OS 
Recovery - - 30’ 60’ - - 30’ 60’ 
Figure 3.3 Intrinsic and sustained stress activation in isogenic EBS-DM cells during 
osmotic stress.  EBS-DM cells have intrinsic and sustained upregulation of stress-activated 
protein kinases (P-p38 and P-JNK). (i) EGFP-K14 WT and EGFP-K14 R125P cells were 
exposed to 5 min of 150 mM urea treatment, and left to recover for 30 min and 1 hr 
respectively. Soluble fractions of cell extracts were prepared from these cells. Immunoblot 
analysis of these cell lysates shown using antibodies to P-K5, P-JNK (Thr183/Tyr185), 
JNK, P-p38 (Thr180/Tyr182) and p38. GAPDH used as loading control. (ii) Densitometry 
values of P-p38 and P-JNK protein levels for the respective cell lines at different conditions, 
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3.2.4  EBS-DM mutation predisposes keratinocytes to have directional 
persistence in single cell migration 
To determine whether the EBS-DM mutation has any effect on the directional 
migration of keratinocytes, single cell motility of each cell line was investigated by 
using live-cell DIC (differential interference contrast) imaging to monitor the random 
migration of keratinocytes (Sehgal et al., 2006; Hamill et al., 2009). Tracked plots of 
randomly migrating single cell suggested that the KEB-7 cells show more directional 
persistence and migrated further away from the central origin [Figure. 3.4 (i) (B)], 
whereas majority of the NEB-1 cells migrated around the central origin in a non-
directional manner [Figure. 3.4 (i) (A)]. The total distances travelled over 5 hrs by 
each cell from each cell line were represented as a distribution in the form of 
histograms: NEB-1 (49-638 μm) and KEB-7 (68-996 μm) respectively [Figure 3.4 (ii) 
(A-B)]. The mean distance travelled by KEB-7 cells (444.0 ± 31.48 μm) was 
significantly higher (*** p < 0.001) than that of NEB-1 cells (276.1 ± 18.05 μm) 
[Figure 3.4 (iii)], thus demonstrating an intrinsic faster migration rate over a period of 
5 hrs. 
3.2.5  Keratinocytes harboring EBS-DM mutation close up wounds faster in 
scratch wound assays  
Epidermal keratinocytes do not normally migrate as single cells but as sheets of 
interconnected cells, so it is possible that the migration response of single cells is 
exaggerated and/or the stress state is abnormally high. Therefore, in vitro scratch 
wound assays were used to examine the collective migration of keratinocytes, 
monitored by live-cell phase contrast imaging of the cell monolayer after wounding. It 
was confirmed that KEB-7 shows faster migration than NEB-1 at 26 hrs post-
wounding [Figure 3.5 (i)], and that EGFP-K14 R125P cells close up wound faster 
than that of EGFP-K14 WT cells at 14 hrs post-wounding [Figure 3.5 (ii)]. These 
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results were consistent with previous studies (Morley et al., 2003; Liovic et al., 2009) 
and further demonstrated that the presence of keratin aggregates, which is correlated 
with intrinsic stress in these EBS-DM keratinocytes, is associated with faster 
migration in both single and collective cell migration assays.  
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Figure 3.4 EBS-DM mutation predisposes keratinocytes to have directional 
persistence in single cell migration. EBS-DM cells have higher motility rates in single 
cell migration. (i) Live-cell DIC images of single cell from each cell line were obtained 
every 5 min for a total of 5 hours. DIC images of single cell were then filtered, 
segmented and adjusted to auto-threshold by macros written with ImageJ. Each track 
represented a cell over a period of 5 hours for n = 55 (NEB-1) and n = 45 (KEB-7). (ii) 
Total distance travelled by each cell for 5 hrs was extracted and represented in the form 
of histograms. (iii) Data presented as mean distance travelled and as mean ± S.E.M. 














Figure 3.5 Keratinocytes harbouring EBS-DM mutation close up wounds faster in 
scratch wound assays. EBS-DM cells have faster migration speeds in collective cell 
migration. (i-ii) Cells grown to confluence in an Essen ImageLock 96-well plate were 
subjected to wounding with a 96-well WoundMaker Tool. Images acquired immediately 
and at 1 hr intervals for 14 or 26 hrs using the IncuCyte imaging system. Data were 
processed by ImageJ software. Red line marks the denuded area from which cells were 
removed at the start of the wound (0 hr); green line marks the remaining uncovered area after 
















































3.2.6  EBS-DM cells express more wound response proteins at both the mRNA 
transcript and protein levels  
The observations that EBS-DM cells have intrinsic stress activation and that they 
migrated faster than wild-type cells lead to the hypothesis that they are in an 
“activated” state of the keratinocyte activation cycle. To test this hypothesis, the 
levels of proteins associated with a wound response (reviewed in Santoro and 
Gaudino, 2005) were examined in the four cell lines at sub-confluence. An 
upregulation of K17 (wound-induced keratin) expression was observed in the EBS-
DM cells as compared to wild-type cells, at both the mRNA transcript [Figure 3.6 (I) 
(i)] and protein levels [Figure 3.6 (II) (i)]. Other wound-associated genes observed to 
be up-regulated in the EBS-DM cells as compared to wild-type cells included the β1 
integrin (wound-associated integrin), fibronectin (wound-associated extracellular 
matrix, ECM protein), and MMP-9 (wound-associated matrix metalloproteinase), a 
gelatinase induced during wound healing and a marker for migratory phenotype 
[Figure 3.6 (I) (ii- iv), Figure 3.6 (II) (ii) and (iii)]. These differences in expression 
levels of wound response proteins between EBS-DM and wild-type cells suggest that 
EBS-DM cells are more activated than the wild-type cells, and these increased levels 
of wound response proteins such as β1 integrin and MMP-9 may be the factors 
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Figure 3.6 EBS-DM cell lines expressed high levels of wound response proteins at both 
the mRNA transcript and protein levels. EBS-DM cells were more “activated” than wild-
type cells. (I) RNA isolated from NEB-1, KEB-7, EGFP-K14 WT and EGFP-K14 R125P cell 
lines at sub-confluence. cDNAs were prepared and analyzed by real-time PCR for 
quantification using specific primers to (i) K17, (ii) β1 integrin, (iii) fibronectin, (iv) MMP-9, 
normalized to RPLP0. Data presented as mRNA expression relative to NEB-1 and as mean ± 
S.D for n = 3 of each group. Statistical significance was assessed by one-way analysis of 
variance, followed by Tukey‟s test, * p < 0.05 vs. NEB-1 or EGFP-K14 WT group. (II) 
Soluble fractions of cell extracts were prepared from each cell line at sub-confluence. 
Immunoblot analysis of these cell lysates shown using antibodies to (i) K17 (E3), (ii) β1 
integrin (CD29) and (iii) fibronectin (clone 10). Actin used as loading control. Densitometry 
values of (i) soluble K17 levels, (ii) β1 integrin levels and (iii) fibronectin levels of the 
respective cell lines at subconfluence, normalized to actin loading control. Data presented as 







































































































































































3.2.7  Loss of keratin aggregates as EBS-DM cells become confluent 
Experiments were then undertaken to assess whether driving the mutant cells into 
confluence would influence the number of keratin aggregates. Subconfluent (80% 
confluence) keratinocytes were first cultured to 100% confluence (into a monolayer) 
and further grown to 1 and 2 days post-confluence (i.e. quiescence, or approaching 
quiescence) before fixing them or harvesting them for immunoblot analysis. It was 
observed that as these mutant keratinocytes were grown from full confluence to 1 and  
2 days post-confluence, EGFP-K14 R125P cells began to lose their peripheral keratin 
aggregates [Figure 3.7 (i) and (ii)]. These changes in appearance could be due to a 
change in activation status as they transited from activated to quiescent state. 
3.2.8 Loss of keratin aggregates is accompanied by a change in desmoplakin 
localization 
It was observed that mutant keratinocytes grown beyond confluence have a change in 
desmoplakin localization [Figure 3.8 (A‟) and (B‟)], wherein cytoplasmic 
desmoplakin (seen in subconfluent cells with aggregates) became increasingly 
localized to cell-cell adhesion sites in the confluent EGFP-K14 R125P cells [Figure 
3.8 (A‟‟) and (B‟‟), insert], thus suggesting that the presence of keratin aggregates 
was influenced by the state of the desmosomal adhesion between adjacent mutant 
keratinocytes. This inverse correlation between less extensive desmoplakin 
localization to the desmosomes and the presence of more misfolded keratin 
aggregates in cells with EBS-DM mutation suggests that desmoplakin may directly 
affect the stability of mutant K14-containing filaments. If this is so, then reduction of 
desmosomes may promote a more migratory phenotype and increase keratin 
aggregate formation, whereas more extensive desmosome assembly co uld limit cell 
migration and reduce keratin aggregates.  
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Figure 3.7 Loss of keratin aggregates as EBS-DM cells become confluent.              
Loss of peripheral aggregates as EBS-DM cells approach the quiescent state. (i) 
Immunofluorescence images showing EGFP-K14 R125P cells at different confluence 
states from (A) 80%, (B) 100%, (C) post confluence for 1 day (100% + 1) and (D) 2 days 
(100% + 2). Scale bar, 20 µm. (ii) Quantification of the number of cells with keratin 
aggregates at different confluence states using ImageJ. Data presented as % of cells with 














































































Figure 3.8 Loss of keratin aggregates is accompanied by a change in desmoplakin 
localization. Desmoplakin localization in EBS-DM cells changed from cytoplasmic to cell-
cell adhesion borders as confluence increased. (A-B) Immunofluorescence images showing 
EGFP-K14 R125P cells at 80% and 100% confluence. (A‟-B‟) Immunostaining of EGFP-
K14 R125P cells with anti-desmoplakin I/II (11-5F), and (A‟‟-B‟‟) a 2x magnified image of 







3.2.9  Loss of peripheral aggregates is associated with changes in β1 integrin 
and fibronectin levels  
Because a change in appearance (reduction of keratin aggregates) of the mutant 
keratinocytes was observed by growing them beyond confluence (approaching 
quiescent state), experiments were conducted by immunoblot analysis to determine 
whether increasing quiescence could induce a change in their activation state. In all 
the four cell lines, it was observed that there was a decrease in the levels of wound 
response proteins such as β1 integrin and fibronectin as confluence increased [Figure 
3.9 (i) and (ii)]. Hence, driving the mutant keratinocytes into a quiescent state 
(increasing confluence) could neutralize their activation status and loss of keratin 
aggregates could be an indicator of a shift in activation state.  
3.2.10  EBS-DM cells induce more soluble K17 proteins upon wounding  
For biochemical analysis of the scratch wound- induced activation changes, a multiple 
scratch protocol was devised [Figure 3.10 (I) (A) and (A‟)]. Multiple scratch wounds 
were generated on the confluent monolayer of both EGFP-K14 WT and EGFP-K14 
R125P cells to drive the cells into an activated state. The levels of wound response 
proteins at 18 hrs or 24 hrs post-scratch were then analysed using immunoblot 
analysis. It was observed that there was an increase in β1 integrin levels in both cell 
lines upon wounding, supporting the migratory phenotype of keratinocytes during 
wound closure [Figure 3.10 (II) (i) and (ii)]. It was further demonstrated that EGFP-
K14 R125P keratinocytes induced more soluble K17 proteins (0.23 ± 0.19) than wild-
type keratinocytes (0.15 ± 0.14) at 18 hrs post-scratch, and that the levels of soluble 
K17 proteins in the EBS-DM cells were higher than the wild-type cells at all time 
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points after wounding [Figure 3.10 (II) (i) and (ii)]. Hence, these results confirmed 
that EBS-DM cells are more activated than wild-type cells. 
In summary, the findings in this chapter demonstrate that EBS-DM keratinocytes are 
more activated than wild-type keratinocytes in terms of its constitutive activated 
SAPK activation, up-regulation of wound-associated proteins such as K17 and β1 
integrin and faster migration.  Confluence leads to a reduction of keratin aggregates in 
EBS-DM keratinocytes, accompanied by a decrease in activation state and wounding 
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Figure 3.9 Loss of peripheral aggregates is associated with changes in β1 integrin 
and fibronectin levels. Loss of keratin aggregates is associated with a decrease in 
activation state. (i) Soluble fractions of cell extracts were prepared from each cell line at 
different confluence states from 80%, 100%, post-confluence for 1 day (100% + 1) and 2 
days (100% + 2). Immunoblot analysis of these cell lysates shown using antibodies to β1 
integrin (CD29) and fibronectin (clone 10). Actin used as loading control. (ii) 
Densitometry values of β1 integrin and fibronectin protein levels of the respective cell 
lines in different confluence states, normalized to actin loading control. Data presented as 








































































































































































































Figure 3.10 EBS-DM cells induce more soluble K17 proteins upon wounding. 
EBS-DM cells have a greater wound response than wild-type cells. (I) Formation of 
multiple scratch wounds (A‟) from a monolayer of cells (A). (II) (i) Soluble and 
insoluble fractions of cell extracts were prepared from each cell line that were 
unscratched, post-scratched for 18 hrs and 24 hrs respectively. Immunoblot analysis 
of these cell lysates shown using antibodies to β1 integrin (CD29), K17 (E3) and K5 
(XM-26). Actin used as loading control. (ii) Densitometry values of β1 integrin and 
soluble K17 protein levels of the respective cell lines in different conditions, 













































































3.3  Discussion 
The work described in this chapter is based on the use of an in vitro model of the 
epithelial wound response. (1) An experimental keratinocyte activation cycle was 
established in an in vitro assay system, by growing cells to confluence and then 
scratch wounding them. The transition of the cultured keratinocytes could then be 
studied from subconfluent (activated) to confluence (quiescent) and then re-activating 
the cells by scratch wounding to stimulate the wound response processes. (2) The 
transition from normal state (wild-type cells) to activated state (EBS-DM cells) is 
associated with up-regulation of wound response proteins such as K17, MMP-9, β1 
integrin and fibronectin, as has been described for wounds in vivo, validating this 
model. (3) EBS-DM cells were confirmed to be in a more activated state than wild-
type cells, even without the application of additional stress, as indicated by their 
higher levels of several stress-associated proteins. (4) The tight correlation between 
the appearance of keratin aggregates (rapid remodelling of keratin precursors at the 
leading edge) and the activation state of the keratinocytes suggests that the presence 
of aggregates could be an indicator of activation state.  
The observations of peripheral keratin aggregates in the mutant keratinocytes (KEB-7 
and EGFP-K14 R125P), but not in the wild-type keratinocytes (NEB-1 and EGFP-
K14 WT), were consistent with previous studies in either EBS-DM patient-derived 
keratinocytes or over-expression of mutant constructs in cell culture system (Letai et 
al., 1993; Werner et al., 2004). An abnormal K14 expression profile was observed in 
EBS-DM cells as compared to wild-type cells, although it is not known whether this 
imbalance of keratin levels is a general feature of keratin mutation. Time-lapse 
imaging showed that the peripheral keratin aggregates were highly dynamic, 
undergoing rapid remodelling at sites of lamellipodial protrusions. The present data 
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also showed the inherent stress activation in EGFP-K14 R125P cells, as seen by 
constitutive upregulation of activated stress kinases (P-JNK and P-p38), in agreement 
with earlier work (D'Alessandro et al., 2002). It was reported that during wound 
healing, p38 activation was observed in the leading keratinocytes (Harper et al., 2005). 
Since EBS-DM cells show constitutive stress activation, their responses in single and 
collective cell migration assays were further examined. It was demonstrated that the 
EBS-DM mutation pre-disposed the cells to migrate further and faster in single and 
collective cell migration respectively, suggesting that the inherent stress is connected 
to the increased motility of these mutant keratinocytes.  
Keratinocytes that are “activated”, or in a wound-healing state, expressed several 
wound response markers. For instance, K6, K16 and K17 are important wound-
induced keratins that when ablated, resulted in compromised wound healing 
(Mazzalupo et al., 2003) and delayed re-epithelialization (Wojcik et al., 2000). 
Migrating keratinocytes also undergo a switch in integrins (β4 to β1) at wound sites 
(reviewed in Santoro and Gaudino, 2005), which facilitates migration over the fibrin-
fibronectin rich provisional wound matrix (O'Keefe et al., 1985; Nickoloff et al., 
1988). Other keratinocyte-upregulated components such as MMP-2 and MMP-9 are 
also known to facilitate wound healing (Salo et al., 1994). 
To determine whether these EBS-DM mutant keratinocytes were in an “activated” 
state equating to wound healing, levels of these wound- induced proteins were 
examined in both the wild-type and EBS-DM cell lines. It was found that wound-
induced proteins such as K17, MMP-9, β1 integrin and fibronectin were intrinsically 
upregulated in EBS-DM cells as compared to wild-type cells, supporting the 
proposition that EBS-DM cells are in a constitutively activated state, effectively 
“primed” for wound healing.  
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Cells grown to confluence in culture (epithelial cell monolayer) are known to mimic a 
quiescent state of the keratinocyte activation cycle (reviewed in Santoro and Gaudino, 
2005). In the present study, EBS-DM cells were grown to high confluence in culture 
to bring them out of their activation state. It was observed that as confluence 
increased, there was a reduction of peripheral keratin aggregates seen in the mutant 
cells, accompanied by a change in desmoplakin localization from a cytoplasmic 
distribution of desmoplakin to its localization at cell-cell borders. 
Desmoplakin is known to interact directly with keratin intermediate filaments through 
part of its C-terminal domain (Kouklis et al., 1994).  Previous studies have shown that 
desmosomes are able to adopt two alternative adhesive states, one calcium-dependent 
(weakly adhesive) and the other calcium-independent (hyper-adhesive) (Kimura et al., 
2007), which could be modulated by PKC (Wallis et al., 2000).  The calcium 
independent state was distinguished by strong desmoplakin staining at cell-cell 
borders in confluent cultures, to which its hyper-adhesiveness was attributed (Kimura 
et al., 2007), whereas desmosomes at the wound edge were characterized by a 
calcium-dependent state, with weak desmoplakin staining at cell-cell borders, 
possibly due to internalisation of desmosomes (Garrod et al., 2005).  
The importance of desmoplakin in tethering keratin intermediate filaments to cell-cell 
junctions was revealed by the phenotype of desmoplakin conditional knockout mice, 
which exhibited peeling skin and desmosomes that lacked inner plaques and were 
devoid of keratin attachment (Vasioukhin et al., 2001). In the present study, the 
reduction of keratin aggregates upon increasing confluence could be explained by a 
cessation of keratin remodelling at the leading edge, as cells no longer need to migrate 
and keratin filaments become attached to stabilized desmosomes at cell-cell borders. 
Members of our group have observed a connection between desmosomal adhesive 
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state and keratin aggregate formation (unpublished data) and the work presented here 
also suggests that restoring desmoplakin localization might be crucial in attenuating 
the activation status of EBS-DM cells. 
Next, it was established that the activation states of EBS-DM cells decreased upon 
increasing confluence, as seen by a decline in β1 integrin and fibronectin protein 
levels. Finally, the activated state of these confluent keratinocytes could be restored 
by scratch wounding, where a higher induction of soluble K17 in EBS-DM cells at 18 
hrs post-wounding was observed as compared to wild-type cells, thus confirming the 
constitutive stress activation of EBS-DM cells. 
Recent findings have shown that ERK1/2 activation in EBS-DM keratinocytes could 
protect these mutant cells against apoptosis during mechanical stress (Russell et al., 
2010). This suggests that cells effectively “primed” for wound healing are more able 
to adapt to stress, and that altered filament kinetics may play a role in this. 
Identification of the mechanisms underlying the regulation of keratin filament kinetics 
could give us some insights to the pathogenesis of skin fragilty disorder or even 
aggresome formation (Mallory body) in cholestatic liver diseases (Fickert et al., 2003).  
In conclusion, the results in this chapter demonstrated that EBS-DM cells are 
constitutively activated, and the presence of keratin aggregates (rapid remodelling of 
keratin precursors at the leading edge) could be an indicator for the activation state. A 































CHAPTER 4        
EGF INVOLVEMENT IN REGULATING 




4.1  Introduction 
The keratinocyte activation cycle is regulated by extracellular signal cues such as the 
tumor necrosis factor α (TNF-α), epidermal growth factor (EGF), transforming 
growth factor α and β (TGF-α and TGF-β) and interferon γ (IFN-γ) (Freedberg et al., 
2001). EGF and TGF-α, members of the EGF family and ligands for EGF receptor 
(EGFR), are considered the key mitogens and chemotactic factors that drive wound 
closure (reviewed in Kirfel and Herzog, 2004). It has been shown that both EGF and 
TGF-α can play an important role in colony expansion through the induction of 
epithelial cell migration (Barrandon and Green, 1987). This induction of cell 
migration is attributed to the rapid formation of lamellipodia and filopodia (Chinkers 
et al., 1979), mediated by the activation of small guanosine triphosphatase (GTPase) 
Rac by EGF (Nobes and Hall, 1995). 
During re-epithelialization of wounds, epidermal keratinocytes revert to a migratory 
phenotype and move over a fibronectin-rich provisional wound matrix (Midwood et 
al., 2004). Forward locomotion is mediated by the formation of lamellipodia that 
extend into the wound (reviewed in Lauffenburger and Horwitz, 1996; Welch et al., 
1997), and this may involve a coordination between the three interconnected filament 
systems, namely intermediate filaments, actin microfilaments and microtubules  
(reviewed in Mikhailov and Gundersen, 1998; Waterman-Storer and Salmon, 1999; 
Chang and Goldman, 2004). In addition, intermediate filament-associated proteins 
such as BPAG-1 and plectin from the plakin family (Leung et al., 2002) also have a 
role to play in cell migration during wound healing. It was shown that BPAG-1 
knockout mice have defects in wound healing (Guo et al., 1995) while plectin-/- 
fibroblasts have difficulty in reorganizing their actin cytoskeleton, resulting in 
reduced cell migration (Andra et al., 1998). Together, these studies show that there is 
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an interplay between filaments and filament-associated proteins contributing to cell 
migration. 
Keratin intermediate filaments play a major role in the structural stability of epithelial 
tissues by forming a cytoskeletal scaffold and providing mechanical resistance to 
stress (reviewed in Owens and Lane, 2003). Keratin intermediate filaments typically 
connect to both desmosomes and hemidesmosomes and thereby not only contribute to 
stability between epithelial cells but also to the stability of the epithelial attachment to 
the basement membrane (reviewed in Kowalczyk et al., 1999; Nievers et al., 1999). 
Besides its structural role, accumulating experimental evidence has shown that the 
keratin cytoskeletal network is highly dynamic, with constant turnover in cells 
(Windoffer and Leube, 1999; Yoon et al., 2001; Windoffer et al., 2004). Time-lapse 
imaging of cultured cells expressing fluorescent-tagged keratins revealed the 
dynamics of keratin particles being transported along microtubules (Yoon et al., 2001; 
Liovic et al., 2003) or actin stress fibers (Woll et al., 2005; Kolsch et al., 2009). A 
recent model to account for the assembly and disassembly of keratins, independent of 
biosynthesis, has been proposed by Leube and colleagues and is suggested to explain 
how the rigid keratin cytoskeletal network can be remodelled rapidly without network 
disruption (reviewed in Windoffer et al., 2011). For instance, during cell migration, 
keratin precursors were observed to nucleate at the lamellipodial regions, possibly 
associated with focal adhesions (Windoffer et al., 2006), and then to elongate and 
move towards the cell interior in an actin-mediated retrograde manner, before 
becoming incorporated into the peripheral keratin network (Woll et al., 2005). 
Although much of this work was done by imaging live cells and measuring 
morphological changes in keratin structures, the molecular mechanism regulating 
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keratin remodelling in wound- induced stress response is not well understood, and 
Leube‟s model remains hypothetical to date (reviewed in Windoffer et al., 2011). 
Keratin aggregates in EBS-DM cells form in lamellipodia [Figure 3.2] and 
lamellipodia are produced in response to EGF-induced Rac activation (Nobes and 
Hall, 1995) during cell migration. In this chapter, it is hypothesized that EGF 
influences keratin remodelling to affect cell migration during wound response. 
Experiments are carried out using the EBS-DM (EGFP-K14 R125P) cells (previously 
established in Chapter 3 to be in a constitutively activated state) as a model to dissect 
the signalling pathways involved. The results obtained show that EGF can affect 
keratin synthesis and solubility by increasing soluble K14 levels and also regulate 
keratinocyte migration in scratch wound assays. It is demonstrated that when EGFP-
K14 R125P cells are cultured in media without EGF, a reduction of keratin aggregates 
is observed, which can be restored upon re-stimulation with EGF. This EGF-mediated 
effect appears to be associated with the cytoskeletal linker protein, plectin.  
Inactivation of ERK1/2 kinase downstream of EGF signalling results in fewer mutant 
keratinocytes with peripheral aggregates, accompanied by a decrease in plectin levels. 
In the mutant keratinocytes, ERK1/2 knockdown with siRNA also results in a 
decrease of both peripheral aggregates and plectin levels. Fluorescence live-cell 
imaging is used to confirm the relationship between ERK1/2 activation, keratin 
aggregate status and cell migration in mutant keratinocytes. Conversely, plectin 
knockdown could reduce the number of mutant keratinocytes with peripheral 
aggregates and slow down mutant cell migration in scratch wound assays. In 
summary, these results suggest that EGF signalling plays a role in regulating keratin 
remodelling in wound- induced stress activated cells during migration, through 
modulating plectin levels. 
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4.2  Results 
4.2.1  EBS-DM cells have more soluble K5 and K14 proteins than wild-type 
cells 
It has been shown that remodelling of the keratin intermediate filament network is 
mediated by post-translational modifications such as keratin phosphorylation, which 
might favour the unpolymerised state of keratins by increasing their solubility 
(Toivola et al., 2002; Omary et al., 2006). 
In Chapter 3, it was observed that there was an abnormal K14 expression profile in 
KEB-7 (EBS-DM) cells when compared to NEB-1 (wild-type) cells. Experiments 
were therefore carried out to determine whether the abnormal K14 expression profile 
was consistently observed when compared to another wild-type cell line (N/TERT-1 
cells) and whether there is any difference in keratin solubility. Soluble/supernatant 
and insoluble/pellet fractions were prepared from N/TERT-1 (wild-type) cells and 
KEB-7 (EBS-DM) cells at subconfluence. Immunoblot analysis of cell lysate 
fractions showed that at the basal level, KEB-7 (EBS-DM) cells expressed more K14 
(2.98 ± 0.79 folds) (* p < 0.05) and K5 (2.61 ± 0.47 folds) (** p < 0.01) proteins than 
N/TERT-1 (wild-type) cells (1.00 ± 0.00) in the soluble fraction (non-filamentous, 
disassembled) but not in the insoluble fraction (pelletable, filamentous) [Figure 4.1 (i-
ii)]. These results confirmed the abnormal K14 expression profile in EBS-DM cells. It 
is possible that the presence of severe keratin mutation results in increased synthesis 
or it could be that the location of the R125P mutation alters K14 phosphorylation (a 
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Figure 4.1 EBS-DM cells have more soluble K5 and K14 proteins than wild-type cells. 
(i) Soluble and insoluble fractions of cell extracts were prepared from these cell lines at 
subconfluence. Immunoblot analysis of these cell lysates shown using antibodies to K14 
(LL001) and K5 (XM-26). Actin used as loading control. (ii) Densitometry results showing 
the intensity of soluble K14 or K5 levels for each cell line, normalized to its actin loading 
control and data presented as relative to N/TERT-1 group and as mean ± S.D for n = 3 of 
each treatment. Statistical significance was assessed by unpaired t-test, * p < 0.05, ** p < 









4.2.2  EGF treatment increases K14 synthesis and solubility in wild-type but not 
EBS-DM cells 
EGF is known to be an essential mitogenic and chemotactic factor for keratinocytes 
during wound healing (reviewed in Kirfel and Herzog, 2004), and to induce 
keratinocyte migration (Barrandon and Green, 1987). EGF is also known to induce 
keratin gene expression (Jiang et al., 1993; Tomic-Canic et al., 1998) which is 
mediated by downstream signalling pathways involving transcription factors such as 
c-Fos and c-Jun components of AP-1 that activate keratin promoter (Ma et al., 1997; 
Sinha et al., 2000). In an effort to understand the mechanisms regulating keratin 
remodelling in response to stress, the EGF signalling pathway was therefore explored 
to assess its effects on the keratin cytoskeleton.  
To address whether EGF could regulate keratin remodelling, the effects of EGF on 
keratin synthesis and solubility were examined in both cell lines. N/TERT-1 cells 
cultured in serum-free media without EGF for 48 hrs were subjected to EGF (10 
ng/ml, 100 ng/ml) treatments for 48 hrs. It was found that there was a significant 
increase (* p < 0.05) in K14 mRNA transcript in N/TERT-1 cells upon treatment with 
EGF (10 ng/ml) (1.36 ± 0.22 folds) and EGF (100 ng/ml) (1.44 ± 0.20 folds) as 
compared to untreated control (1.00 ± 0.00), whereas there was no significant change 
in K5 mRNA transcript in N/TERT-1 cells upon treatment with EGF (100 ng/ml) 
(0.99 ± 0.16 folds) as compared to untreated control (1.00 ± 0.00) [Figure 4.2 (I) (i) 
(A-C)], indicating increased K14 synthesis in response to EGF. 
To determine the changes in keratin protein solubility upon EGF treatment, 
soluble/supernatant and insoluble/pellet fractions were prepared from N/TERT-1 cells. 
It was found that the soluble fraction of K14 (non-filamentous, disassembled) in 
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N/TERT-1 cells increased significantly (* p < 0.05) upon treatment with EGF (100 
ng/ml) (2.36 ± 0.63 folds), as compared to untreated control (1.00 ± 0.00), whereas 
there was no significant change in the insoluble fraction of K14 (pelletable, 
filamentous), indicating increased solubility of K14 in response to EGF [Figure 4.2 (I) 
(ii) and (iii)]. There was also no significant change in the soluble K5 expression of 
N/TERT-1 cells upon EGF (100 ng/ml) treatment (1.23 ± 0.88 folds) as compared to 
untreated control (1.00 ± 0.00) [Figure 4.2 (I) (ii) and (iii)]. 
EBS-DM cells (KEB-7) were cultured without EGF for 48 hrs prior to the same EGF 
treatment regimes. It was found that there was no significant change in K14 mRNA 
transcript in KEB-7 cells upon treatment with EGF (100 ng/ml) (1.14 ± 0.18 folds) as 
compared to untreated control (1.00 ± 0.00), as well as no significant change in K5 
mRNA transcript in KEB-7 cells upon treatment with EGF (100 ng/ml) (1.12 ± 0.28 
folds) as compared to untreated control (1.00 ± 0.00) [Figure 4.2 (II) (i) (A-C)]. 
To determine the changes in keratin protein solubility upon EGF treatment, 
soluble/supernatant and insoluble/pellet fractions were prepared from KEB-7 cells. It 
was found that there was a slight increase in the soluble K14 expression (non-
filamentous, disassembled) upon EGF (100 ng/ml) treatment (1.42 ± 0.30 folds), 
though it was not significant as compared to untreated control (1.00 ± 0.00) [Figure 
4.2 (II) (ii) and (iii)]. Similarly, there was also a slight increase in the soluble K5 
expression upon EGF (100 ng/ml) treatment (1.33 ± 0.36 folds), but it was also not 
significant as compared to untreated control (1.00 ± 0.00) [Figure 4.2 (II) (ii) and (iii)]. 
These results suggest that changes in keratin expression in EBS-DM cells are 
relatively subtle to EGF treatment, possibly because of a constitutively activated EGF 
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Figure 4.2 (I) EGF treatment increases K14 synthesis and solubility in wild-type cells. 
N/TERT-1 cells cultured in serum-free media without EGF for 48 hrs were subjected to 
EGF treatments (10 ng/ml and 100 ng/ml) for 48 hrs. (i) RNA was isolated from each 
treatment group. cDNAs were prepared and analyzed by real-time PCR for quantification 
using specific primers to (A) KRT14, (B) KRT5, normalized to RPLP0. Data presented as 
mRNA expression relative to untreated control (CTRL), and as mean ± S.D for n = 3 of 
each treatment. Statistical significance was assessed by one-way analysis of variance, 
followed by Tukey‟s test, * p < 0.05 vs. CTRL group. (C) Amplified cDNA products from 
real-time PCR showing the levels of KRT14 and KRT5 mRNA expression upon EGF 
treatment (ii) Soluble and insoluble fractions of cell extracts were prepared from each 
treatment group. Immunoblot analysis of these cell lysates shown using antibodies to K14 
(LL001) and K5 (XM-26). Actin used as loading control. (iii) Densitometry results 
showing the intensity of soluble K14 or K5 levels for each EGF treatment group, 
normalized to its actin loading control and data presented as relative to untreated CTRL 
group and as mean ± S.D for n = 3 of each treatment. Statistical significance was assessed 
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Figure 4.2 (II) No significant change in keratin synthesis and solubility in EBS-DM 
cells in response to EGF treatments . KEB-7 cells cultured in media without EGF for 48 
hrs were subjected to EGF treatments (10 ng/ml and 100 ng/ml) for 48 hrs. (i) RNA was 
isolated from each treatment group. cDNAs were prepared and analyzed by real-time 
PCR for quantification using specific primers to (A) KRT14, (B) KRT5, normalized to 
RPLP0. Data presented as mRNA expression relative to untreated control (CTRL), and as 
mean ± S.D for n = 3 of each treatment. Statistical significance was assessed by one-way 
analysis of variance, followed by Tukey‟s test. (C) Amplified cDNA products from real-
time PCR showing the levels of KRT14 and KRT5 mRNA expression upon EGF 
treatment. (ii) Soluble and insoluble fractions of cell extracts were prepared from each 
cell line. Immunoblot analysis of these cell lines shown using antibodies to K14 (LL001) 
and K5 (XM-26). Actin used as loading control. (iii) Densitometry results showing the 
intensity of soluble K14 or K5 levels for each EGF treatment group, normalized to its 
actin loading control and data presented as relative to untreated CTRL group and as mean 
± S.D for n = 3 of each treatment. Statistical significance was assessed by one-way 



























































































































4.2.3  EGF regulates keratinocyte migration through its downstream signalling 
pathways 
Since remodelling of the keratin cytoskeleton is active during cell migration and EGF 
is known to stimulate migration, the effect of EGF on cells with defective keratins 
was investigated. It was observed that collective migration of keratinocytes, measured 
by the area recovered in a scratch wound assay, could be slowed down drastically in 
the presence of AG1478, a known EGFR inhibitor, in both EGFP-K14 WT (0.12 ± 
0.05) (+++ p < 0.001) and EGFP-K14 R125P (0.06 ± 0.03) (### p < 0.001) cells [Figure 
4.3 (iii) and (iv)] as compared to DMSO-treated controls [Figure 4.3 (i) and (iv)]. In 
addition, the effects of a downstream signalling kinase in the EGF pathway, ERK1/2, 
was examined by incubating the cells with U0126 [(MEK inhibitor known to prevent 
MEK1/2 from phosphorylating its downstream target, ERK1/2 (Favata et al., 1998)] 
prior to scratch wounding. The data showed that U0126 treatment could also slow 
down cell migration significantly in both EGFP-K14 WT (0.46 ± 0.12) (++ p < 0.001) 
and EGFP-K14 R125P (0.63 ± 0.14) (## p < 0.01) cells [Figure 4.3 (ii) and (iv)] as 




Figure 4.3 EGF regulates keratinocyte migration through its downstream signalling 
pathways. (i-iii) Cells grown to confluence in an Essen ImageLock 96-well plate were 
subjected to wounding with a 96-well WoundMaker Tool and treated with either DMSO, 
AG1478 (10 µM) or U0126 (10 µM) in fresh media. Images were acquired immediately and 
at 1 hr intervals for 20 hrs using the IncuCyte imaging system. Data were then processed by 
ImageJ software. Red line marks the denuded area from which cells were removed at the 
start of the wound (0 hr); green line marks the remaining uncovered area after 20 hrs wound 
closure time (20 hrs). (iv) Areas between red (or green) lines were derived from a macro 
written with ImageJ and quantified. Data presented as ratio of area covered/initial wound 
area and as mean ± S.D for n = 3 of each group. Statistical significance was assessed by 
one-way analysis of variance, followed by Tukey‟s test, * p < 0.05 vs. EGFP-K14 WT 
CTRL group;
 ++
 p < 0.01, 
+++
 p < 0.001 vs. EGFP-K14 WT CTRL group; and 
## 
p < 0.01, 
### 
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4.2.4  EGF influences keratin aggregate formation 
To investigate whether EGF plays a role in mediating keratin remodelling in wound-
induced stress activated cells, EBS-DM (EGFP-K14 R125P) cells were cultured in 
media without EGF for two passages and subconfluent cultures were assessed for the 
number of cells with aggregates [Figure 4.4 (I) (i)]. In the absence of EGF, cells 
proliferated in tight colonies [Figure 4.4 (I) (i) (A)] whereas colony boundaries were 
more diffuse in those cells constantly cultured with EGF [Figure 4.4 (I) (i) (B)]. It was 
observed that there was fewer cells having aggregates in the –EGF group [Figure 4.4 
(I) (i) (A)] as compared to those constantly cultured with EGF [Figure 4.4 (I) (i) (B)]. 
Moreover, desmoplakin staining showed that cells cultured in –EGF group have well-
developed desmosomes with neighboring cells (cell-cell borders) [Figure 4.4 (I) (ii) 
(A)] as compared to cells constantly cultured with EGF (where desmoplakin was 
more cytoplasmic) [Figure 4.4 (I) (ii) (B)]. 
In order to remove the effects of serum on keratin aggregate formation in the EGFP-
K14 R125P cells, experiments on subconfluent cells were carried out by first serum-
starving the cells for 6 hrs before EGF treatment [Figure 4.4 (II) (i) (A)]. In addition, 
a „rescue‟ experiment was performed where cells in the –EGF control (CTRL) group 
were re-stimulated with EGF (100 ng/ml) for a short-term exposure of 3 hrs. The 
results showed that there was an increase in the number of cells with peripheral 
aggregates after 3 hrs of EGF stimulation [Figure 4.4 (II) (i) (B)]. It was shown that 
cells in the CTRL + EGF group also yielded a significant (* p < 0.05) increase in the 
number of cells with aggregates (12.3 ± 4.2) as compared to control group (7.37 ± 2.6) 
[Figure 4.4 (II) (ii)]. Moreover, it was observed that there was a significant (# p < 0.05) 
reduction in the number of cells with aggregates in the CTRL + EGF + AG1478 
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group, (7.8 ± 1.4) as compared to CTRL + EGF group (12.3 ± 4.2) [Figure 4.4 (II) 
(ii)].  
These studies support a role for the EGF signalling pathway in regulating keratin 
aggregate formation, possibly because EGF induces keratin synthesis to a level where 










Figure 4.4 (I) EGF influences keratin aggregate formation. Loss of keratin 
aggregates was associated with a decrease in EGF exposure. (i) Immunofluorescence 
images showing the effects of EGF removal on keratin aggregates formation. EGFP-
K14 R125P cells cultured in (A) media without EGF for two passages or (B) constantly 
cultured with EGF before fixation. Scale bar, 40 μm. (ii) Immunofluorescence images 
showing the effects of EGF removal on keratin aggregate formation and desmoplakin 
localization. EGFP-K14 R125P mutant cells cultured in (A) media without EGF for 
two passages or (B) constantly cultured with EGF were immunostained with antibodies 





























Figure 4.4 (II) EGF influences keratin aggregate formation through its downstream 
signalling pathways. (i) Immunofluorescence images showing the effects of EGF removal 
on keratin aggregates formation.  (A) EGFP-K14 R125P cells were cultured in media 
without EGF (CTRL) and serum starved for 6 hrs before (B) re-stimulated with EGF (100 
ng/ml) for 3 hrs. Scale bar, 40 μm. (ii) EGFP-K14 R125P cells were cultured in media 
without EGF (CTRL), serum starved for 6 hrs, re-stimulated with EGF for 3 hrs prior to 
treatment with inhibitors U0126 (MEK1/2 inhibitor) and AG1478 (EGFR inhibitor) for 1 hr. 
Quantification of the number of EGFP-K14 R125P keratinocytes showing keratin aggregates 
after EGF removal (CTRL), EGF re-stimulation for 3 hrs and treatment with inhibitors 
U0126 (MEK1/2 inhibitor) and AG1478 (EGFR inhibitor) for 1 hr. Numbers of cells with 
aggregates were counted using ImageJ. Data presented as % of cells with aggregates as mean 
± S.D for n = 4 sets of 700-900 cells counted. Statistical significance was assessed by one-
way analysis of variance, followed by Tukey‟s test, * p < 0.05, vs. CTRL group or # p < 0.05 
vs. CTRL + EGF group.  
 
 







4.2.5  EGF also modulates plectin levels 
Because of the changes in keratin aggregate appearance, the effect of EGF stimulation 
was examined in further detail. The phosphorylation status of downstream signalling 
kinase ERK1/2 in these treatment groups was examined by immunoblot analysis 
[Figure 4.5]. As expected, there was an increase in ERK1/2 phosphorylation 
[phospho-ERK1/2 (P-ERK1/2)] upon EGF stimulation, which could be abolished by 
both U0126 (10 μM) and AG1478 (10 μM) treatments [Figure 4.5]. 
As well as its effects on keratin and desmoplakin, differential effects of EGF 
signalling pathway activation on keratin mutant cells were seen for the 
hemidesmosomal-associated protein, plectin, but not adherens junction protein, E-
cadherin or armadillo protein, plakoglobin [Figure 4.5]. The cytoskeleton linker 
protein plectin is one of the major keratin-associated proteins in keratinocytes forming 
part of the hemidesmosomes. Treatment with EGF increased plectin levels in the 3 hrs 
treatment regime [Figure 4.5]. However, only the EGFP-K14 R125P cells showed 
plectin downregulation upon inhibitor treatment, but not the EGFP-K14 WT cells, 
suggesting that plectin levels are especially sensitive to EGF signalling in the mutant 
EGFP-K14 R125P cells. Thus, an increase in EGF leads to both an increase in plectin 
levels and an increase in keratin aggregate formation in the EBS-DM cells, and both 
are reversed by an EGF signalling inhibition in the mutant cells [compare Figures 4.4 
(II) (ii) and 4.5]. These results suggest that EGF may influence keratin dynamics by 
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Figure 4.5 EGF also modulates plectin levels. EGFP-K14 WT and EGFP-R125P cell 
lines were cultured in media without EGF and serum starved for 6 hrs before the 
treatment regimes. They were re-stimulated with EGF for 3 hrs prior to treatment with 
inhibitors U0126 (MEK1/2 inhibitor) and AG1478 (EGFR inhibitor) for 1 hr. Soluble 
fractions of cell extracts were prepared from the cells. Immunoblot analysis of these cell 
lysates shown using antibodies to plectin (clone 31), E-cadherin (clone 36), plakoglobin 











4.2.6  Misregulated ERK1/2 activation in EBS-DM cell lines 
The level of activated ERK1/2 was examined in all the four cell lines at 
subconfluence. Both KEB-7 and EGFP-K14 R125P (cells expressing EBS-DM 
mutation) show higher levels of P-ERK1/2 than NEB-1 and EGFP-K14 WT (both 
K14 wild-type) cell lines respectively [Figure 4.6 (i)]. Moreover, when both EGFP-
K14 WT and EGFP-K14 R125P cells were serum-starved and immunoblotted with P-
ERK1/2 antibody, intrinsic activation of ERK1/2 was observed in the EBS-DM cells 
which were not seen in the wild-type cells [Figure 4.6 (ii)]. Re-stimulation with EGF 
(100 ng/ml) restored ERK1/2 phosphorylation in both the cell lines. Thus, cells 
harboring the K14 R125P mutation show constitutive ERK1/2 activation. 
Activation of ERK1/2 was further examined in both EGFP-K14 WT and EGFP-K14 
R125P keratinocytes by over-expressing FLAG-ERK2 for 24-48 hrs and then probing 
by immunoblotting. ERK1/2 activation upon FLAG-ERK2 over-expression was 
sustained from 24-36 hrs in both cells [Figure 4.6 (iii)]. However, at 48 hrs post-
transfection, P-ERK1/2 levels in EGFP-K14 WT keratinocytes had declined, whilst 
the signal was still sustained in EGFP-K14 R125P cells, even when its FLAG 
expression had diminished [Figure 4.6 (iii)]. This indicates a high level of constitutive 
ERK1/2 activation in EGFP-K14 R125P cells, possibly connected with their low level 





Figure 4.6 Misregulated ERK1/2 activation in EBS-DM cell lines. Intrinsic and sustained 
activation of ERK1/2 in EBS-DM cells. (i) Soluble fractions of cell extracts were prepared 
from each cell line at sub-confluence. Immunoblot analysis of these cell lysates shown using 
antibodies to P-ERK1/2 (Thr202/Tyr204) and ERK1/2. Actin used as loading control. (ii) 
Both EGFP-K14 WT and EGFP-K14 R125P cells were serum-starved for 6 hrs before re-
stimulation with EGF (100 ng/ml) for 3 hrs. Soluble fractions of cell extracts were prepared. 
Immunoblot analysis of these cell lysates shown using antibodies to P-ERK1/2 
(Thr202/Tyr204) and ERK1/2. GAPDH used as loading control. (iii) EGFP-K14 WT and 
EGFP-R125P cells were transiently transfected with either FLAG CTRL or FLAG-ERK2 
expression plasmid for 24-48 hrs. Soluble fractions of cell extracts were prepared from each 
cell line. Immunoblot analysis of these cell lysates shown using antibodies to FLAG, P-
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4.2.7  Co-localization of P-ERK1/2 and the peripheral keratin aggregates 
Immunofluorescence analysis with antibodies to P-ERK1/2 showed co- localization of 
activated ERK1/2 with the peripheral keratin aggregates in the mutant keratinocytes 
[Figure 4.7 (i) A‟‟]. Co-localization results showed a significant increase (*** p < 
0.001) in Pearson‟s coefficient of correlation values of P-ERK1/2 (0.78 ± 0.08) as 
compared to ERK1/2 (0.26 ± 0.10) staining respectively [Figure 4.7 (ii) and (iii)], 
which demonstrated that the activated forms of ERK1/2 co- localized with mutant 
keratin aggregates. 
4.2.8  ERK1/2 inhibition reduces peripheral keratin aggregates 
Because P-ERK1/2 co- localized with peripheral keratin aggregates of the EGFP-K14 
R125P cells, the effect of the MEK1/2 inhibitor, U0126 on these mutant keratinocytes 
was examined. Cells were exposed to DMSO or U0126 (10-100 μM) treatments for 1 
hr before fixation [Figure 4.8 (i) (A-D)]. Immunofluoresence images showed a dose-
dependent reduction in the number of cells with aggregates from U0126 (10 μM) 
(0.81 ± 0.09 folds) (** p < 0.01) to U0126 (100 μM) (0.56 ± 0.08 folds) (*** p < 
0.001) as compared to DMSO-treated control (1.00 ± 0.00) [Figure 4.8 (ii)]. These 
observations were further confirmed by staining cells with P-ERK1/2 antibody after 1 
hr treatment with U0126 (100 μM). Immunofluoresence images showed that co-
localization of P-ERK1/2 with the peripheral aggregates was abolished upon U0126 
treatment as compared to DMSO-treated control [Figure 4.8 (iii) (A‟‟) and (B‟‟)]. It 
was also observed that ERK1/2 inhibition resulted in more of the mutant keratin 





Figure 4.7 Co-localization of P-ERK1/2 and peripheral keratin aggregates. 
Interaction between P-ERK1/2 and keratin aggregates. (i) Immunofluorescence images 
showing the localization of both (A‟) P-ERK1/2 (Thr202/Tyr204) and (B‟) ERK1/2 in 
EGFP-K14 R125P cells, merged with images of (A-B) EGFP-K14 R125P respectively. 
(A‟‟-B‟‟) Image areas used as co-localization analysis shown. Scale bar, 30 µm. (ii) 
(A‟‟‟-B‟‟‟) Pearson coefficient of correlation was 0.8081 (P-ERK1/2) and 0.3827 
(ERK1/2) respectively. (iii) Co-localization quantification of 20 EGFP-K14 R125P cells 
at the aggregate region stained with either P-ERK1/2 (Thr202/Tyr204) or ERK1/2. Data 
presented as Pearson coefficient of correlation value and as mean ± S.D.
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Figure 4.8 ERK1/2 inhibition reduces peripheral keratin aggregates. ERK1/2 was 
involved in regulating keratin aggregate formation. (i) Immunofluorescence images showing 
the effects of MEK1/2 inhibition on the formation of peripheral keratin aggregates. EGFP-
K14 R125P mutant cells subjected to either (A) DMSO (CTRL) or (B-D) U0126 (MEK1/2 
inhibitor) (10, 50, 100 μM) treatment for 1 hr. Scale bar, 40 μm. (ii) Quantification of the 
number of EGFP-K14 R125P keratinocytes with peripheral aggregates after either DMSO 
or U0126 (MEK1/2 inhibitor) (10, 50 and 100 µM) treatments for 1 hr. Number of cells with 
peripheral keratin aggregates were counted in each of the treatment groups using ImageJ. 
Data presented as relative control (number of cells with aggregates) as mean ± S.D for n = 8 
sets of 400-1000 cells counted. Statistical significance was assessed by one-way analysis of 
variance, followed by Tukey‟s test, ** p < 0.01, *** p < 0.001 vs. DMSO (CTRL) group. 
(iii) Immunofluoresence images showing EGFP-K14 R125P mutant cells subjected to either 
DMSO or U0126 (MEK1/2 inhibitor) (100 µM) treatments for 1 hr. Cells were then stained 








4.2.9  ERK1/2 inhibition only reduces plectin levels in EBS-DM cells 
Immunoblot analysis of protein levels after 1 hr treatment with U0126 (10-100 μM) 
showed complete loss of phosphorylated ERK1/2 in both EGFP-K14 WT and EGFP-
K14 R125P cells [Figure 4.9]. Since plectin in the EGFP-K14 R125P cells was 
affected during the EGF treatment regime described previously, plectin levels upon 
U0126 treatment was examined to understand its role in regulating keratin aggregate 
formation. Basal level of plectin of the untreated EGFP-K14 R125P cells was already 
significantly higher than that of the EGFP-K14 WT cells [Figure 4.9]. In addition, a 
dose-dependent decrease in the levels of plectin was only observed in the EGFP-K14 
R125P cells upon increasing concentrations of U0126 treatment, but this was not seen 
in the EGFP-K14 WT cells [Figure 4.9], further supporting the possibility that plectin 
levels are associated with the formation of keratin aggregates and this effect is 
downstream of ERK1/2 activity. Hence, these experiments indicated that the 
formation of keratin aggregates might be modulated by the activity of ERK1/2 kinase 





Figure 4.9 ERK1/2 inhibition only reduces plectin levels in EBS-DM cells. 
EGFP-K14 WT and EGFP-K14 R125P cells subjected to either DMSO (CTRL) or 
U0126 (MEK1/2 inhibitor) (10, 50, 100 µM) treatments for 1 hr. Soluble fractions of 
cell extracts were prepared from these cells. Immunoblot analysis of these cell 
lysates were shown using antibodies to plectin (clone 31), P-ERK1/2 



































4.2.10  ERK1/2 knockdown reduces peripheral keratin aggregates  
To eliminate the possibility of non-specific effects of U0126 treatment, siRNA 
knockdown experiments were performed in EGFP-K14 R125P cells, specifically 
targeting the genes ERK1 and ERK2. At 48 hrs and 72 hrs post-transfection of the 
siRNA, there was a significant decline (*** p < 0.001; ### p < 0.001) in both ERK1 
and ERK2 expression at the mRNA transcript [Figure 4.10 (i)] and protein [Figure 
4.10 (ii)] levels. The results consistently showed fewer mutant cells with keratin 
aggregates in ERK1/ERK2 siRNA transfected cells as compared to control siRNA 
transfected cells at 72 hrs post-transfection [Figure 4.10 (iii)], further supporting a 
direct regulation of keratin aggregate formation by ERK1/2 activity. At 72 hrs post-
transfection, ERK1/ERK2 knockdown was the most effective and a decrease in the 
number of mutant cells with aggregates was observed. At this time, a slight decrease 
in plectin levels was also apparent [Figure 4.10 (ii)]. This lends support to the 
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Figure 4.10 ERK1/2 knockdown reduces peripheral keratin aggregates.            
Direct involvement of ERK1/2 activation in regulating keratin aggregate formation.  (i) 
RNA isolated from EGFP-K14 R125P cells that were transiently transfected with either 
CTRL siRNA for 72 hrs or ERK1/ERK2 siRNA for 48 hrs and 72 hrs respectively. 
cDNA were prepared and analyzed by real-time PCR for quantification using specific 
primers to ERK1 and ERK2, normalized to HPRT. Data presented as relative mRNA 
expression to CTRL siRNA and as mean ± S.D for n = 3 of each group. Statistical 
significance was assessed by one-way analysis of variance, followed by Tukey‟s test, 
*** p < 0.001 vs. ERK1 CTRL siRNA group; 
###
 p < 0.001 vs. ERK2 CTRL siRNA 
group. (ii) Soluble fractions of cell extracts were prepared from EGFP-K14 R125P cell 
line that was transiently transfected with either CTRL siRNA for 72 hrs or ERK1/ERK2 
siRNA for 48 hrs and 72 hrs respectively. Immunoblot analysis of these cell lysates 
shown using antibodies to plectin (clone 31), P-ERK1/2 (Thr202/Tyr204) and ERK1/2. 
Actin used as loading control. (iii) Immunofluoresence images showing EGFP-K14 
R125P cells transiently transfected with either CTRL siRNA or ERK1/ERK2 siRNA 





4.2.11  ERK1/2 regulates keratin dynamics and cell migration 
The link between ERK1/2 activity and keratin aggregate formation was further 
supported by time- lapse live-cell imaging of subconfluent EGFP-K14 R125P cells 
during exposure to U0126 treatment, imaged over 1 hr [Figure 4.11]. In basal 
conditions, keratin aggregates were localized at the leading edge of each cell during 
migration. Upon U0126 (100 μM) treatment, the cells were observed to initially 
retract, and showed a decrease in keratin dynamics, and aggregate formation appeared 
to cease very quickly. After washout of U0126 and replenishment with fresh medium, 
keratin aggregates reappeared in the peripheral cytoplasm and cells began to migrate 
again [Figure 4.11]. These experiments further demonstrated that P-ERK1/2 












Figure 4.11 ERK1/2 regulates keratin dynamics and cell migration.            
ERK1/2 activation affects keratin dynamics and cell migration. Time-lapse imaging of 
EGFP-K14 R125P cells under the effect of U0126 (MEK1/2 inhibitor) (100 µM). (A) 
Cells at the basal level were recorded at intervals of 1 min for 1 hr, (A‟) treated with 
U0126 for 1 hr, (A‟‟) followed by a wash out of U0126, replenished with fresh media 
and further imaged for 1 hr. Images were processed using imageJ and different color 
codings were used to demarcate the distance travelled by the keratinocytes at 0 (green), 


































4.2.12  Plectin knockdown reduces peripheral keratin aggregates 
To establish whether plectin directly regulated keratin aggregate formation, siRNA 
knockdown experiments were performed in both EGFP-K14 WT and EGFP-K14 
R125P cells, specifically targeting the plectin gene, PLEC. At 48 hrs and 72 hrs post-
transfection of the PLEC siRNA, there was a significant decrease in plectin 
expression of the EGFP-K14 WT (* p < 0.05) and EGFP-K14 R125P (** p < 0.01) 
cells at the mRNA transcript as compared to CTRL siRNA transfected cells [Figure 
4.12 (i)]. This led to the down-regulation of plectin levels in both cell lines after 48 
hrs and 72 hrs post-transfection [Figure 4.12 (ii)]. Significantly fewer mutant cells 
with keratin aggregates were observed in PLEC siRNA transfected cells as compared 
to control siRNA transfected cells at 72 hrs post-transfection [Figure 4.12 (iii)], 
confirming an involvement of plectin in the likelihood of keratin aggregate formation 
in the EBS-DM cells.   
4.2.13  Plectin knockdown in EBS-DM cells slows down wound closure 
The role of plectin in regulating cell migration of both wild-type and EBS-DM cells 
were then examined in scratch wound assays. At 72 hrs post-transfection, plectin 
knockdown was the most effective and a decrease in the number of mutant cells with 
aggregates was observed. At this time, wound closure was slowed down significantly 
(*** p < 0.001) in PLEC siRNA transfected mutant cells (0.50 ± 0.10) as compared to 
control siRNA transfected mutant cells (0.78 ± 0.10) [Figure 4.13 (i) and (ii)], thus 
suggesting that plectin could also affect cell migration, possibly through modulating 
keratin dynamics in the mutant cells. However, a reverse result was observed in the 
wild-type cells, wherein PLEC siRNA transfected wild-type cells (0.74 ± 0.15) 
resulted in faster wound closure as compared to control siRNA transfected wild-type 
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cells (0.58 ± 0.15) [Figure 4.13 (i) and (ii)], an observation that was consistent to that 
reported in (Osmanagic-Myers et al., 2006). This intriguing observation suggests that 
plectin expression in the EBS-DM cells may be different from that of the wild-type 
cells and that it may affect cell behaviour in terms of cell migration in this context. 
More work will be needed to understand these differences.  
In summary, the results presented in this chapter demonstrate that EGF signalling not 
only affects keratin synthesis and solubility but also affects keratin remodelling, as 
aggregate formation in EBS-DM cells, through its downstream ERK1/2 signalling 
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Figure 4.12 Plectin knockdown reduces peripheral keratin aggregates. Direct 
involvement of plectin in regulating keratin aggregate formation. (i) RNA isolated from 
both EGFP-K14 WT and EGFP-K14 R125P cells that were transiently transfected with 
either CTRL siRNA for 72 hrs or PLEC siRNA for 48 hrs and 72 hrs respectively. cDNAs 
were prepared and analyzed by real-time PCR for quantification using specific primers to 
plectin, normalized to HPRT. Data presented as relative mRNA expression to CTRL siRNA 
and as mean ± S.D for n = 3 of each group. Statistical significance was assessed by one-way 
analysis of variance, followed by Tukey‟s test, * p < 0.05; ** p < 0.01 vs. CTRL siRNA 
group. (ii) Soluble fractions of cell extracts were prepared from both EGFP-K14 WT and 
EGFP-K14 R125P cell line that was transiently transfected with either CTRL siRNA for 72 
hrs or PLEC siRNA for 48 hrs and 72 hrs respectively. Immunoblot analysis of these cell 
lysates shown using antibodies to plectin (clone 31). Actin used as loading control. (iii) 
Immunofluoresence images showing EGFP-K14 R125P mutant cells transiently transfected 
with either CTRL siRNA or PLEC siRNA treatment for 72 hrs. Scale bar, 40 µm. 
  
 
















Figure 4.13 Plectin knockdown in EBS-DM cells slows down wound closure. Direct 
involvement of plectin in regulating cell migration. (i) EGFP-K14 WT and EGFP-K14 
R125P cells were transiently transfected with either CTRL siRNA or PLEC siRNA and 
grown to confluence in an Essen ImageLock 96-well plate. After 48 hrs post-transfection, 
the cells were subjected to wounding with a 96-well WoundMaker Tool.  Images were 
acquired immediately and at 1 hr intervals for 18 hrs using the IncuCyte imaging system. 
Data were then processed by ImageJ software. Red line marks the denuded area from which 
cells were removed at the start of the wound (0 hr); green line marks the remaining 
uncovered area after 18 hrs wound closure time (18 hrs). (ii) Areas between red (or green) 
lines were derived from a macro written with ImageJ. Data presented as ratio of area 
covered/initial wound area and as mean ± S.D for n = 3 of each group. Statistical 
significance was assessed by one-way analysis of variance, followed by Tukey‟s test, # p < 








































4.3  Discussion 
The results reported in this chapter demonstrate several important aspects of 
regulation of keratin remodelling, namely that (1) EGF can regulate keratin 
expression and remodelling in keratinocytes, (2) EGF signalling through ERK1/2 can 
modulate the activated state of EBS-DM cells and (3) plectin probably plays a role in 
keratin remodelling during cell migration. 
Keratin remodelling involves an interchange between the soluble subunits and the 
insoluble filamentous protein, and is mediated by regulation of post-translational 
modifications such as phosphorylation (Chou and Omary, 1993). In the present study, 
it is shown that there is an imbalance in soluble keratin (K14 and K5) levels in KEB-7 
cells when compared to wild-type cells, suggesting that there is increased keratin 
synthesis or remodelling in the mutant cells.  
EGF is known to induce keratin synthesis and expression (Wang et al., 2006; Yoneda 
et al., 2011). In the present study, it is further shown that EGF can increase keratin 
synthesis and solubility, indicated by an increase in both K14 mRNA expression and 
soluble K14 proteins, in the wild-type but not EBS-DM cells. The subtle changes in 
keratin expression in EBS-DM cells upon EGF treatments may possibly be explained 
by a constitutively activated ERK1/2 signalling in these mutant cells, which may 
account for its higher basal keratin expression. Together, these results suggest a role 
for EGF in keratin synthesis and remodelling in keratinocytes, and also highlight a 
misregulated EGF signalling in EBS-DM cells.  
During migration, cells constantly remodel their cytoskeleton in response to 
extracellular cues. This is especially important in wound healing, where basal 
keratinocytes undergo a dramatic reorganization of the cytoskeleton during the 
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transition from stationary cuboidal tissue residents to flattened, polarized migrating 
cells as they migrate across the wound bed (Ortonne et al., 1981). EGF has long been 
known to be a key mitogen and motogen of keratinocytes in driving wound closure 
(Hudson and McCawley, 1998) and this EGF-mediated cell motility is attributed to 
activation of downstream ERK1/2 kinase that can contribute to alterations in the actin 
cytoskeleton through Rac- induced lamellipodia formation (Klemke et al., 1997; Vial 
et al., 2003).  
In this study, EGFR and MEK1/2 inhibitors were used in scratch wound assays to 
show that EGF and ERK1/2 activation were required for facilitating wound closure in 
the keratinocyte cell lines used in these experiments. It was observed that EGFR 
inhibition was more potent in slowing down cell migration than MEK1/2 inhibition in 
both cell lines, suggesting that other pathways parallel to EGF-ERK1/2 signalling, 
such as PKC or Akt pathways, might also be involved in regulating cell migration.  
A direct role of EGF in mediating keratin remodelling was demonstrated in stress 
activated EBS-DM cells, whereby it was observed that fewer cells expressed the 
classic keratin aggregates that are the hallmark of severe EBS when the cells were 
cultured in media without EGF as compared to cells constantly cultured in EGF.  
Besides its effect on keratin solubility and cell migration, EGF also probably affects 
other cytoskeleton components. A previous study reported that desmoplakin 
localization can be affected by EGF (Yin et al., 2005). In the present study, it was 
observed that there was a change in localization of desmoplakin proteins, from 
cytoplasmic to membrane-bound (junction-associated) in the mutant keratinocytes in 
response to EGF removal. Desmoplakin is an important component of desmosomes 
that provides anchoring sites for keratin intermediate filaments through its C-terminal 
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domain, to facilitate cell-cell adhesion (reviewed in Getsios et al., 2004). Interference 
with desmosomal adhesion leads to reduced tissue integrity and tissue blistering 
(Anhalt et al., 1990). Indeed, a recent study has shown that EBS-DM cells exhibited a 
down-regulation of junction proteins as compared to wild-type cells, suggesting that 
keratin mutations led to a reduction in cell-cell adhesion, which could contribute to 
defective tissue integrity and skin blistering (Liovic et al., 2009).  
The present study showed that by increasing cell-cell adhesion upon EGF removal, 
keratin dynamics were slowed down and resulted in a reduction in the number of 
mutant cells with keratin aggregates. A „rescue‟ experiment was performed by re-
stimulating the cells with EGF and it was observed that there was an increase in the 
number of cells with peripheral aggregates, which correlated with increased ERK1/2 
activation. These results suggested that EGF signalling could induce an increase in the 
activation state of EBS-DM cells and increase the likelihood of the mutant cells 
forming keratin aggregates. This is the converse of the decrease in aggregates seen as 
cells become confluent whilst approaching a quiescent state (Chapter 3).  
During wound healing, hemidesmosomes are reorganised in response to chemotactic 
factors such as EGF, allowing cells to migrate (Mainiero et al., 1996). Plectin, being 
localized at hemidesmosomes (reviewed in Wiche, 1998), could be affected by the 
influence of EGF. In this study, it was observed that the levels of plectin were 
increased in response to EGF stimulation, and that the plectin levels were decreased 
by EGFR and ERK1/2 inhibition in mutant cells (but not wild-type cells), and this 
correlated with a decrease in peripheral keratin aggregates. Hence, these observations 
suggest that plectin is involved in keratin remodelling under the influence of EGF.  
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It was also found in this study that ERK1/2 kinase in EBS-DM cells (EGFP-K14 
R125P) are constitutively activated, both intrinsically and sustained, as compared to 
wild-type cells. To study the possible role of ERK1/2 kinase in regulating keratin 
remodelling, co-localization studies were undertaken and it was observed that 
activated ERK1/2 kinase in the mutant cells co- localized with peripheral keratin 
aggregates at sites of lamellipodial protrusion. The sustained activation of ERK1/2 at 
lamellipodial protrusion and its minimial nuclear localization in mutant keratinocytes 
would suggest that there was a lack of nuclear anchoring proteins such as DUSPs that 
could mediate dephosphorylation of ERK1/2 in the nucleus (Caunt et al., 2008a; 
Caunt et al., 2008b). Indeed, one observation made from EBS-DM cell lines was the 
differential regulation of DUSPs where the authors showed that MKP-1, MKP-2 and 
hVH3 (DUSP-5) were significantly downregulated in KEB-7 cells as compared to 
NEB-1 cells at basal conditions (Liovic et al., 2008). This suggests that the up-
regulation of ERK1/2 activity could be a consequence of lower DUSPs activity in the 
mutant cells. Moreover, the possibility of a scaffold protein modulating the 
localization of activated ERK1/2 in close proximity to peripheral keratin aggregates is 
apparent because recent studies have shown that scaffold protein such as KSR could 
control whether ERK1/2 phosphorylate cytosolic or nuclear substrates by regulating 
its dimerisation state (Casar et al., 2008). More work will be needed to understand this 
better.  
Previous studies have also reported that keratinocytes exposed to various stress 
stimuli show abnormally elevated ERK1/2 activation and keratin phosphorylation. For 
instance, it was shown that in response to osmotic stress, KEB-7 showed higher and 
persistent levels of activated ERK1/2 that correlated with increased phosphorylated 
keratin 5 (Morley et al., 2003). Moreover, studies have reported that phosphorylation 
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of K8-S432 is mediated by EGF through ERK1/2 signalling (Ku and Omary, 1997), 
and this ERK1/2-mediated phosphorylation could contribute to K8 reorganisation and 
epithelial tumour cell migration (Busch et al., 2012). Another study also revealed that 
the increased ERK1/2 signalling in response to mechanical stretching could provide 
EBS-DM keratinocytes resistance to stretch-induced apoptosis (Russell et al., 2010). 
These studies show how keratinocytes can adapt to stress stimuli by remodelling their 
keratin cytoskeleton via phosphorylation.  
In this study, the results further substantiated the role of ERK1/2 as a regulator of 
keratin remodelling in wound- induced stress activated cells. By inhibiting ERK1/2 
activity, it was observed that there was a reduction in the number of cells with 
peripheral keratin aggregates. In addition, ERK1/2 inhibition resulted in keratinocytes 
having more bundled keratin filaments at the perinuclear regions as compared to 
untreated control.  
One observation was that the basal plectin level was already higher in the mutant cells 
as compared to wild-type cells. Moreover, this plectin level seemed to be particularly 
sensitive to ERK1/2 inhibition in the mutant cells but not wild-type cells. One could 
speculate that because the mutant keratinocytes with peripheral keratin aggregates 
would undergo continual actin and keratin remodelling till they formed elongated 
filaments, they would have to synthesize more plectin proteins in order to stabilize the 
intermediate filament network. Since ERK1/2 inhibition resulted in the reduction of 
both actin and keratin dynamics in the mutant cell line, plectin cross- linkers that could 
not incorporate into the filament network would be degraded and thus reduce its level. 
This is in contrast to wild-type keratinocytes that could incorporate proper actin and 
keratin filament network with plectin cross-linkers and hence were possibly 
unaffected by ERK1/2 inhibition. A previous work has also described an altered 
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plectin stability in EBS-DM cells when KEB-7 cells were subjected to cyclic 
mechanical stretch. It was found that plectin was relocated from cell junctions and 
associated with the fragmented keratin rings that formed upon mechanical stress, a 
phenomenon that was not observed in the wild-type cells (Russell et al., 2004). 
To substantiate these results, it was shown in this study that ERK1/2 knockdown 
resulted in a reduction of number of cells with keratin aggregates and a decrease in 
plectin levels, thus confirming a direct role of ERK1/2 in regulating keratin aggregate 
formation and plectin levels. This observation was also confirmed by performing 
time- lapse imaging of U0126 treated EGFP-K14 R125P cells, where a decrease in 
keratin dynamics was accompanied with slower cell migration that could be restored 
upon removing the U0126 inhibitor. This demonstrates that ERK1/2 could regulate 
keratin dynamics during cell migration.  
Recent study has also revealed the role of plectin in its ability to organize and 
stabilize the intermediate filament system in plectin-/- keratinocytes (Osmanagic-
Myers et al., 2006). The keratin network of these keratinocytes is less rigid and has 
irregularly loosened bundles of intermediate filaments. In view of this observation, 
the role of plectin in regulating keratin aggregate formation was examined in this 
study. It was demonstrated that plectin knockdown mutant keratinocytes have a 
reduction in the number of cells with keratin aggregates, accompanied by a reduced 
cell migration in scratch wound assays, a result consistent to the findings of plectin-/- 
fibroblasts (Andra et al., 1998) but different from that of plectin-/- keratinocytes 
(Osmanagic-Myers et al., 2006). On the contrary, plectin knockdown wild-type 
keratinocytes were able to migrate faster in scratch wound assay similar to that 
reported in (Osmanagic-Myers et al., 2006). These differences in results could 
possibly be attributed to the presence of different plectin isoforms, as expressed in 
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EBS-DM keratinocytes compared to normal keratinocytes. This particular switch in 
plectin isoforms might be important to cause a change in keratinocyte activation state 
so as to be “primed” for wound response. Further experiments will be needed to 
verify this idea.  
In conclusion, the results in this chapter show that EGF signalling could play a role in 
regulating keratin remodelling in constitutively activated EBS-DM cells during cell 
migration, through modulating plectin levels. A schematic diagram summarising the 
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CHAPTER 5        





5.1  Introduction 
Structural modifications of keratin intermediate filaments, which ranges from 
physiological assembly and disassembly of keratin subunits, to detrimental keratin 
aggregation in many forms of stress and disease, are deemed to be important for 
cellular response to environmental cues (reviewed in Magin et al., 2004; Pekny and 
Lane, 2007; Godsel et al., 2008). These changes in keratin filament network is mostly 
mediated by phosphorylation, as seen in keratin reorganization upon sheer stress 
(Ridge et al., 2005), during cell division (Celis et al., 1985) and phosphatase inhibitor 
treatments (Paramio, 1999). The sites and extent of post-translational modifications 
that keratins can undergo are largely defined by their structural characteristics. For 
instance, the tripartite structure of keratins is comprised of a central α-helical coiled-
coil domain flanked by the non-α-helical “head” and “tail” domains. It is well 
established that the “head” and “tail” domains are consensus sites for post-
translational modifications such as glycosylation and phosphorylation, and have 
important mechanistic link to disease manifestations (reviewed in Omary et al., 2006). 
For example, mice that over-expressed human K8 S74A, which cannot be 
phosphorylated by SAPK at Ser74, had an increased predisposition to Fas-mediated 
liver injury than wild-type mice. This was further supported by mice over-expressing 
K8 G62C that showed a dramatic decrease in K8 Ser74 phosphorylation and a similar 
injury phenotype to the K8 S74A mutant (Ku and Omary, 2006). These studies 
demonstrated that the highly conserved S74-containing phosphoepitope (LLpSPL) of 
K8 could serve to sequester SAPK activity, thus acting as a “phosphate sponge” to 
protect tissues from injury (Ku and Omary, 2006). A similar function was also found 
for the phosphosite of K20 S13, which served as a unique marker for intestinal tissue 
injury (Zhou et al., 2006). In addition, transgenic mice expressing K18 S53A mutant 
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further revealed that this phosphosite was crucial in protecting hepatocytes from liver 
injury (Ku et al., 1998b). Moreover, mice that over-expressed human K18 S34A, 
which prevented Ser34 phoshorylation and 14-3-3 binding, resulted in abnormal 
mitotic bodies after partial hepatectomy and persistent 14-3-3 nuclear localization (Ku 
et al., 1998a; Ku et al., 2002). A role for keratin reorganisation was also found in a 
phosphosite of K8 S432, which was mediated by MAPK after EGF stimulation and 
cdc2 kinases during mitotic arrest respectively (Ku and Omary, 1997). Hence, these 
studies demonstrate that phosphorylation at the “head” and “tail” domains have 
importance in disease manifestions and that they play a role in keratin remodelling. 
However, to date, there is limited experimental evidence of post-translational 
modifications occuring in the keratin rod domain, other than caspase-mediated 
cleavage of type I keratins occuring at the rod domain during apoptosis (Caulin et al., 
1997; Ku et al., 1997; Ku and Omary, 2001) and a recent study showing sumoylation 
at rod 2B domain (Snider et al., 2011). The rod domain is comprised of heptad repeats, 
ie. repeats of seven amino acid residues (a-b-c-d-e-f-g)n, in which positions “a” and “d” 
are generally occupied by hydrophobic residues that drive coiled-coil heterodimer 
formation. Positions “e” and “g” are normally occupied by hydrophilic and charged 
residues that may provide additional interactions to strengthen the binding. The 
starting residues of rod 1A domain and the ending residues of rod 2B domain, known 
as the helix initiation and the helix termination motifs respectively, comprise of ~ 20 
amino acid sequence motifs that are highly conserved among the different keratins. 
These motifs are crucial for initiating keratin intermediate filament assembly and thus 
any mutations residing in these motifs will interfere with the early stages of filament 
elongation (Steinert et al., 1993). 
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In this chapter, it is hypothesized that phosphorylation can occur at the rod 1A domain 
because other post-translational modification such as sumoylation of lysine residues 
were found in the rod 2B domain (Snider et al., 2011). This hypothesis is tested using 
cell culture models and demonstrated that the tyrosine residue, but not the serine 
residue, located in K14 rod 1A domain could possibly be phosphorylated and gives  
rise to cells having peripheral aggregates, reminiscent to the appearance of EBS-DM 
cells. It is also shown that this phosphorylated tyrosine residue is responsible for 
increased stress response and contributes to cell migration, thus suggesting its role in 
the pathogenesis of EBS. 
 
5.2  Results 
5.2.1  Schematic diagram showing the position of possible keratin 
phosphorylation sites in the K14 rod 1A domain 
Keratins are obligate heterodimers of epidermal type I (Steinert et al., 1983) and type 
II (Steinert et al., 1985) keratins in a 1:1 molar ratio, which exhibit a parallel, in-
register alignment (Parry et al., 1985; Hatzfeld and Weber, 1990; Steinert, 1990). The 
pairing of type I (K14) and type II keratin (K5) is initiated by the rod 1A domain 
(helix initiation motif) and terminated at the rod 2B domain (helix termination motif). 
In the rod 1A domain of K14, the highly conserved arginine residue at 125 [in bold in 
Figure 5.1] is the “mutational hot spot” for being the most frequently mutated amino 
acid, giving rise to a wide spectrum of skin disorders ranging from epidermolysis 
bullosa simplex to epidermolytic hyperkeratosis (Szeverenyi et al., 2008). As can be 
seen from the helical model of K14 rod 1A domain, K14 R125 (positively charged 
residue) reside in the “g” position of the heptad repeat that is responsible for 
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electrostatic interactions between the asparagine residue of K5 at 176 (K5 N176) at 
the “e” position of the heptad repeat [Figure 5.1]. Residing beside K14 R125 residue 
is a serine residue at 128 (K14 S128) and a tyrosine residue at 129 (K14 Y129). K14 
Y129 occupies in the “d” position of the heptad repeat that drives coiled-coil 
formation of the heterodimer between the phenylalanine residue of K5 at 179 (K5 
F179) at the “a” position of the heptad repeat [Figure 5.1]. Hence, any alterations of 
these residues could disrupt heterodimer formation and lead to skin fragility disorders. 
 5.2.2  Muliple sequence alignment of human keratins (K12-K17) and its 
orthologs 
To determine whether the serine and tyrosine residues residing in the helix initiation 
motif are conserved in the type I keratin family, a multiple sequence alignment of 
selected keratins (K12-K17) was performed. The clustalw results showed that the 
tyrosine residue was remarkably conserved in all the human keratins (K12-K17) and 
across its orthologs (Mus musculus and Rattus norvegicus) whereas even though the 
serine residue was also highly conserved in all the human keratins (K12-K17), it was 
not conserved across its orthologs as exemplified by K14 and K16 [Figure 5.2, 
multiple alignment using clustalw at www.interfil.org/toolClustal.php]. Reports 
pertaining to keratin mutations affecting the serine or tyrosine residues of the helix 
initiation motif were identified from the Human Intermediate Filament Database 
(www.interfil.org) and it was observed that these mutations were found to be 
associated with diseases such as epidermolytic palmoplantar keratoderma, 
epidermolytic hyperkeratosis, epidermolysis bullosa simplex and pachyonychia 
congenital types 1 and 2 [Table 5.1]. Interestingly, it was found out that K14 Y129D 
(a possible phospho-mimicking residue) gave rise to severe EBS-DM condition (Chan 
et al., 1996) whereas K14 Y129C (a possible non-phosphorylatable residue) gave rise 
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to a milder phenotype, intermediate between EBS-generalized and EBS-DM 
conditions (Rugg et al., 2007), suggesting that the disease phenotype was not due to 
the lost of the highly conserved hydrophobic tyrosine residue per se (since both 
mutations replace the tyrosine residue) but rather the charged status of K14 Y129 may 
be involved in determining the degree of heterodimer disruption and hence affect the 
severity of the skin fragility disorder. Since these two serine and tyrosine residues are 
potential phosphorylation sites for either serine/theronine or tyrosine kinases to act on, 
it is hypothesized that phosphorylation can occur at the rod 1A domain, typically at 
the helix initiation motif.  
 
Figure 5.1 Schematic diagram showing the position of possible keratin 
phosphorylation sites at the K14 rod 1A domain.  
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  Figure 5.2 Multiple sequence alignment of human keratins (K12-K17) and its orthologs  
 
              defgabcdefg 
  Human|K12             LGILSGNDGGLLSGSEKETMQNLNDRLASYLDKVRALEEANTELENKIREWYETRGTGTA 
  R_norvegicus|K12      LCIFSGNDGGLLSGSEKETMQNLNDRLASYLGKVRALEEANAELENKIREWYETRRTGDS 
  M_musculus|K12        LCIFSGNDGGLLSGSEKETMQNLNDRLASYLGKVRSLEEANAELENKIREWYETRRTRDA 
 
  Human|K13             --DFGACDGGLLTGNEKITMQNLNDRLASYLEKVRALEEANADLEVKIRDWHLKQ---SP 
  R_norvegicus|K13      --DFGSVDGGLLSGNEKITMQNLNDRLASYLEKVRALEAANADLEVKIRDWHLKQ---SP 
  M_musculus|K13        --DFGGVDGGLLSGNEKITMQNLNDRLASYLDKVRALEAANADLEVKIRDWHLKQ---SP 
 
  Human|K14             -------GDGLLVGSEKVTMQNLNDRLASYLDKVRALEEANADLEVKIRDWYQRQ---RP 
  R_norvegicus|K14      SGFGGGLGDGLLVGSEKVTMQNLNDRLATYLDKVRALEEANSDLEVKIRDWYQRQ---RP 
  M_musculus|K14        GGLGGGIGDGLLVGSEKVTMQNLNDRLATYLDKVRALEEANTELEVKIRDWYQRQ---RP 
 
  Human|K15             --GFGGGDGGLLSGNEKITMQNLNDRLASYLDKVRALEEANADLEVKIHDWYQKQ---TP 
  R_norvegicus|K15      --DFGGGDGGLLSGNEKVTMQNLNDRLASYLDKVRALEEANTELEVKIRDWYQKQ---SP 
  M_musculus|K15        --DFGGGDGGLLSGNEKVTMQNLNDRLASYLDKVRALEQANTELEVKIRDWYQKQ---SP 
 
  Human|K16             --GGFAGGDGLLVGSEKVTMQNLNDRLASYLDKVRALEEANADLEVKIRDWYQRQ---RP 
  R_norvegicus|K16      --FGGGLGDGLLVGSEKVTMQNLNDRLATYLDKVRALEEANSDLEVKIRDWYQRQ---RP 
  M_musculus|K16        --LGGGIGDGLLVGSEKVTMQNLNDRLATYLDKVRALEEANRDLEVKIRDWYQRQ---RP 
 
  Human|K17             -------VDGLLAGGEKATMQNLNDRLASYLDKVRALEEANTELEVKIRDWYQRQ---AP 
  R_norvegicus|K17      -------VDGLLAGGEKATMQNLNDRLASYLDKVRALEEANTELEVKIRDWYQKQ---AP 
  M_musculus|K17        -------VDGLLAGGEKATMQNLNDRLASYLDKVRALEEANTELEVKIRDWYQKQ---AP 
                                              .*** *.** **********:** ***:** ** :** **::*:  :    . 
  
  
Figure 5.2    Multiple sequence alignment of human keratins (K12-K17) and its orthologs using 
clustalw at www.interfil.org/toolClustal.php  
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Serine mutation (s) /  
Disease phenotype / Original report 
Tyrosine mutation (s) /  
Disease phenotype / Original report 
K9 No report yet Y167del insWL/ Epidermolytic palmoplantar 
keratoderma / (He et al., 2004) 
K10 No report yet Y160D /  Epidermolytic 
hyperkeratosis / 
(Chipev et al., 1994) 
Y160S /  Epidermolytic 




S128del /  EBS-DM / 
(Wood et al., 2003; 
Bolling et al., 2011) 
S128P / EBS-DM / 
(Jerabkova et al., 2010) 
Y129D /  EBS-DM / 
(Chan et al., 1996) 
Y129C /  Severity 
intermediate between 
EBS-generalized and EBS-
DM / (Rugg et al., 2007) 
K16 S130del /  Pachyonychia congenital type 1  / (Smith 
et al., 1999; Wilson et al., 2011) 
No report yet 
K17 S97del /  Pachyonychia congenital type 2  / 
(Terrinoni et al., 2001) 
Y98D /  Pachyonychia congenital type 2  / (Smith et 
al., 1997) 
Table 5.1  Reports pertaining to keratin mutations affecting the serine or tyrosine residues of the helix initiation 
motif were identified from the Human Intermediate Filament Database (www.interfil.org).  
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5.2.3  Spontaneous formation of keratin aggregates in K14 Y129 but not K14 
S128 phospho-mimetic cells  
To test the hypothesis, several EGFP-tagged constructs that were phospho-null (K14 
S128A and K14 Y129F) and phospho-mimetic (K14 S128D and K14 Y129E) were 
generated using site-directed mutagenesis [Figure 5.3 (i)]. By transiently expressing 
these EGFP-tagged constructs in NEB-1 cells, it was observed that the phospho-
mimetic construct EGFP-K14 Y129E gave rise to cells that have peripheral 
aggregates, whereas EGFP-K14 S128D gave rise to cells with only filamentous 
keratin networks, a phenotype similar to phospho-null constructs EGFP-K14 S128A 
and EGFP-K14 Y129F [Figure 5.3 (ii)]. These observations suggested that altering 
the charge of K14 Y129 residue (negatively charged K14 Y129E mimicking 
phosphorylation) could affect keratin remodelling during filament elongation (similar 
to EGFP-K14 R125P cells described in Chapter 4) but not negatively charged K14 
S128 residue (K14 S128D), hence supporting a role for phosphorylation at the rod 1A 
domain, particularly targeting the K14 Y129 residue.  
However, the conventional view of keratin structure suggests that in normal 
physiological condition the K14 Y129 residue at position “d” of the heptad repeats 
would be buried in the hydrophobic core of the heterodimer, thus making it less 
accessible to kinase action. It was of interest to find out if shifting this tyrosine 
residue away from its position “d” to a position “c” at the outermost positions of the 
coiled coil, making it readily accessible to kinase action, would affect keratin 
remodelling. The results showed that by expressing EGFP-K14 S128del in NEB-1 
cells, which could shift the K14 Y129 residue from the “d” to a “c” position [Figure 
5.3 (iii)], cells with peripheral aggregates were observed [Figure 5.3 (ii)], suggesting 
that K14 Y129, now being accessible, could possibly be phosphorylated to give rise to 
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this phenotype. One might argue that the deletion of K14 S128 residue could distort 
the entire keratin protein sequence and thus gave rise to keratin aggregates. Helical 
wheel modelling of the residues repositioned by deleting K14 S128 revealed that both 
the hydrophobic and electrostatic interactions would be restored by K14 L130 
(hydrophobic) occupying the “d” position and K14 D131 (negatively charged) 
occupying the “g” position [Figure 5.3 (iii)]. Hence, deleting K14 S128 residue 
should not affect the helical structure to a significant extent. This prediction was 
supported by a control experiment in which EGFP-K5 S181del was expressed in 
NEB-1 cells: this construct shifts the K5 F182 residue to the “c” position [Figure 5.3 
(iv)]. This gave rise to cells with filamentous keratin networks [Figure 5.3 (ii)]. 
Helical wheel modelling again predicted that reshuffling the residues by deleting K5 
S181 would retain both the hydrophobic and electrostatic interactions by placing K5 
I183 (hydrophobic) in the “d” position and K5 D184 (negatively charged) in the “e” 
position [Figure 5.3 (iv)]. Hence, the deletion of K5 S181 did not affect the helical 
structure to a significant extent, as it did not generate a dominant negative or 
disruptive phenotypes and the recombinant K5 is still able to incorporate into 
filaments.  
These data demonstrated that deletion of an amino acid at these „c‟ positions in the 
helix initiation motif does not per se disrupt the keratin network, due to the 
compensation by adjacent hydrophobic and charged residues that maintained 
appropriate electrostatic interactions. Thus, the severe pathogenic effect of the K14 
mutations S128del and Y129D are unlikely to be due to misfolding of the helix, but to 
the altered phosphorylation status of the mutant protein.  It was also interesting to note 
that patients harbouring serine deletions at the helix initiation motif of K14 or 
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K16/K17 suffered from EBS-DM or pachyonychia congenital type I/II respectively 
[Table 5.1].  
One obstacle to the hypothesis of phosphorylation acting on the rod domains has 
always been the prediction that the coiled-coil rod domains woud be inaccessible to 
kinase action. However, this obstacle may be lessened by recent suggestion that the 
helix 1A region of keratins may not be as tightly folded as was previously thought 
(Parry et al., 2002; Smith et al., 2002; Strelkov et al., 2002). It was suggested that in 
the intermediate filament dimer, the head domain may fold back across helix 1A and 
the dimer may alternate between a two-stranded coiled-coil rope and two separate α-
helical strands, with linker L1 acting as a flexible hinge (Parry et al., 2002; Strelkov et 
al., 2002). It was postulated that this arrangement could be destabilized under 
appropriate conditions such as phosphorylation or in the presence of cations, which 
could cause the head domain to detach from the surface of the dimer, thereby 
unwinding the α-helical strands of the two-stranded coiled-coil segment 1A, and the 



















Figure 5.3 (i) Schematic diagrams showing the mutations of K14 S128 and K14 Y129 at 
helix initiation motif to generate phosphomimetics (ii) Spontaneous formation of 
keratin aggregates in K14 Y129 but not K14 S128 phosphomimetic cells. Keratin 
aggregates co-existed with filaments in phosphomimetic cells. (ii) Transient expression of 
(A) EGFP-K14 S128A, (B) EGFP-K14 S128D, (C) EGFP-K14 S128del, (D) EGFP-K14 
Y129F, (E) EGFP-K14 Y129E and (F) EGFP-K5 S181del in NEB-1 keratinocytes. Scale 







Figure 5.3 (iii) Schematic diagrams showing the shift of K14 Y129 from “d” to a “c” 
position after K14 S128 is deleted. Note that the interactions between the 
hydrophobic cores are restored by K14 L130 shifting to the “d” position and 
electrostatic interactions are also restored by K14 D131 shifting to the “e” position. 
 
Figure 5.3 (iv) Schematic diagrams showing the shift of F182 from “d” to a “c” 
position after K5 S181 is deleted. Note that the interactions between the 
hydrophobic cores are restored by K5 I183 shifting to the “d” position and 






5.2.4  Similar keratin aggregates seen in K14 R125P and K14 Y129E cells 
Stable cell lines expressing these phospho-mimetic constructs in N/TERT-1 cells were 
generated, and a similar phenotype of peripheral keratin aggregates was confirmed in 
both AcGFP-K14 R125P and AcGFP-K14 Y129E cells [Figure 5.5 (i)]. Ratios of 
exogenous (transfected) to endogenous K14 expression were compared in all the 
stable cell lines and found to be close to a 1:1 ratio [Figure 5.5 (ii)]. Hence, the 
peripheral keratin aggregates observed in the AcGFP-K14 Y129E cells were 
inherently due to K14 Y129E mutation and did not represent artefacts of over-
expression resulting from the AcGFP-tag.   
5.2.5  Sustained stress activation in phosphomimetic cells during osmotic stress 
Since AcGFP-K14 Y129E cells showed the same phenotype as AcGFP-K14 R125P 
cells, it was of interest to find out whether they have similar stress response to 
osmotic stress as determined in the EGFP-K14 R125P cells in Chapter 3. It was 
observed that there was a higher level of p38 kinase activation after 240 min recovery 
from osmotic stress treatment in the phospho-mimetic keratinocytes, but not the 
phospho-null keratinocytes [Figure 5.5]. This suggested that the presence of keratin 
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Figure 5.4 Similar keratin aggregates seen in AcGFP-K14 R125P and AcGFP-
K14 Y129E cells. Phosphorylation of K14 Y129 may contribute to keratin aggregate 
formation. (i) Stable expression of (A) AcGFP-K14 WT, (B) AcGFP-K14 R125P, (C) 
AcGFP-K14 S128del, (D) AcGFP-K14 Y129F and (E) AcGFP-K14 Y129E  in N/TERT-1 
keratinocytes. Scale bar, 30 µm. (ii) Insoluble fractions of cell extracts were prepared from 
these cell lines at subconfluence. Immunoblot analysis of these cell lysates shown using 












AcGFP-K14 Y129E AcGFP-K14 Y129F 
CTRL 5’OS CTRL 5’OS 
- 120’ 240’ Recovery - 60’ 
P-p38 
(Thr180/Tyr182) 
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Figure 5.5 Sustained stress activation in phosphomimetic cells during osmotic stress. 
Phosphomimetic cells have sustained levels of stress-activated protein kinases (P-p38). (i) 
AcGFP-K14 Y129F and AcGFP-K14 Y129E cells were exposed to 5 min of 150 mM urea 
treatment, and left to recover for 60 min, 120 min and 240 min respectively. Soluble 
fractions of cell extracts were prepared from these cells. Immunoblot analysis of these cell 
lysates shown using antibodies to P-p38 (Thr180/Tyr182) and p38. GAPDH used as loading 
control. (ii) Densitometry values of P-p38 protein levels for the respective cell lines at 


































































































5.2.6  Phospho-null cells close up wound slower than wild-type cells in scratch 
wound assays 
To determine whether K14 Y129 phosphorylation state could play a role in cell 
migration, both the AcGFP-K14 WT and phospho-null AcGFP-K14 Y129F cells were 
subjected to scratch wound assays [Figure 5.6 (i)]. It was found that there was a 
significant decrease (* p < 0.05) in wound closure in these phospho-null AcGFP-K14 
Y129F cells (0.78 ± 0.14) as compared to AcGFP-K14 WT cells (0.91 ± 0.13) [Figure 
5.6 (ii)], thus suggesting that the phosphorylation state of K14 Y129 affects cell 
migration.  
5.2.7 Double mutant AcGFP-K14 R125P_Y129F infected cells form less 
peripheral keratin aggregates than AcGFP-K14 R125P infected cells 
Knowing that K14 Y129 phosphomimetic construct increased the stress response in 
AcGFP-K14 Y129E cells through the formation of keratin aggregates and that 
phospho-null AcGFP-K14 Y129 reduced cell migration, it was hypothesized that K14 
R125P mutants may have an intrinsic effect through phosphorylation at K14 Y129. A 
AcGFP-K14 R125P_Y129F double mutant construct was therefore generated to 
introduce both K14 R125P (hypothetical phosphorylation facilitator) and K14 Y129F 
(phospho-null mimetic) into the same cell. Both lentiviral-packaged AcGFP-K14 
R125P and AcGFP-K14 R125P_Y129F constructs were collected for transient 
infections of N/TERT-1 cells at different multiplicity of infections (M.O.Is = 0.5, 1.0 
and 2.0) [Figure 5.7 (i- ii)]. The number of keratinocytes with peripheral aggregates 
were counted and compared at the same infection efficiency. It was observed that 
there was a significant decrease (** p < 0.01) in the number of cells with aggregates 
in the double mutant AcGFP-K14 R125P_Y129F cells (4.01 ± 1.05 %) as compared 
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to those with only the AcGFP-K14 R125P construct (9.11 ± 0.80 %) [Figure 5.7 (ii)]. 
This supports the hypothesis that phosphorylation of K14 Y129 is part of the 
mechanism generating aggregates in the K14 R125P mutant cells. This could be due 
to disruption of keratin heterodimer formation (by proline residue) increasing 




Figure 5.6 Phospho-null cells close up wound slower than wild-type cells in scratch 
wound assay. K14 Y129 phosphorylation affects cell migration. (i) AcGFP-K14 WT and 
AcGFP-K14 Y129F cells grown to confluence in an Essen ImageLock 96-well plate were 
subjected to wounding with a 96-well WoundMaker Tool. Images were acquired immediately 
and at 1 hr intervals for 20 hrs using the IncuCyte imaging system. Data were then processed 
by ImageJ software. Red line marks the denuded area from which cells were removed at the 
start of the wound (0 hr); green line marks the remaining uncovered area after 20 hrs wound 
closure time (20 hrs). (ii) Areas between red (or green) lines were derived from a macro 
written with ImageJ. Data presented as ratio of area covered/initial wound area and as mean ± 
S.D for n = 3 of each group. Statistical significance was assessed by unpaired t-test, * p < 




























































Figure 5.7 Double mutant AcGFP-K14 R125P_Y129F infected cells form less peripheral 
keratin aggregates than AcGFP-K14 R125P infected cells. A decrease in keratin 
aggregates of EBS-DM cells was associated with non-phosphorylatable K14 Y129. (i) 
N/TERT-1 cells were transiently infected with the viral-packaged AcGFP-K14 
R125P_Y129F double mutant construct for 72 hrs before fixation. Immunofluorescence 
images showing the effects of viral-packaged double mutant AcGFP-K14 R125P_Y129F 
construct at increasing multiplicity of infection (M.O.I.) values from 0.5 to 1.0. Scale bar, 40 
μm. (ii) Bar graphs showing the effects of viral-packaged AcGFP-K14 R125P and AcGFP-
R125P_Y129F constructs at increasing M.O.I. values on keratin aggregate formation. Cells 
were counted in each of the viral infected group at each M.O.I. using ImageJ and quantified. 
Data presented as % infection efficiency (No. of GFP positive cells/total no. of cells x 100%) 
and % GFP cells with aggregates (No. of GFP cells with aggregates/ No. of GFP cells x 
100%) and as mean ± S.D for n = 3 sets of 500-3000 cells counted. Statistical significance 






5.3  Discussion 
The findings in this chapter raise several novel and important aspects of keratin 
modifications in the pathogenesis of EBS-DM. (1) These results revealed the first 
suggestion of phosphorylation in the helix initiation motif of K14 rod 1A domain, i.e.  
at the K14 tyrosine 129 residue, and suggest that this may be involved in EBS 
pathogenesis. (2) Evidence is presented suggesting that the Dowling-Meara mutation 
at K14 R125 is less likely to give rise to aggregates if the tyrosine residue K14 Y129 
cannot be phosphorylated. (3) These data also suggest that phosphorylation of K14 
Y129 might be an indication of a keratinocyte activated state due to increased keratin 
remodelling and cell migration. 
Keratin intermediate filaments are organised into a dynamic scaffold that form the 
cytoskeleton of the cell. The keratin subunits are constantly undergoing a reversible 
process of assembly and disassembly during mitosis and in response to various stress 
stimuli (reviewed in Goldman et al., 2008). One of the more established mechanism 
through which keratin assembly is modulated is via keratin phosphorylation by 
protein Ser/Thr kinases as exemplified by K8, K18 and K19 (Chou and Omary, 1991; 
Zhou et al., 1999). However, tyrosine phosphorylation in keratins is not as well 
characterized as serine phosphorylation because there were barely detectable 
phospho-tyrosine levels in crude epidermal keratin preparations (Steinert et al., 1982) 
or low levels of phosphorylated tyrosine residue were seen in keratins upon exposure 
to EGF treatment (Aoyagi et al., 1985). Previous studies had also shown indirectly 
that the tyrosine residues in K8 and K19 could be phosphorylated by inhibition of 
tyrosine phosphatases using the potent and irreversible tyrosine phosphatase inhibitor 
pervanadate (Feng et al., 1999), and that tyrosine phosphorylation was involved in the 
rapid and reversible keratin network remodeling through the use of orthovanadate, 
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another tyrosine phosphatase inhibitor (Strnad et al., 2002). Although these studies 
showed that tyrosine phosphorylation could occur in keratins, they did not specify the 
identity of the tyrosine residue being phosphorylated until recently, a direct evidence 
that K19 could be phosphorylated on its tyrosine-391 residue located at the tail 
domain was demonstrated (Zhou et al., 2010). 
The results in this chapter demonstrate that tyrosine phosphorylation is also possible 
in the rod 1A domain of K14, at the K14 Y129 residue residing in the helix initiation 
motif. This K14 Y129 residue is located at the “d” position of the heptad repeats 
necessary for driving coiled coil formation of the heterodimer, and is highly 
conserved in all the epidermal keratins and across its orthologs. Mutation in this 
tyrosine residue (ie. K14 Y129D) results in significant structural distortions of the α-
helical backbone (Smith et al., 2004), which could explain why patients harboring this 
kind of mutation suffer from EBS-DM (a severe skin blistering disorder) (Chan et al., 
1996).  Interestingly, a variant of the K14 Y129 mutation (K14 Y129C) results in 
patients suffering from a milder phenotype of skin blistering disorder, intermediate 
between EBS-generalized and EBS-DM (Rugg et al., 2007), suggesting that replacing 
the highly conserved tyrosine residue did not contribute to the severity of blistering 
disorder per se but rather the charge of the mutated residue or the degree of structural 
distortion was the determinant factor.  In this study, the possibility of tyrosine 
phosphorylation at this K14 Y129 residue was explored by generating phospho-
mimetic (K14 Y129E) and phospho-null (K14 Y129F) constructs. It was 
demonstrated that the phospho-mimetic expression resulted in cells having peripheral 
keratin aggregates as opposed to the phospho-null construct. Since the formation of 
keratin granules or aggregates are largely thought to be mediated by phosphorylation 
due to their appearance in response to various phosphatase inhibitors (Kasahara et al., 
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1993; Takuma et al., 1993; Yatsunami et al., 1993; Feng et al., 1999; Strnad et al., 
2001), it was clear that K14 Y129 phosphorylation was contributing to keratin 
aggregate formation. The possibility that K14 S128 could be phosphorylated was not 
apparant because over-expression of K14 S128D did not result in cells having keratin 
aggregates. 
In normal physiological conditions, apolar residues occupying the “a” and “d” 
positions of the heptad repeats are packed together in the interior of the helix bundle 
(hydrophobic core), whereas those hydrophilic residues occupying the “e” and “g” 
positions have opposing charges and form a salt bridge stabilized by electrostatic 
interactions that are in contact with the solvent-exposed surface, hence shielding the 
apolar residues from the aqueous environment (Pauling and Corey, 1953). It was of 
interest to find out whether by shifting the K14 Y129 residue out of the hydrophobic 
core to the exterior surfaces of the helix would it increase its probability of being 
phosphorylated. With this in mind, K14 S128del and K5 S181del constructs were 
generated and it was demonstrated that deleting these residues itself did not hinder the 
formation of keratin heterodimer as observed in K5 S181del over-expression 
(filamentous keratin network) and that the appearance of keratin aggregates in K14 
S128del was largely due to the shifting of K14 Y129 residue to the “c” position of the 
heptad repeats that might increase its phosphorylation state as opposed to the shifting 
of a phospho-null K5 F182 to the “c” position of the heptad repeats in K5 S181 
deletion. 
Stable cell lines harbouring the phospho-mimetic and phospho-null expression 
constructs were generated and it was demonstrated that the phospho-mimetic AcGFP-
K14 Y129E cell line has intrinsic and sustained stress kinase activation which was 
reminiscent to the EBS-DM cell lines (AcGFP-K14 R125P), thus strengthening the 
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role of keratin aggregates as an indicator for keratinocyte activation as described in 
Chapter 3. It was also shown that the phosphorylation state of K14 Y129 might play a 
role in cell migration since AcGFP-K14 Y129F cells closed up wound slower than 
AcGFP-K14 WT cells. 
EBS-DM cells harbouring the K14 R125P mutation are known to exhibit faster cell 
migration and intrinsic stress response (as discussed in Chapter 3). A proline mutation 
in this position is likely to be disruptive to helical formation, since it was previously 
reported that a proline residue residing in the α-helical strand could result in a kink of 
the α-helix axis by about 26º (Barlow and Thornton, 1988). Because the K14 Y129 
residue (d) resides beside the K14 R125 residue (g) in the helical structure, a K14 
R125P mutation could distort the helical structure and expose K14 Y129 residue to 
the exterior and thus facilitate its phosphorylation. This notion was tested by 
simultaneously introducing mutations at both these residues in N/TERT-1 cells. It was 
demonstrated that there was a significant decrease in the number of keratinocytes with 
aggregates in the transiently infected AcGFP-K14 R125P_Y129F double mutant cells 
as compared to the AcGFP-K14 R125P transiently infected cells. In conclusion, these 
results support the hypothesis that Y129 phosphorylation could play a role in the 
pathogenesis of EBS-DM condition. A schematic diagram summarising the results of 
Chapter 5 is depicted in Figure 5.8. 
It would be interesting to find out which tyrosine kinase may be involved in 
phosphorylating K14 Y129 residue, as this could be important in regulating the stress 
response in wound- induced situations. Potential tyrosine kinases could be FAK 
(Schaller et al., 1992) or Src (sarcoma) kinases (Oppermann et al., 1979) because 
these tyrosine kinases are known to play a role in cell migration and recent study has 
shown that FAK-Src complex could regulate adhesion turnover through paxillin, ERK 
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and myosin light-chain kinase at the leading edge (Webb et al., 2004), rendering them 
in close proximity to the keratin aggregates. Further work will be done to investigate 
this possibility. 
In summary, the results in this chapter have opened up new avenues for strategies 
targeting post-translational modifications of keratins in view of the treatment of 
devastating skin blistering disorders ranging from epidermolysis bullosa simplex to 
epidermolytic hyperkeratosis.  In this case, phospho-Y129 could be a useful biomarker 

















CHAPTER 6        





6.1  Significance and implications of these studies 
In the introduction to this thesis (Chapter 1), a literature review of epidermal tissue 
maintenance is presented, describing a process in which differential keratin 
expression in keratinocytes is regulated as the cells migrate upwards through the 
epidermal layers, paralleled by changes in expression of adhesion junctions. A defect 
in any of these cytoskeletal components (keratins or junctional proteins) can result in 
epidermal malfunction, mainly resulting in skin blistering disorders. Hence, these 
cytoskeletal components are important for providing mechanical resilience to the skin. 
In mechanical injury, the normal processes of keratinocyte differentiation are 
perturbed and keratinocytes initiate an activation cycle (Freedberg et al., 2001) that 
takes them through the wound healing process and back to a steady state after 
epidermal regeneration. Wound healing is a tightly regulated sequence of events 
wherein cell-matrix junctional proteins are altered (partial dissolving of 
hemidesmosomes), and the keratinocytes produce a different set of integrins for 
lateral migration and express matrix metalloproteinases for remodelling of the 
provisional matrix at the wound bed (reviewed in Santoro and Gaudino, 2005). An 
impaired wound healing process can lead to the formation of chronic (non-healing) 
wounds such as diabetic ulcers and pressure ulcers (Menke et al., 2007), where the 
epidermis is hyperpoliferative (indicated by mitotically active cells in the suprabasal 
layers), hyperkeratotic (indicated by thick cornified layer) and parakeratotic (indicated 
by presence of nuclei in the cornified layer). These histological observations suggest 
that the chronic wound keratinocytes do not sucessfully complete either the activation 
(keratinocytes are able to proliferate but do not migrate) or differentiation (incomplete 
differentiation due to presence of nuclei in cornified layer) stage of the keratinocyte 
activation cycle (Morasso and Tomic-Canic, 2005). Hence, chronic wounds failed to 
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proceed through an orderly and timely process of healing, resulting in poor 
anatomical and functional outcome (Lazarus et al., 1994).  
Because knowing the mechanisms underlying keratinocyte activation cycle is crucial 
to understanding wound healing processes, it was of interest to explore and attempt to 
unravel the mechanisms underlying these processes in this thesis work. In Chapter 3 
of this thesis, the EBS-DM keratinocytes (harbouring K14 R125P mutation) were 
shown to be a valid cell culture model of activated keratinocytes because of their 
intrinsic stress and upregulation of wound-response proteins, predisposing them to 
migrate faster in wound closure assays as reported in previous studies (D'Alessandro 
et al., 2002; Morley et al., 2003). Thus, EBS-DM keratinocytes may be a useful model 
for analysing early stages of epidermal wound activation. It is also suggested that the 
appearance of keratin aggregates (keratin remodelling at the leading edge) could be an 
indicator of the activated state because aggregates diminished or disappeared when 
monolayer keratinocytes approached the quiescent state of the keratinocyte activation 
cycle upon increasing confluence (mimicking wound closure).  
Desmosomes are now known to be highly dynamic structures that are assembled 
during cell-cell contact. This desmosomal assembly is a coordinated process, with an 
initial phase of rapid desmoplakin accumulation at cell-cell borders, followed by the 
assembly and translocation of cytoplasmic particles containing both desmoplakin and 
plakophilin, mediated by both desmoplakin- intermediate filament interactions and 
actin microfilaments (Godsel et al., 2005). Moreover, a recent study has shown that 
desmoplakin assembly and dynamics in migrating epithelial cells is initially 
dependent on actin microfilaments prior to association with keratin intermediate 
filaments, thus revealing a role for desmosomal assembly during wound healing 
(Roberts et al., 2011). The EBS-DM keratinocytes used here reflect similar 
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desmoplakin changes, as a change in localization of desmoplakin was seen to occur 
upon transition from subconfluence to confluence, i.e. from cytoplasmic desmoplakin 
(subconfluent, activated state) to desmoplakin at cell-cell adhesion borders (confluent, 
approaching quiescent state).  
Previous studies have proposed a role of K17 in the timely closure of embryonic skin 
wounds (Mazzalupo et al., 2003), and it has been reported that K17 induction can 
regulate cell growth via controlling protein synthesis during the wound healing 
process (Kim et al., 2006). In the present study, it was also demonstrated that during 
reversion from confluent to activated state in in vitro scratch wound assays, EBS-DM 
cells induced more soluble K17 proteins than wild-type cells, confirming their 
constitutively activated state.  
The role of EGF in regulating wound closure and keratin remodelling was explored in 
Chapter 4. EGF stimulation induces keratinocyte migration, as shown by earlier 
studies (Barrandon and Green, 1987), and the same effect was observed here in the 
EBS-DM cells. EGF was shown to increase lamellipodial formation (Chinkers et al., 
1979), and it is specifically in the lamellipodia that the EBS-DM keratin aggregates 
form [Figure 3.2]. Keratinocyte motility, stimulated by EGF signalling and blocked 
by EGF signalling inhibition, was observed to be tightly coupled to the degree of 
keratin aggregate formation. EGF-induced changes in desmoplakin localization were 
also observed in EBS-DM cells, suggesting a reduction of desmosome adhesions, 
which is coherent to a shift in migratory behaviour in the activation of keratinocytes.  
Plectin is a major cytoskeleton linker protein, which is expressed as several different 
isoforms (plectin 1, 1a, 1b, 1c, 1d, 1e, 1f and 1g) due to differential splicing, with 
organelle-specific localization and show preferential binding to hemidesmosomes, 
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focal adhesions, mitochondria, microtubules or Z-disks (reviewed in Wiche and 
Winter, 2011). Previous studies have shown differences in wound closure speeds in 
different plectin knockout cell lines, depending on which plectin isoform the cells 
predominantly expressed. For instance, plectin isoform 1-/- fibroblasts migrated slower 
in scratch wound assays (Abrahamsberg et al., 2005) whereas plectin-/- keratinocytes 
resulted in faster migration, which upon re-expression of plectin 1a could cause 
slower migration (Osmanagic-Myers et al., 2006). Hence, these results revealed the 
differential role played by plectin isoforms in regulating cell migration. It is not 
known which plectin isoforms are preferentially being expressed in the wild-type and 
the EBS-DM cells yet, and the expression of different plectin isoforms may be 
different in the two cell lines, which contribute to different migration speeds in wound 
closure assays. Further experiments will be needed to validate this idea.  
It was also demonstrated that constitutive activation of ERK1/2 kinase in EBS-DM 
cells, downstream of EGF signaling, contributed to their activated state and this 
ERK1/2-dependent EGF effect could also modulate plectin levels. Overall, the results 
confirm a potential role of EGF in regulating the constitutively activated state of EBS-
DM keratinocytes. Further experiments will be undertaken to see whether this can 
ultimately be manipulated for therapeutic applications.  
In Chapter 5, a hypothesis is developed on the role of keratin phosphorylation in 
keratinocyte activation and keratin aggregate formation. Assembly and disassembly of 
intermediate filament proteins is known to be driven by phosphorylation cycles  
(Inagaki et al., 1989; Izawa and Inagaki, 2006), thought to occur predominantly in the 
head and tail domains (reviewed in Omary et al., 2006). The findings in the present 
study provide the first suggestion that phosphorylation can occur in the rod 1A 
domain of K14 and have identified a tyrosine residue in the helix initiation motif as a 
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potential target site. Past work aimed at defining the phosphorylation sites of keratin 
intermediate filament proteins have mostly focussed on serine/threonine residues 
located at the “head” and “tail” domains of K8/K18 (Ku and Omary, 1997; Ku et al., 
1998a; Omary et al., 2009), and this has become a paradigm for post-translational 
modifications in keratins. Any changes in phosphorylation status of these 
serine/threonine residues could contribute to both physiological processes and 
pathological diseases (Omary et al., 2006). Hence, understanding their regulation 
could give some insights to keratin remodelling in stress.  
Keratins can also be glycosylated (King and Hounsell, 1989; Ku et al., 2010) and 
ubiquitylated (Ku and Omary, 2000; Jaitovich et al., 2008), and recent studies have 
also demonstrated the possibility of sumoylation (Snider et al., 2011). The Snider 
study reported that sumoylation occurs on lysine residues in rod 2B domain of 
K8/K18/K19, thus indicating that the rod domain may be accessible for post-
translational modifications (Snider et al., 2011), contrary to earlier views that this 
domain should be tightly packed in a coiled-coil with its type II partner (K5 in this 
case).  
In the present study, it is demonstrated that engineering a phosphomimetic residue at 
K14 Y129 (AcGFP-K14 Y129E) can give rise to peripheral keratin aggregates and 
that such cells show constitutive stress kinase activation, reminiscent to that of EBS-
DM cells (KEB-7 and EGFP-K14 R125P). The localization of keratin aggregates 
observed in EBS-DM cells are clearly different from the cytoplasmic granules that are 
generated during stress stimuli (heat or osmotic stress), phosphatase inhibitor (okadaic 
acid or orthovanadate) treatments or mitosis (Strnad et al., 2002; Toivola et al., 2002; 
Woll et al., 2007), as unlike the cytoplasmic granules, EBS-DM keratin aggregates are 
mainly confined to the lamellipodia. This may depend on either the types of kinases 
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(serine/threonine vs. tyrosine) phosphorylating the keratin or the site of keratin 
residues being phosphorylated (“head” or “tail” domains vs. rod domain). Further 
work will be needed to understand how these different kinases regulate keratin 
reorganisation and to identify their target residue in the keratin structure.  
Previous studies suggest that the helix 1A region of keratins may not be as tightly 
folded as was originally thought to be (Parry et al., 2002; Smith et al., 2002; Strelkov 
et al., 2002), and this may possibly allow tyrosine kinase to gain access and 
phosphorylate the K14 Y129 residue. One can postulate that in times of stress, 
phosphorylation of K5 partner leads to unwinding of the α-helical strands of the two-
stranded coiled-coil segment 1A or K5 may simply begin to interact with another 
keratin such as wound- induced K17, allowing K14 to be susceptible to tyrosine 
phosphorylation. 
Using phospho-null variants, it was demonstrated that K14 Y129 phosphorylation 
status may also play a role in cell migration. It is predicted that the K14 R125P 
mutation seen in EBS-DM cells may lead to more phosphorylation at K14 Y129 by 
increasing the accessibility of this residue to potential tyrosine kinases such as FAK 
or Src, which are recruited and localized at focal contacts during lamellipodial 
formation (reviewed in McLean et al., 2005), the site where keratin aggregates are 
localized. Although there is no direct interaction between these tyrosine kinases and 
keratin aggregates [as quantitated using immunostaining by members of our group 
(unpublished data)], they may be associated in a parallel manner, wherein mutant 
keratin filament reorganisation at the leading edge may increase the probability of 
K14 Y129 being phosphorylated by these tyrosine kinases when these kinases are 
recruited to focal contacts to regulate adhesion turnover during lamellipodial 
formation. In support of this, a recent study has shown that vimentin disassembly by 
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phosphorylation at the cell periphery facilitates lamellipodial protrusions (Helfand et 
al., 2011). 
Further breakthroughs are needed to better understand the mechanism of keratin 
intermediate filament assembly, and its spatial and temporal regulation in living cells. 
As more of the complexity of keratin function is understood, it is becoming very 
important to know how different keratin networks are generated, maintained and 
regulated in epithelial cells. 
 
6.2  Conclusion 
The work carried out in this thesis has been achieved mainly due to the availability of 
immortalised cell lines derived from EBS patients and also the generation of cell lines 
stably expressing EGFP-tagged K14 mutation. Taken into account all the findings in 
this thesis, it is proposed that constitutive stress activation arising from keratin 
mutation (K14 R125P) could be a possible mechanism to the pathogenesis of 
inherited skin blistering disorder such as EBS Dowling-Meara type. Much evidence 
points to the fact that EBS-DM keratinocytes are in a constitutively activated state, 
based on their higher SAPK activation, and they have faster stress and wound 
response than normal keratinocytes. It is shown that EGF-ERK1/2 signalling can 
modulate the activated state of EBS-DM keratinocytes and this can be seen by 
changes in keratin aggregates at the leading edge. Evidence is presented that 
phosphorylation of a tyrosine residue (K14 Y129) in the helical rod 1A domain is 
likely to contribute to keratin aggregate formation in EBS-DM keratinocytes and that 
increasing the phosphorylation state of this residue is associated with increased cell 
migration, possibly because both processes are likely to be mediated by a common 
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tyrosine kinase such as FAK or Src. It is proposed that the remodelling of keratin 
filaments, which occurs at the lamellipodia and is mediated by recruitment of tyro sine 
kinases at these sites, is increased in EBS-DM cells due to the greater probability of 
K14 Y129 phosphorylation that results from the K14 R125P mutation. This elevated 
phosphorylation may be responsible for the observed aggregate formation at the 
leading edge. Furthermore, if lamellipodial formation is induced by remodelling of 
intermediate filaments as proposed by (Helfand et al., 2011), then increased keratin 
remodelling (resulting from increased phosphorylation) could lead to increased 
keratinocyte migration, explaining the faster scratch wound closure observed in these 
cells. 
It is also suggested that phospho-K14 Y129 could be a useful biomarker of 
keratinocyte activation. More work is needed to validate this hypothesis. Knowing 
these mechanisms will open up new avenues to alleviate wound injury and also offer 
new therapeutic options for the treatment of hereditary skin blistering disorder such as 
EBS. 
 
6.3  Future perspectives 
An exciting consequence of the research described in this thesis is that it may open up 
a new approach to therapy for a group of diseases that have so far been incurable, ie. 
epithelial fragility disorders caused by keratin mutations, such as epidermolysis 
bullosa simplex. Several gene correction strategies have been suggested for inherited 
skin disorders. To overcome the dominant negative effects of keratin mutations, 
translation of mutated keratins can be inhibited by siRNA (Hickerson et al., 2006; 
Leachman et al., 2008) or the mRNA exon segments encoding the mutant keratin can 
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be replaced using spliceosome-mediated RNA trans-splicing (SMaRT) (Wally et al., 
2010). Another approach is to induce the expression of another gene with similar 
function, but which is not susceptible to the disruptive effect of the mutant gene. For 
instance, desmin, an intermediate filament protein normally expressed in muscle cells, 
can be used to reinforce the fragile keratin network in EBS-DM cells (Magin et al., 
2000; D'Alessandro et al., 2004). Functional redundancy of the keratin protein family 
can also be exploited to improve EBS-DM conditions. For example, sulphoraphane, a 
component of broccoli, can upregulate K16 and K17 to compensate for the loss of 
K14 protein in K14 knockout mouse and reduce blister formation (Kerns et al., 2007). 
Despite many efforts, gene therapy has only entered the phase 1b of clinical trial in 
pachonychia congenita (Leachman et al., 2010).  
The findings in this thesis further suggest another strategy to deal with the EBS-DM 
condition by targeting the EGF/SAPK signalling pathways, which contribute to the 
constitutive activation of EBS-DM keratinocytes. This therapeutic strategy could be 
designed to target any keratin mutation that results in sustained stress activation 
irrespective of their type of mutation. The identification of phospho-K14 Y129 could 
be a useful biomarker of keratinocyte activation and could be used for treatment 
efficacy. The next stages in this research will involve the use of these EBS-DM cell 
lines in larger scale to test and screen for compounds that can reduce their stress 
activation state, in a bid to alleviate EBS patient conditions and improve the patient‟s 
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